General Information of Disease (ID: DISVP4LU)

Disease Name Adult glioblastoma
Synonyms glioblastoma; adult glioblastoma; grade IV adult astrocytic tumor; adult glioblastoma multiforme; grade IV adult astrocytic tumour; grade IV adult astrocytic neoplasm
Disease Hierarchy
DIST55AV: Adult infiltrating astrocytic neoplasm
DISI0V5E: Glioblastoma
DISVP4LU: Adult glioblastoma
Disease Identifiers
MONDO ID
MONDO_0020690
UMLS CUI
C0278878
MedGen ID
124527

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Aminolevulinic acid hci DMS4BLQ Approved Small molecular drug [1]
Bevacizumab DMSD1UN Approved Monoclonal antibody [2]
Irinotecan DMP6SC2 Approved Small molecular drug [3]
Vorinostat DMWMPD4 Approved Small molecular drug [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 661 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCC3 TTVLG21 Limited Biomarker [5]
ACACB TTY84UG Limited Altered Expression [6]
ADAMTS5 TTXSU2Y Limited Altered Expression [7]
ANO1 TTOJI4S Limited Biomarker [8]
ATP2A2 TTE6THL Limited Altered Expression [9]
BCAT1 TTES57P Limited Biomarker [10]
BCAT2 TTF9OQ6 Limited Biomarker [11]
BCL2A1 TTGT9C7 Limited Altered Expression [6]
CA12 TTSYM0R Limited Biomarker [12]
CALCRL TTY6O0Q Limited Altered Expression [13]
CAPN1 TT1WBIJ Limited Biomarker [14]
CASP9 TTB6T7O Limited Altered Expression [15]
CCL5 TT9DWLC Limited Biomarker [16]
CCR5 TTJIH8Q Limited Altered Expression [16]
CD160 TTOFEAS Limited Altered Expression [17]
CD276 TT6CQUM Limited Biomarker [18]
CD33 TTJVYO3 Limited Biomarker [19]
CD69 TTPQE9F Limited Altered Expression [20]
CDC42BPA TT5Z0EF Limited Biomarker [21]
CDC7 TTSMTDI Limited Altered Expression [22]
CDK18 TTUMFAR Limited Altered Expression [23]
CHEK1 TTTU902 Limited Biomarker [24]
CMA1 TT8VUE0 Limited Altered Expression [25]
CREB1 TTH4AN3 Limited Altered Expression [26]
CRYAB TT7RUHB Limited Biomarker [27]
CSNK1E TTA8PLI Limited Biomarker [28]
CXCL11 TTWG0RE Limited Biomarker [29]
DGKA TTGL8F0 Limited Biomarker [30]
DUSP1 TTG8HIM Limited Biomarker [31]
EIF2AK1 TTRUJBV Limited Biomarker [32]
EPHA3 TTHS2LR Limited Altered Expression [33]
FABP4 TTHWMFZ Limited Biomarker [34]
FADS2 TTT2VDU Limited Biomarker [35]
FGL2 TTYBS89 Limited Biomarker [36]
FOLH1 TT9G4N0 Limited Biomarker [37]
GCH1 TTLSWP6 Limited Biomarker [38]
GDF2 TTAP4T1 Limited Biomarker [39]
GPRC6A TTI1PRE Limited Biomarker [40]
GRIA1 TTVPQTF Limited Biomarker [41]
GSN TTUH7OM Limited Altered Expression [42]
HBEGF TT15SL0 Limited Biomarker [43]
HMGA1 TTBA219 Limited Altered Expression [44]
HOXA11 TTEX4ZA Limited Biomarker [45]
IDUA TT0IUKX Limited Altered Expression [46]
ITGA4 TTJMF9P Limited Genetic Variation [47]
ITGAE TTH0Z37 Limited Biomarker [48]
KLF4 TTTI53X Limited Altered Expression [49]
LASP1 TTZJA87 Limited Biomarker [50]
LGR5 TTTSGRH Limited Biomarker [51]
LPAR3 TTE2YJR Limited Biomarker [40]
MAD1L1 TTNE9U7 Limited Genetic Variation [52]
MAP2K7 TT6QY3J Limited Biomarker [53]
MERTK TTO7LKR Limited Biomarker [54]
MKNK2 TTRECN3 Limited Biomarker [55]
MRC1 TTKV8W5 Limited Genetic Variation [56]
MRGPRX1 TTIX6PK Limited Biomarker [40]
MSI2 TTTXQF6 Limited Biomarker [29]
MSMB TTYH1ZK Limited Posttranslational Modification [57]
MST1R TTBQ3OC Limited Biomarker [58]
MYH2 TTBIL13 Limited Biomarker [59]
NCL TTK1V5Q Limited Biomarker [60]
NOTCH2 TT82FVD Limited Biomarker [61]
OXER1 TT7WBSV Limited Biomarker [40]
OXTR TTSCIUP Limited Biomarker [62]
PAM TTF4ZPC Limited Altered Expression [13]
PARG TT39J16 Limited Genetic Variation [63]
PARP3 TTD8MEH Limited Biomarker [64]
PDCD1LG2 TTW14O3 Limited Altered Expression [20]
PFKFB3 TTTHMQJ Limited Biomarker [65]
PGR TTUV8G9 Limited Altered Expression [66]
PKD2L1 TTAHD89 Limited Biomarker [67]
PLG TTP86E2 Limited Altered Expression [68]
PLOD2 TT8MEUD Limited Altered Expression [69]
PPID TTNAFOU Limited Biomarker [70]
PPIF TTRFQTB Limited Biomarker [70]
PRKCI TTWJTHX Limited Biomarker [71]
PTK2 TTON5IT Limited Posttranslational Modification [72]
RAC3 TT9BQ50 Limited Biomarker [73]
RECK TTRZBW7 Limited Altered Expression [74]
SEMA3A TTVKD3S Limited Biomarker [75]
SERPINH1 TTPSWQG Limited Biomarker [76]
SIRT2 TTLKF5M Limited Biomarker [77]
SLC12A3 TTP362L Limited Biomarker [78]
SLC22A3 TTG2UMS Limited Biomarker [79]
SLC6A8 TTYUHB5 Limited Biomarker [80]
SLC7A5 TTPH2JB Limited Biomarker [81]
SOCS3 TTI0ME6 Limited Biomarker [82]
SPHK2 TTCN0M9 Limited Biomarker [83]
SPRY1 TT0PSN6 Limited Biomarker [84]
SRC TT6PKBN Limited Biomarker [85]
SREBF1 TTER0UB Limited Biomarker [86]
SRPK1 TTU3WV6 Limited Biomarker [87]
STAT6 TTWOE1T Limited Biomarker [88]
STC2 TT4EFTR Limited Altered Expression [89]
TACR1 TTZPO1L Limited Altered Expression [17]
TENT4B TTB5R6M Limited Biomarker [90]
TF TT8WXAV Limited Biomarker [91]
TOP1 TTGTQHC Limited Biomarker [92]
TOP2A TTCGY2K Limited Biomarker [93]
TRPM8 TTXDKTO Limited Biomarker [94]
TRPV2 TTBECWA Limited Biomarker [95]
TTK TTP7EGM Limited Altered Expression [46]
USP13 TTVJIO2 Limited Biomarker [96]
USP5 TTGYTMA Limited Biomarker [97]
VTCN1 TTCK85E Limited Altered Expression [98]
XIAP TTK3WBU Limited Altered Expression [99]
XPO1 TTCJUR4 Limited Biomarker [100]
ADRA1A TTNGILX Disputed Genetic Variation [101]
ADRA2B TTWM4TY Disputed Genetic Variation [101]
ANGPT2 TTKLQTJ Disputed Biomarker [102]
BBC3 TT7JUKC Disputed Biomarker [103]
BRS3 TTKYEPM Disputed Genetic Variation [101]
CASP7 TTM7Y45 Disputed Biomarker [104]
CDK4 TT0PG8F Disputed Biomarker [105]
CLIC1 TT8KZG6 Disputed Altered Expression [106]
CXCR6 TT2BVUA Disputed Genetic Variation [101]
EBP TT4VQZX Disputed Biomarker [107]
EZR TTE47YC Disputed Altered Expression [108]
FGF2 TTGKIED Disputed Biomarker [109]
G6PC TTBQMJ8 Disputed Biomarker [110]
GAL TTXZAJ5 Disputed Altered Expression [111]
HOXB13 TTZ6I58 Disputed Altered Expression [112]
HSF1 TTN6STZ Disputed Altered Expression [113]
HSPB3 TTLH8WG Disputed Biomarker [114]
ITGAV TTT1R2L Disputed Biomarker [115]
KLRK1 TTLRN4A Disputed Biomarker [116]
L1CAM TTC9D3K Disputed Altered Expression [117]
LGALS1 TTO3NYT Disputed Biomarker [118]
LPAR2 TTB7Y8I Disputed Genetic Variation [101]
MAOB TTGP7BY Disputed Biomarker [119]
MIF TT6804T Disputed Biomarker [120]
NES TTHZ752 Disputed Altered Expression [121]
PROM1 TTXMZ81 Disputed Altered Expression [122]
PTPRZ1 TT4SEA8 Disputed Biomarker [123]
RRM2 TT1S4LJ Disputed Biomarker [93]
SLC15A3 TTAYPWS Disputed Biomarker [124]
SLC16A1 TTN1J82 Disputed Altered Expression [25]
SLC16A3 TTG6VD5 Disputed Biomarker [25]
SLC22A8 TTTQR47 Disputed Biomarker [125]
SLC37A4 TT1KPBZ Disputed Biomarker [110]
SOX2 TTCNOT6 Disputed Biomarker [126]
SSTR4 TTAE1BR Disputed Genetic Variation [101]
TACC3 TTQ4UFD Disputed Biomarker [127]
TNC TTUCPMY Disputed Biomarker [128]
TP53BP1 TTX4UE9 Disputed Biomarker [129]
ABCG2 TTIMJ02 moderate Biomarker [130]
AHSG TTKF4WV moderate Biomarker [131]
ANGPTL3 TT59GO7 moderate Altered Expression [132]
APEX1 TTHGL48 moderate Biomarker [133]
ARF1 TT70KXY moderate Posttranslational Modification [134]
ARG2 TTV1AG6 moderate Altered Expression [135]
AURKA TTPS3C0 moderate Biomarker [136]
BACH1 TT2ME4S moderate Altered Expression [137]
BMI1 TTIPNSR moderate Biomarker [138]
BMP1 TT0L58T moderate Altered Expression [139]
BSG TT5UJWD moderate Biomarker [140]
CAD TT2YT1K moderate Biomarker [141]
CALR TTUZ7OA moderate Biomarker [80]
CCN2 TTIL516 moderate Biomarker [142]
CD22 TTM6QSK moderate Biomarker [143]
CD34 TTZAVYN moderate Biomarker [144]
CD58 TT5KSBY moderate Biomarker [145]
CDK6 TTO0FDJ moderate Biomarker [146]
CEBPB TTUI35N moderate Altered Expression [147]
CLDN4 TTMTS9H moderate Biomarker [148]
CSNK2A2 TT7GR5W moderate Biomarker [149]
CSPG4 TT7MYXI moderate Biomarker [150]
CTH TTLQUZS moderate Biomarker [151]
CTSB TTF2LRI moderate Biomarker [152]
CTSG TTQAJF1 moderate Altered Expression [153]
CTSK TTDZN01 moderate Altered Expression [154]
DEK TT1NMGV moderate Biomarker [155]
DIABLO TTN74LE moderate Biomarker [99]
E2F2 TT5FYX0 moderate Biomarker [156]
F11R TT3C8EG moderate Altered Expression [157]
FABP5 TTNT2S6 moderate Biomarker [158]
GAPDH TTUGSWA moderate Altered Expression [159]
GPR55 TTNET8J moderate Biomarker [160]
HDAC7 TTMUEK1 moderate Altered Expression [161]
HSPA8 TTMQL3K moderate Posttranslational Modification [162]
IGFBP3 TTZHNQA moderate Biomarker [163]
IRF3 TTYR7OH moderate Biomarker [164]
KYNU TTWQM3J moderate Biomarker [165]
LIN28A TTO50LN moderate Biomarker [166]
LNPEP TTY2KP7 moderate Biomarker [167]
LRP6 TTSXOWE moderate Altered Expression [168]
LSS TT7O8ZA moderate Biomarker [169]
MAP3K11 TTETX6Q moderate Biomarker [170]
MTDH TTH6SA5 moderate Biomarker [171]
NCAM1 TTVXPHT moderate Genetic Variation [145]
NECTIN4 TTPO9EG moderate Altered Expression [172]
NEK2 TT3VZ24 moderate Biomarker [173]
NOX4 TTQRBSJ moderate Altered Expression [174]
OPRL1 TTNT7K8 moderate Altered Expression [175]
OSM TTIVXSE moderate Biomarker [176]
PKMYT1 TTB4PAZ moderate Biomarker [177]
PRKCE TT57MT2 moderate Biomarker [145]
PRMT5 TTR1D7X moderate Biomarker [178]
RALBP1 TTVSRUA moderate Biomarker [179]
RARG TT1Q3IE moderate Biomarker [180]
RIPK1 TTVJHX8 moderate Biomarker [179]
ROCK1 TTZN7RP moderate Biomarker [181]
ROR2 TTUDPCI moderate Altered Expression [168]
SETD2 TTPC3H4 moderate Biomarker [182]
SOX5 TTXHSZK moderate Biomarker [146]
SQSTM1 TTOT2RY moderate Biomarker [183]
STS TTHM0R1 moderate Biomarker [184]
TAAR1 TTIU98M moderate Biomarker [185]
TNFRSF10B TTW20TU moderate Biomarker [186]
TNFSF4 TTBW580 moderate Altered Expression [187]
VANGL1 TT18WJB moderate Biomarker [188]
VEGFB TTPJQHE moderate Biomarker [189]
WNK1 TTJ9UMX moderate Biomarker [190]
YAP1 TT8UN2D moderate Biomarker [191]
ABCA1 TTJW1GN Strong Biomarker [192]
ABCC1 TTOI92F Strong Biomarker [193]
ACAT1 TTK3C21 Strong Biomarker [194]
ACKR3 TTRQJTC Strong Genetic Variation [101]
ADAM10 TTVXEGU Strong Altered Expression [195]
ADAM17 TT6AZXG Strong Biomarker [196]
ADAMTS4 TTYG6BU Strong Altered Expression [7]
ADCYAP1 TTW4LYC Strong Altered Expression [197]
ADCYAP1R1 TT5OREU Strong Altered Expression [198]
ADM TTV14YH Strong Posttranslational Modification [199]
AGRP TT4DE1O Strong Altered Expression [200]
AGXT TTF5NVW Strong Biomarker [201]
AIF1 TT12MEP Strong Altered Expression [202]
AKT2 TTH24WI Strong Biomarker [203]
AKT3 TTO6SGY Strong Biomarker [204]
ALKBH5 TTOHB1M Strong Biomarker [205]
ANG TTURHFP Strong Altered Expression [206]
ANGPT1 TTWNQ1T Strong Biomarker [207]
ANGPTL4 TTWALY5 Strong Biomarker [208]
ANXA2 TT4YANI Strong Biomarker [209]
ANXA5 TT2Z83I Strong Biomarker [136]
APLN TT87D3J Strong Biomarker [210]
APLNR TTJ8E43 Strong Biomarker [210]
AQP9 TTQEI32 Strong Altered Expression [211]
ARRB1 TTMVD4A Strong Altered Expression [212]
ASIC1 TTRJYB6 Strong Biomarker [213]
ASIC3 TTLGDIS Strong Genetic Variation [214]
ATG7 TTLVB9Z Strong Altered Expression [215]
ATR TT8ZYBQ Strong Biomarker [23]
AURKB TT9RTBL Strong Biomarker [216]
AXL TTZPY6J Strong Biomarker [217]
BAK1 TTFM7V0 Strong Biomarker [218]
BCL2L2 TTQ79W8 Strong Biomarker [219]
BCL6 TTC9YX5 Strong Altered Expression [220]
BIRC3 TTAIWZN Strong Biomarker [221]
BMP7 TTKOBRA Strong Biomarker [222]
BMX TTN2I9E Strong Biomarker [223]
BRD2 TTDP48B Strong Biomarker [224]
BTG1 TTL7N2W Strong Biomarker [225]
BTK TTGM6VW Strong Altered Expression [226]
BUB1 TT78309 Strong Biomarker [227]
CA9 TT2LVK8 Strong Biomarker [228]
CALCR TTLWS2O Strong Biomarker [80]
CASP2 TT12VNG Strong Altered Expression [229]
CASR TTBUYHA Strong Biomarker [230]
CAV1 TTXUBN2 Strong Altered Expression [231]
CBL TT7QT13 Strong Genetic Variation [232]
CBX7 TTBN3HC Strong Biomarker [233]
CCK TT90CMU Strong Biomarker [234]
CCL11 TTCF05Y Strong Biomarker [235]
CCN1 TTPK79J Strong Altered Expression [236]
CCNA2 TTAMQ62 Strong Altered Expression [237]
CCNB1 TT9P6OW Strong Biomarker [238]
CCND3 TT1JXNR Strong Biomarker [239]
CCNE1 TTCEJ4F Strong Biomarker [240]
CCR1 TTC24WT Strong Biomarker [241]
CD163 TTTZ9DE Strong Biomarker [19]
CD200 TT0BE68 Strong Biomarker [242]
CD274 TT8ZLTI Strong Biomarker [243]
CD44 TTWFBT7 Strong Biomarker [244]
CD47 TT28S46 Strong Biomarker [245]
CD70 TTNCIE0 Strong Altered Expression [246]
CD9 TTZEIBV Strong Altered Expression [247]
CDC20 TTBKFDV Strong Biomarker [248]
CDC25A TTLZS4Q Strong Biomarker [249]
CDH11 TTRGWZC Strong Biomarker [250]
CDH2 TT1WS0T Strong Altered Expression [251]
CDH5 TTXLCFO Strong Altered Expression [252]
CDK1 TTH6V3D Strong Biomarker [253]
CDK3 TTMYWL7 Strong Altered Expression [254]
CDK7 TTQYF7G Strong Biomarker [255]
CDK9 TT1LVF2 Strong Altered Expression [255]
CDKN1A TT9GUW0 Strong Altered Expression [256]
CEACAM3 TTPX7I5 Strong Biomarker [257]
CFLAR TTJZQYH Strong Biomarker [258]
CHST15 TTFK7E1 Strong Biomarker [259]
CLCN3 TT8XNZ7 Strong Altered Expression [260]
CNP TT71P0H Strong Altered Expression [261]
CNTF TTGEM5Q Strong Biomarker [262]
COL18A1 TT63DI9 Strong Biomarker [263]
CRTC2 TTFWETR Strong Biomarker [264]
CRYZ TTP6UO8 Strong Biomarker [265]
CSE1L TTTRULD Strong Biomarker [266]
CSF1R TT7MRDV Strong Biomarker [267]
CSNK2A1 TTER6YH Strong Genetic Variation [268]
CTAG1A TTE5ITK Strong Biomarker [269]
CTSL TT36ETB Strong Altered Expression [270]
CTSS TTUMQVO Strong Biomarker [271]
CXCR4 TTBID49 Strong Biomarker [272]
CYP46A1 TT4EB85 Strong Biomarker [273]
DBH TTYIP79 Strong Biomarker [274]
DCN TTB3XAN Strong Altered Expression [275]
DDR1 TTI1FPZ Strong Biomarker [276]
DDX58 TTVB0O3 Strong Biomarker [277]
DHCR24 TTTK0NH Strong Biomarker [278]
DHPS TTBO2A9 Strong Altered Expression [279]
DICER1 TTTEOPU Strong Biomarker [280]
DKK3 TTY2ZV6 Strong Biomarker [168]
DLL4 TTV23LH Strong Altered Expression [281]
DNM2 TTVRA5G Strong Biomarker [282]
DPYSL2 TTZCW3T Strong Biomarker [283]
DRD5 TTS2PH3 Strong Altered Expression [284]
DYRK1A TTSBVFO Strong Altered Expression [285]
E2F1 TTASI04 Strong Biomarker [286]
E2F3 TTWIJYH Strong Altered Expression [287]
EBI3 TTJF68X Strong Altered Expression [288]
ECE1 TTQ9RYT Strong Biomarker [289]
EDNRA TTKRD0G Strong Genetic Variation [101]
EEF2K TT1QFLA Strong Biomarker [290]
EGLN1 TT9ISBX Strong Biomarker [291]
EIF2AK2 TTXEZJ4 Strong Altered Expression [292]
EIF2AK4 TT9U4EP Strong Altered Expression [293]
EIF4E2 TT2ZSKV Strong Biomarker [294]
EIF4EBP1 TTKGEBL Strong Biomarker [295]
EIF5A TTIVCNR Strong Biomarker [296]
EIF5A2 TTH53G9 Strong Altered Expression [279]
ENG TTB30LE Strong Biomarker [297]
ENPEP TT9PBIL Strong Biomarker [298]
ENPP1 TTZTIWS Strong Biomarker [299]
ENTPD1 TTYM8DJ Strong Altered Expression [300]
EPHA1 TTLFZVU Strong Biomarker [301]
EPHA2 TTRJB2G Strong Biomarker [302]
EPHA4 TTG84D3 Strong Biomarker [303]
EPHB2 TTKPV6O Strong Altered Expression [304]
ERAP1 TT60XFL Strong Altered Expression [305]
ERBB4 TTWALCO Strong Genetic Variation [306]
EREG TTYSB89 Strong Biomarker [307]
ERN1 TTKIAT3 Strong Biomarker [308]
ESRRB TTKF0XS Strong Altered Expression [253]
ETS2 TT9AH0M Strong Biomarker [309]
EZH2 TT9MZCQ Strong Biomarker [276]
F10 TTCIHJA Strong Altered Expression [310]
F3 TT38MDJ Strong Biomarker [311]
FAP TTGPQ0F Strong Altered Expression [312]
FASLG TTO7014 Strong Biomarker [313]
FAT1 TTGUJYV Strong Altered Expression [314]
FCGR2B TT5RWKQ Strong Posttranslational Modification [315]
FDPS TTIKWV4 Strong Altered Expression [316]
FDXR TT3W4IX Strong Biomarker [317]
FECH TTQ6VF4 Strong Biomarker [318]
FHL1 TTI7ENL Strong Altered Expression [319]
FKBP4 TTHY0FT Strong Biomarker [320]
FKBP5 TT0J5KQ Strong Biomarker [320]
FLT1 TT1VAUK Strong Biomarker [321]
FOSL1 TTY8LZG Strong Altered Expression [322]
FOXC2 TTLBAP1 Strong Altered Expression [323]
FOXM1 TTD3KOX Strong Biomarker [227]
FOXO1 TTLRVIA Strong Biomarker [324]
FPR1 TT5Y4EM Strong Biomarker [325]
FSCN1 TTTRS9B Strong Biomarker [326]
FST TTDNM9W Strong Biomarker [327]
FTO TTFW3BT Strong Biomarker [328]
FUS TTKGYZ9 Strong Biomarker [329]
FUT4 TTNV1KZ Strong Altered Expression [330]
FZD10 TTP1S2F Strong Altered Expression [331]
FZD7 TTUQMO5 Strong Biomarker [332]
G3BP1 TTG0R8Z Strong Biomarker [333]
GABRA1 TT1MPAY Strong Altered Expression [334]
GCLM TTNFESW Strong Altered Expression [335]
GDF15 TT4MXVG Strong Biomarker [336]
GDNF TTF23ML Strong Biomarker [337]
GJA3 TTFZRG0 Strong Altered Expression [338]
GJB6 TTAU8SJ Strong Biomarker [339]
GLB1 TTNGJPH Strong Altered Expression [340]
GLI1 TTJOMH6 Strong Altered Expression [341]
GLUL TTURQ2G Strong Altered Expression [342]
GNRH1 TT0ID4A Strong Altered Expression [343]
GNRHR TT8R70G Strong Altered Expression [344]
GPD1 TTKTEAH Strong Biomarker [345]
GPI TT19JIZ Strong Altered Expression [346]
GRIA2 TTWM461 Strong Altered Expression [347]
GRIA4 TTPJR0G Strong Biomarker [348]
GRK5 TTTCXO0 Strong Biomarker [349]
GRM2 TTXJ47W Strong Biomarker [348]
GRPR TTC1MVT Strong Biomarker [350]
GSR TTEP6RV Strong Biomarker [351]
HAX1 TT21BYA Strong Biomarker [352]
HDAC1 TT6R7JZ Strong Biomarker [353]
HDAC4 TTTQGH8 Strong Biomarker [354]
HDAC5 TTUELN5 Strong Posttranslational Modification [355]
HDAC6 TT5ZKDI Strong Biomarker [53]
HDAC9 TT8M4E1 Strong Biomarker [356]
HGFAC TTD96RW Strong Biomarker [357]
HHAT TT1VNCG Strong Biomarker [358]
HIPK2 TTOB49C Strong Biomarker [359]
HK2 TTK02H8 Strong Altered Expression [360]
HLA-G TTLKFB3 Strong Biomarker [361]
HMGA2 TTSTVM0 Strong Biomarker [362]
HMGB2 TTA78JQ Strong Altered Expression [363]
HMOX2 TTWZRL4 Strong Altered Expression [364]
HNRNPA2B1 TT8UPW6 Strong Biomarker [58]
HOXA13 TTN26OM Strong Biomarker [365]
HSP90AA1 TT78R5H Strong Genetic Variation [366]
HSPA5 TTW26OG Strong Altered Expression [367]
HSPB8 TTY0OJN Strong Biomarker [368]
HTR7 TTO9X1H Strong Biomarker [369]
ID1 TTBXVDE Strong Biomarker [370]
ID2 TTW8A5N Strong Biomarker [371]
IDO1 TTZJYKH Strong Altered Expression [372]
IFNB1 TT4TZ8J Strong Biomarker [373]
IGFBP2 TTU4QSN Strong Biomarker [374]
IGFBP6 TTLAYV8 Strong Biomarker [375]
IGFBP7 TTUQ01B Strong Altered Expression [341]
IKBKB TTJ3E9X Strong Altered Expression [376]
IL13RA2 TTMPZ7V Strong Biomarker [377]
IL16 TTW4R0B Strong Biomarker [378]
IL20 TTNZMY2 Strong Altered Expression [379]
IL31RA TT9HPX0 Strong Biomarker [380]
IL4R TTDWHC3 Strong Genetic Variation [381]
ILK TT7ALZG Strong Biomarker [382]
IMPDH2 TTTB4UP Strong Altered Expression [383]
IRS1 TTAJSQ0 Strong Biomarker [384]
IRS2 TTF95B8 Strong Altered Expression [385]
ITGA2 TTSJ542 Strong Biomarker [386]
ITGA5 TTHIZP9 Strong Biomarker [115]
JAG2 TTOJY1B Strong Altered Expression [387]
KAT2B TTVK7SB Strong Biomarker [388]
KCNH1 TT9XKUC Strong Altered Expression [389]
KCNH2 TTQ6VDM Strong Biomarker [390]
KCNJ3 TTGM19J Strong Biomarker [391]
KDM1A TTNR0UQ Strong Altered Expression [392]
KDM5A TTIG67W Strong Altered Expression [393]
KDM6B TTDIJUQ Strong Biomarker [394]
KDR TTUTJGQ Strong Biomarker [210]
KHDRBS1 TTAT6C7 Strong Altered Expression [395]
KIF11 TTBGTCW Strong Biomarker [396]
KIR2DS2 TTV3CFI Strong Biomarker [397]
KPNB1 TTHOJ5F Strong Biomarker [258]
LAG3 TTNVXAW Strong Biomarker [398]
LAPTM4B TTEJQT0 Strong Biomarker [399]
LDLR TTH0DUS Strong Biomarker [400]
LGMN TTPTWV5 Strong Biomarker [401]
LIF TTGZ5WN Strong Biomarker [402]
LILRB1 TTC0QRJ Strong Biomarker [403]
LIMK1 TTWL9TY Strong Biomarker [404]
MAGEA1 TT63M7Q Strong Altered Expression [405]
MALT1 TTCI81G Strong Biomarker [406]
MAP3K1 TTW8TJI Strong Biomarker [407]
MAPK11 TT73U6C Strong Biomarker [408]
MAPK3 TT1MG9E Strong Altered Expression [304]
MAPK8 TT0K6EO Strong Altered Expression [409]
MAPKAP1 TTWDKCL Strong Genetic Variation [410]
MARCKS TTHRM39 Strong Biomarker [411]
MAZ TT059DA Strong Biomarker [412]
MBP TT2RY5P Strong Altered Expression [413]
MC4R TTD0CIQ Strong Genetic Variation [414]
MCOLN1 TT9XBVO Strong Biomarker [415]
MDK TTV8UE7 Strong Biomarker [259]
MDM4 TT9OUDQ Strong Biomarker [193]
MELK TTBZOTY Strong Altered Expression [416]
METAP2 TTZL0OI Strong Biomarker [417]
MGAT1 TTYJRN5 Strong Altered Expression [418]
MIA TT5HNVS Strong Biomarker [419]
MKI67 TTB4UNG Strong Biomarker [420]
MLH1 TTISG27 Strong Altered Expression [421]
MMP14 TTJ4QE7 Strong Biomarker [422]
MMP15 TTNSTO3 Strong Biomarker [423]
MMP16 TTNP4CU Strong Altered Expression [424]
MPL TTIHYA4 Strong Biomarker [425]
MSI1 TTSM4BA Strong Biomarker [426]
MSLN TT4RXME Strong Biomarker [427]
MTAP TTDBX7N Strong Altered Expression [178]
MYCN TT9JBY5 Strong Biomarker [428]
NAMPT TTD1WIG Strong Altered Expression [429]
NCR1 TTQNRJM Strong Altered Expression [430]
NDUFA13 TTRU1NG Strong Biomarker [431]
NEDD8 TTNDC4K Strong Altered Expression [432]
NEDD9 TT1UREA Strong Biomarker [433]
NEK8 TT8AH9I Strong Biomarker [434]
NEK9 TTM57AW Strong Biomarker [435]
NELL1 TT7H4BF Strong Biomarker [436]
NFKBIA TTSHAEB Strong Genetic Variation [437]
NPM1 TTHBS98 Strong Biomarker [438]
NR1I2 TT7LCTF Strong Biomarker [439]
NR1I3 TTRANFM Strong Biomarker [230]
NRP1 TTIPJCB Strong Biomarker [436]
NRP2 TTRXUVC Strong Altered Expression [440]
NTSR1 TTTUMEP Strong Biomarker [441]
NUAK2 TTHVOTQ Strong Altered Expression [442]
ORAI1 TTE76YK Strong Altered Expression [443]
OSMR TTAH0KM Strong Altered Expression [444]
PABPC1 TTHC8EF Strong Altered Expression [445]
PAK1 TTFN95D Strong Biomarker [446]
PAK4 TT7Y3BZ Strong Altered Expression [447]
PARP1 TTVDSZ0 Strong Biomarker [448]
PBK TTMY6BZ Strong Biomarker [449]
PCSK6 TT75LN9 Strong Altered Expression [450]
PDCD1 TTNBFWK Strong Altered Expression [451]
PDE1C TTW2HRK Strong Altered Expression [452]
PDE4D TTSKMI8 Strong Genetic Variation [453]
PDGFRB TTI7421 Strong Biomarker [454]
PDK1 TTCZOF2 Strong Altered Expression [455]
PDK3 TTDEQIP Strong Altered Expression [456]
PDXP TT9UYG4 Strong Biomarker [181]
PECAM1 TT4EZB2 Strong Altered Expression [457]
PFKFB2 TTQYVKD Strong Biomarker [458]
PIM1 TTTN5QW Strong Biomarker [459]
PIN1 TTJNTSI Strong Biomarker [460]
PKM TT4LOT8 Strong Biomarker [461]
PLAUR TTNOSTX Strong Biomarker [462]
PLCB1 TTLPGU7 Strong Altered Expression [463]
PLD2 TTRLMKF Strong Biomarker [464]
PLK1 TTH4IP0 Strong Biomarker [465]
PLK4 TTGPNZQ Strong Posttranslational Modification [466]
PLP2 TTK5OG6 Strong Altered Expression [467]
PLXDC1 TTPSK7A Strong Altered Expression [468]
PML TTLH9NY Strong Biomarker [469]
PNP TTMCF1Y Strong Altered Expression [470]
PPARA TTJ584C Strong Altered Expression [471]
PPP1CA TTFLH0E Strong Biomarker [472]
PRKCA TTFJ8Q1 Strong Biomarker [473]
PRKDC TTK3PY9 Strong Biomarker [474]
PRMT1 TTVOJAI Strong Biomarker [475]
PRNP TTY5F9C Strong Biomarker [476]
PTBP1 TTWMX0U Strong Biomarker [477]
PTGS1 TT8NGED Strong Altered Expression [478]
PTK2B TTTEFBV Strong Altered Expression [479]
PTN TTA9EJK Strong Biomarker [480]
PTP4A3 TT7YM8D Strong Altered Expression [481]
PTPN14 TTNIR6C Strong Biomarker [482]
RAC1 TT2M9CG Strong Biomarker [483]
RACK1 TTJ10AL Strong Biomarker [484]
RAD51 TTC0G1L Strong Altered Expression [485]
RBPJ TT72D4Z Strong Biomarker [486]
REG3A TTL4H8N Strong Biomarker [487]
RIPK2 TTCQ2E5 Strong Altered Expression [488]
RNMT TTG45HY Strong Altered Expression [489]
ROBO1 TTND1YP Strong Altered Expression [326]
ROS1 TTSZ6Y3 Strong Biomarker [490]
RPS6KA3 TTUM2ZR Strong Altered Expression [491]
S1PR1 TT9JZCK Strong Altered Expression [492]
SAA1 TTY0DN9 Strong Biomarker [115]
SATB1 TTLFRIC Strong Biomarker [493]
SCAP TTL6U2P Strong Biomarker [494]
SELP TTE5VG0 Strong Altered Expression [495]
SERPING1 TTVQ6R9 Strong Altered Expression [496]
SFRP4 TTX8I1Y Strong Biomarker [497]
SGK1 TTTV8EJ Strong Biomarker [190]
SIRT3 TTVZLIJ Strong Biomarker [498]
SIRT5 TTH0IOD Strong Altered Expression [499]
SKP2 TT5B2EO Strong Biomarker [500]
SLC12A4 TTJ8C67 Strong Altered Expression [501]
SLC1A1 TTG2A6F Strong Altered Expression [502]
SLC1A3 TT8WRDA Strong Biomarker [503]
SLC1A5 TTF7WRM Strong Biomarker [184]
SLC38A1 TT1YE9Z Strong Biomarker [184]
SLC38A3 TTMAVJQ Strong Biomarker [184]
SLC38A5 TTC8YPT Strong Biomarker [184]
SLC5A2 TTF8JAT Strong Altered Expression [504]
SLC7A11 TTBZMIO Strong Altered Expression [505]
SLC9A1 TTGSEFH Strong Altered Expression [506]
SLIT2 TTDWK85 Strong Biomarker [326]
SMAD1 TT9GR53 Strong Altered Expression [507]
SMN1 TT8QL6X Strong Biomarker [508]
SOCS1 TT8COJM Strong Biomarker [82]
SORT1 TTRX9AV Strong Biomarker [509]
SRGN TTCHB06 Strong Biomarker [510]
ST8SIA4 TTDP8YM Strong Biomarker [511]
STC1 TTDLUER Strong Biomarker [512]
STK17A TTEYF03 Strong Biomarker [513]
TDGF1 TTN7HMG Strong Altered Expression [514]
TDO2 TTXNCBV Strong Altered Expression [515]
TENT4A TT0XZ4Q Strong Altered Expression [516]
TERF1 TT1Y6J2 Strong Biomarker [517]
TERF2 TT5XSLT Strong Biomarker [518]
TGFA TTTLQFR Strong Genetic Variation [519]
TGFB2 TTI0KH6 Strong Biomarker [520]
TGM2 TT2F4OL Strong Biomarker [521]
THBS1 TTKI0H1 Strong Biomarker [522]
TMSB4X TTMVAIU Strong Biomarker [523]
TNFAIP3 TT5W0IO Strong Biomarker [179]
TNFRSF11A TT3K9S2 Strong Posttranslational Modification [524]
TNFRSF12A TTKPS7V Strong Altered Expression [525]
TNFRSF13B TTL9OD4 Strong Genetic Variation [526]
TNFSF10 TTA5MS9 Strong Biomarker [527]
TNFSF12 TTBTDM1 Strong Altered Expression [528]
TNFSF13 TTOI1RM Strong Biomarker [529]
TRAF6 TTCDR6M Strong Altered Expression [530]
TREM2 TTQRMSJ Strong Altered Expression [531]
TRH TT2Z39D Strong Altered Expression [532]
TRIM24 TT9Q7AE Strong Altered Expression [533]
TRIM27 TTTO3QN Strong Biomarker [534]
TRIM28 TTQ2BKV Strong Biomarker [535]
TRPM2 TTEBMN7 Strong Altered Expression [536]
TRPM7 TTFPVZO Strong Biomarker [537]
TSPO TTPTXIN Strong Biomarker [538]
TUSC2 TTJ8O14 Strong Altered Expression [539]
TXN TTZJ5U9 Strong Biomarker [540]
UGCG TTPHEX3 Strong Biomarker [541]
ULK3 TTYENHQ Strong Biomarker [542]
USP1 TTG9MT5 Strong Biomarker [543]
USP7 TTXU3EQ Strong Altered Expression [544]
VDAC1 TTAMKGB Strong Altered Expression [545]
VEGFC TT0QUFV Strong Biomarker [546]
VEGFD TTOM5H4 Strong Biomarker [547]
VIPR1 TTCL30I Strong Biomarker [548]
WEE1 TTJFOAL Strong Altered Expression [549]
WNT5A TTKG7F8 Strong Biomarker [550]
ZNF217 TTY3BRA Strong Altered Expression [551]
ACTG1 TTGAZF9 Definitive Biomarker [552]
AGR2 TT9K86S Definitive Biomarker [553]
ALCAM TT2AFT6 Definitive Biomarker [554]
AREG TT76B3W Definitive Biomarker [555]
ATP7B TTOPO51 Definitive Altered Expression [556]
BACE1 TTJUNZF Definitive Altered Expression [557]
BDKRB1 TTG5QIA Definitive Biomarker [558]
CAPN2 TTG5QB7 Definitive Biomarker [559]
CCL3 TT8I4WB Definitive Biomarker [560]
CCR3 TTD3XFU Definitive Biomarker [561]
CD46 TTMS7DF Definitive Biomarker [562]
CDKL1 TTBTI6P Definitive Altered Expression [563]
CXCR1 TTMWT8Z Definitive Biomarker [564]
DGKZ TTSBBXL Definitive Altered Expression [565]
DIO1 TTU3X26 Definitive Genetic Variation [566]
EIF2AK3 TT79U1M Definitive Biomarker [567]
F2R TTL935N Definitive Biomarker [439]
FANCA TTV5HJS Definitive Genetic Variation [568]
FTH1 TT975ZT Definitive Altered Expression [569]
GLI2 TT045OH Definitive Altered Expression [570]
ITGA6 TT165T3 Definitive Biomarker [571]
ITGB8 TTIF29E Definitive Biomarker [572]
KLK6 TTLPF4X Definitive Biomarker [573]
LY96 TT8S9AV Definitive Biomarker [574]
MAP3K2 TTIX0ZU Definitive Biomarker [575]
MAP4K4 TT6NI13 Definitive Biomarker [576]
MAPK9 TT3IVG2 Definitive Biomarker [577]
MARK2 TTAJ45Y Definitive Biomarker [578]
MBTPS1 TTNSM2I Definitive Biomarker [579]
NCK1 TTMA3VF Definitive Biomarker [580]
NOP2 TTBLG3H Definitive Biomarker [581]
NT5E TTK0O6Y Definitive Altered Expression [582]
NTN1 TT0AH4L Definitive Biomarker [583]
PIM3 TTCGOIN Definitive Biomarker [584]
PRKCB TTYPXQF Definitive Biomarker [585]
PRKD1 TTSLUMT Definitive Biomarker [586]
RASA1 TTPNZ1F Definitive Biomarker [581]
ROCK2 TTGWKQJ Definitive Altered Expression [587]
SLC3A2 TT5CZSM Definitive Biomarker [588]
SLC52A2 TT6TKEN Definitive Biomarker [439]
TACSTD2 TTP2HE5 Definitive Biomarker [589]
TDP1 TT64IHJ Definitive Biomarker [590]
TEP1 TTQGAVX Definitive Altered Expression [591]
TNFSF14 TTKVENM Definitive Biomarker [592]
TNKS TTVUSO7 Definitive Altered Expression [591]
TRPA1 TTELV3W Definitive Altered Expression [593]
UBA3 TTXZEUS Definitive Altered Expression [432]
VCAM1 TTHCEF6 Definitive Altered Expression [594]
------------------------------------------------------------------------------------
⏷ Show the Full List of 661 DTT(s)
This Disease Is Related to 17 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC3A1 DTBCKVM Limited Biomarker [595]
SLC17A7 DTNK0FR moderate Biomarker [596]
SLC20A1 DTMULXV moderate Altered Expression [597]
SLC39A9 DTJH79E moderate Altered Expression [598]
ABCC5 DTYVM24 Strong Altered Expression [599]
ATP7A DT0LT17 Strong Biomarker [600]
SLC12A2 DTHKL3Q Strong Biomarker [501]
SLC25A37 DTLBGTZ Strong Biomarker [601]
SLC26A3 DTN1FMD Strong Altered Expression [602]
SLC27A3 DTEW95J Strong Biomarker [603]
SLC4A1 DTB0Q3P Strong Biomarker [604]
SLC7A13 DTMWE5P Strong Biomarker [201]
SLC7A7 DTE4HJ8 Strong Altered Expression [605]
SLC8A2 DTUASRF Strong Biomarker [606]
SLC9A9 DT8LP62 Strong Altered Expression [607]
SLC18A1 DTM953D Definitive Altered Expression [608]
SLC2A3 DT9SQ3L Definitive Biomarker [609]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 DTP(s)
This Disease Is Related to 23 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ACSS2 DEE76VW Limited Genetic Variation [610]
CYP27A1 DEBS639 Limited Altered Expression [611]
CYP27B1 DE3FYEM Limited Biomarker [612]
GGCT DEKW6PB Limited Biomarker [613]
NT5C2 DE1DOKJ Limited Biomarker [614]
PRODH DEVJIHS Limited Genetic Variation [615]
GLS DE3E0VT Disputed Biomarker [616]
APRT DE2MV1R moderate Biomarker [617]
NNMT DECVGJ3 moderate Biomarker [618]
PLPP1 DE6WXTH moderate Biomarker [619]
TGM5 DEW8QEH moderate Biomarker [620]
ACP3 DEDW5H6 Strong Biomarker [487]
AKR1B10 DEP6GT1 Strong Biomarker [621]
CYP4B1 DEMF740 Strong Biomarker [622]
FAAH DEUM1EX Strong Biomarker [623]
GCLC DESYL1F Strong Altered Expression [335]
HIF1AN DEY1CBW Strong Altered Expression [624]
HPGD DEHKSC6 Strong Altered Expression [625]
PSAT1 DEBS17P Strong Biomarker [626]
PTGDS DER3H9C Strong Biomarker [627]
SAT1 DEMWO83 Strong Altered Expression [628]
SULT1A1 DEYWLRK Strong Biomarker [511]
UPRT DE20ETR Strong Biomarker [629]
------------------------------------------------------------------------------------
⏷ Show the Full List of 23 DME(s)
This Disease Is Related to 1018 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACTC1 OTJU04B1 Limited Biomarker [630]
ADAM12 OTZKOTDB Limited Biomarker [631]
ADAM19 OTH88TXU Limited Biomarker [632]
ADARB1 OTGKSZEV Limited Altered Expression [633]
AFDN OTTRU341 Limited Biomarker [634]
AHNAK OT6KH1WG Limited Biomarker [635]
AJAP1 OTAAW121 Limited Altered Expression [636]
AKT1S1 OT4JHN4Y Limited Posttranslational Modification [637]
ALDH1A3 OT1C9NKQ Limited Biomarker [638]
ALDH7A1 OTV57BZD Limited Biomarker [639]
ALG2 OT77B384 Limited Biomarker [640]
ALKBH1 OTADGU5D Limited Biomarker [641]
ARNT2 OTAQD3YV Limited Biomarker [642]
ASAH1 OT1DNGXL Limited Biomarker [643]
ASCL1 OTI4X44G Limited Altered Expression [644]
ATG5 OT4T5SMS Limited Biomarker [645]
ATP1B2 OTYTBYVU Limited Altered Expression [646]
ATP5F1A OT3FZDLX Limited Altered Expression [647]
ATP5F1B OTLFZUQK Limited Altered Expression [647]
B3GAT1 OTXFP98E Limited Altered Expression [17]
BCAN OTPVY3ZR Limited Altered Expression [648]
BCL2L12 OTS6IFZY Limited Biomarker [649]
C1D OTI9PMN1 Limited Biomarker [650]
C1QTNF8 OTU5Z3YK Limited Biomarker [651]
CAMK2B OTS9YK3E Limited Altered Expression [652]
CCDC6 OTXRQDYG Limited Biomarker [653]
CCHCR1 OT22C116 Limited Biomarker [32]
CCN4 OT69BER9 Limited Biomarker [654]
CCRL2 OT5PX0RX Limited Biomarker [32]
CD226 OT4UG0KB Limited Altered Expression [655]
CD63 OT2UGZA9 Limited Biomarker [656]
CDC42 OT5QBC5M Limited Biomarker [657]
CHD5 OTS5EVHH Limited Altered Expression [658]
CLDN5 OTUX60YO Limited Altered Expression [659]
COPS6 OTG9AAG0 Limited Biomarker [660]
CRISP2 OT8HLTV5 Limited Biomarker [661]
CTBP1 OTVYH2DH Limited Altered Expression [662]
CTHRC1 OTV88X2G Limited Biomarker [663]
CXCL16 OTD49T9R Limited Biomarker [664]
DAAM1 OT0VHIYZ Limited Biomarker [665]
DAP3 OTNPEZYM Limited Altered Expression [666]
DCX OTISR7K3 Limited Biomarker [667]
DEGS1 OT4WXPKW Limited Biomarker [668]
DIAPH3 OTPOT23F Limited Biomarker [669]
DIRAS1 OT07F6PE Limited Altered Expression [670]
DOCK4 OTH3XY8B Limited Biomarker [671]
DST OTHZBM4X Limited Biomarker [672]
DUOX1 OTQ2AEW0 Limited Biomarker [673]
DUOXA1 OTNG3HH4 Limited Biomarker [674]
DVL3 OTPRROHJ Limited Biomarker [675]
DYNC2H1 OTLC8K6B Limited Biomarker [676]
ELF4 OT167PR5 Limited Biomarker [677]
ELMO2 OTKDOC2M Limited Biomarker [678]
ERVFRD-1 OT3064D7 Limited Biomarker [679]
EXO1 OTI87RS5 Limited Biomarker [680]
FMOD OT9EJ5H8 Limited Biomarker [337]
FOXD1 OT80PRHS Limited Biomarker [681]
FREM2 OTEK6BZR Limited Biomarker [84]
FSTL1 OT6KEZUD Limited Biomarker [682]
GLUD2 OTF3GGYY Limited Biomarker [683]
GOLPH3 OTDLGYM3 Limited Biomarker [684]
GORASP1 OTQS91S7 Limited Biomarker [685]
GPR151 OT7EACU6 Limited Biomarker [40]
GRP OT8JDFNI Limited Biomarker [686]
HBP1 OTDPGGDV Limited Biomarker [687]
HM13 OTGEO1LP Limited Biomarker [688]
HMGB3 OTCJ2EZY Limited Biomarker [689]
HNRNPC OT47AK4C Limited Altered Expression [58]
HNRNPDL OTB3BFCV Limited Altered Expression [58]
HOXC9 OT60K4M0 Limited Altered Expression [690]
HOXD10 OT0NOWU2 Limited Biomarker [691]
ING5 OTRNNSFM Limited Biomarker [692]
KDM2B OTDMCVW7 Limited Biomarker [693]
KLF6 OTQY9S7F Limited Biomarker [694]
KLRC3 OT9EPHV3 Limited Altered Expression [695]
LAMA5 OTIIXE4M Limited Biomarker [696]
LCN1 OT8BWXTV Limited Biomarker [235]
LGI1 OTPS77HO Limited Biomarker [697]
LGR6 OTPZ1PWR Limited Biomarker [40]
LMLN OTQF0JPY Limited Posttranslational Modification [57]
MAP1B OTVXW089 Limited Biomarker [698]
MAP1LC3B OTUYHB84 Limited Altered Expression [699]
MCAT OTH07FIW Limited Altered Expression [25]
MCTS1 OT7SAOJP Limited Altered Expression [25]
MPEG1 OT7DAO0F Limited Altered Expression [46]
MPST OTCDPH5D Limited Biomarker [700]
MRGPRX3 OTRKCCDS Limited Biomarker [40]
MRGPRX4 OTOBHZVA Limited Biomarker [40]
MRPL41 OTG5URO4 Limited Biomarker [701]
MRTFA OTCVXASM Limited Altered Expression [40]
MTSS1 OT5DTDO2 Limited Posttranslational Modification [702]
MYL9 OT6B22JB Limited Biomarker [703]
MYT1 OTC3660I Limited Altered Expression [704]
MYT1L OTV45MAS Limited Altered Expression [704]
NAP1L1 OTI7WBZV Limited Altered Expression [705]
NCR2 OT2H13BX Limited Altered Expression [706]
NDST1 OT9E10W2 Limited Altered Expression [707]
NFATC1 OT4TMERS Limited Biomarker [708]
NIBAN2 OTVDQSPI Limited Biomarker [15]
NIF3L1 OT4MP90J Limited Biomarker [38]
NKD1 OTY3MO97 Limited Biomarker [709]
NLGN3 OTKDEC1Q Limited Altered Expression [710]
NLK OT2LETFS Limited Altered Expression [711]
NME2 OTCYGLHV Limited Biomarker [712]
NMS OTFYS4LO Limited Biomarker [103]
NOX1 OTZPJQCC Limited Biomarker [673]
NOX5 OTHTH59G Limited Biomarker [673]
NR1D2 OT9CVF41 Limited Biomarker [713]
NTS OTPGDNQS Limited Biomarker [714]
NUP98 OTNT12G2 Limited Altered Expression [633]
NUPR1 OT4FU8C0 Limited Biomarker [715]
NUSAP1 OT85HIJ5 Limited Altered Expression [716]
OPTN OT2UXWH9 Limited Altered Expression [705]
PDCD6 OT2YA5M8 Limited Altered Expression [640]
PDIA6 OT8YBR17 Limited Biomarker [717]
PFKFB4 OTQYEXL2 Limited Biomarker [65]
PHF19 OTF6RUCR Limited Biomarker [718]
PIAS3 OT3TWH9R Limited Biomarker [719]
PIEZO1 OTBG1FU4 Limited Biomarker [720]
PIWIL1 OT7CRGZ3 Limited Biomarker [721]
PIWIL4 OTDA9MY0 Limited Genetic Variation [721]
PMS2 OTNLWTMI Limited Biomarker [722]
POLD4 OTG578YH Limited Biomarker [723]
POLE4 OTCMWUT6 Limited Biomarker [723]
PPP1R1A OTGTAGCV Limited Altered Expression [724]
PRKAA1 OT7TNF0L Limited Altered Expression [725]
PRKAA2 OTU1KZPV Limited Altered Expression [725]
PRKAB1 OT1OG4QZ Limited Altered Expression [725]
PRRT2 OTCJUBDO Limited Altered Expression [726]
PRSS55 OTXXWI5Y Limited Biomarker [661]
PRUNE2 OTGW2974 Limited Altered Expression [695]
PTBP2 OTF4S7NE Limited Biomarker [727]
PTGFRN OTBG4SA2 Limited Altered Expression [728]
PTPN3 OTSLZBVY Limited Altered Expression [729]
QKI OTTAUGLB Limited Biomarker [730]
RAC2 OTAOHFNH Limited Biomarker [73]
RAMP3 OTX6XLLM Limited Biomarker [13]
RAN OT2TER5M Limited Biomarker [731]
RCC2 OTUJVTLS Limited Biomarker [732]
REST OTLL92LQ Limited Biomarker [733]
RMDN3 OTKO7AUM Limited Altered Expression [699]
RND1 OTOC223Z Limited Biomarker [734]
RPL5 OTM8EBRI Limited Altered Expression [735]
RPS15 OT0WYZYG Limited Altered Expression [670]
RPS27 OTFXKY7P Limited Altered Expression [46]
RPS6 OTT4D1LN Limited Biomarker [637]
RSU1 OTO5GHT1 Limited Altered Expression [736]
RTEL1 OTI3PJCT Limited Genetic Variation [737]
RWDD3 OTE76DY5 Limited Altered Expression [738]
SALL4 OTC08PR5 Limited Biomarker [739]
SARDH OTQ49Q27 Limited Altered Expression [740]
SDCBP OTS3NCC5 Limited Biomarker [741]
SETMAR OTE2MIMZ Limited Biomarker [742]
SGTA OTKOJ3JB Limited Biomarker [743]
SLFN11 OTJWFPMY Limited Biomarker [744]
SMAD2 OTC6VB4K Limited Biomarker [745]
SMG1 OTTS3SXE Limited Altered Expression [147]
SNAI2 OT7Y8EJ2 Limited Biomarker [746]
SOX11 OT4LG7LA Limited Altered Expression [747]
SOX9 OTVDJFGN Limited Altered Expression [642]
SPINT1 OT1CLR5L Limited Biomarker [748]
SPZ1 OTQH8HJ5 Limited Biomarker [661]
SRGAP1 OTL89HGW Limited Altered Expression [749]
SRL OT7IEBWZ Limited Altered Expression [740]
SYT1 OTVTPOI6 Limited Biomarker [685]
TAS2R38 OTX5MM36 Limited Biomarker [653]
TBX2 OTTOT7A9 Limited Biomarker [750]
TESC OTI8C76M Limited Biomarker [78]
TET1 OTZDHT1D Limited Biomarker [751]
THEM4 OTSIZU8Y Limited Altered Expression [752]
TICAM2 OTK7GIJ5 Limited Biomarker [753]
TINAGL1 OTZZO56M Limited Biomarker [754]
TLE1 OT50MRZ1 Limited Altered Expression [755]
TMED7 OTONO8E6 Limited Biomarker [753]
TMEM176A OTOZDWXX Limited Biomarker [756]
TMEM59 OTX4EKES Limited Biomarker [757]
TMPRSS13 OTMAOAP3 Limited Posttranslational Modification [57]
TNFRSF19 OTTVT4MB Limited Altered Expression [758]
TNFRSF6B OTKAN9G7 Limited Altered Expression [759]
TP53I3 OTSCM68G Limited Biomarker [701]
TRAF1 OTTLM5RU Limited Biomarker [760]
TRAM1 OT3I0H8E Limited Biomarker [761]
TRIM9 OTKYG33W Limited Biomarker [762]
ADGRA2 OTBT4W36 Disputed Altered Expression [763]
ARFGEF1 OTPAU0L4 Disputed Altered Expression [764]
ARFGEF2 OTM3CQZT Disputed Altered Expression [764]
ASPM OTKXQMNA Disputed Biomarker [765]
ATG4B OTQ4RNRM Disputed Biomarker [766]
ATRX OT77RSQW Disputed Genetic Variation [767]
BTC OTW4B2O0 Disputed Biomarker [768]
C1QTNF1 OT7I7KHC Disputed Biomarker [769]
CBX3 OTOP9RLD Disputed Altered Expression [770]
CD1C OT4XINUJ Disputed Biomarker [771]
DCT OTYVNTBG Disputed Biomarker [772]
ECT2 OTQDUCT6 Disputed Altered Expression [773]
EIF4G2 OTEO98CR Disputed Altered Expression [774]
ELAVL2 OT6EJ8MQ Disputed Biomarker [775]
GPR42 OTEB0ROY Disputed Genetic Variation [101]
HJURP OTWMV16B Disputed Biomarker [776]
HOXB7 OTC7WYU8 Disputed Altered Expression [777]
HPR OTXSC9UB Disputed Biomarker [778]
HSPB2 OTS01646 Disputed Biomarker [114]
IDH2 OTTQA4PB Disputed Biomarker [779]
ING4 OT0VVG4V Disputed Altered Expression [780]
LRIG2 OTDUBLIH Disputed Biomarker [781]
MSC OTBRPZL5 Disputed Biomarker [601]
NANOG OTUEY1FM Disputed Biomarker [782]
NBN OT73B5MD Disputed Biomarker [783]
NINJ1 OTLRZ1EU Disputed Biomarker [784]
NLRP2 OTJA81JU Disputed Biomarker [783]
NUCB2 OTHO6JWN Disputed Biomarker [785]
NUMB OTMB586Q Disputed Altered Expression [44]
OPCML OT93PQ6Y Disputed Altered Expression [786]
PAEP OTQA0NV4 Disputed Biomarker [787]
PCGF1 OTHOU68T Disputed Altered Expression [788]
PEA15 OTKCKTSX Disputed Altered Expression [789]
PIK3R3 OTXGJ8N1 Disputed Altered Expression [790]
POLD1 OTWO4UCJ Disputed Biomarker [253]
POLR1C OT7DVQB0 Disputed Biomarker [791]
PRKN OTJBN41W Disputed Altered Expression [792]
PSD OTUZIXUZ Disputed Biomarker [793]
RAD18 OTQ9PLNT Disputed Altered Expression [794]
RPL17 OTTYMPS6 Disputed Altered Expression [451]
SEC61G OT7MJRXY Disputed Biomarker [795]
SLC16A4 OT1YXBKC Disputed Biomarker [25]
SNAI1 OTDPYAMC Disputed Biomarker [796]
SPATA2 OTOA45GL Disputed Altered Expression [451]
STPG4 OT5K4UFL Disputed Altered Expression [93]
SUZ12 OT655XF8 Disputed Biomarker [797]
TAC1 OTM842YW Disputed Altered Expression [798]
ACTL8 OTUDD0QT moderate Biomarker [799]
ADGRB1 OTJSEXRC moderate Altered Expression [800]
ADGRG1 OTQBB8NT moderate Biomarker [801]
ADI1 OT8IOD03 moderate Biomarker [802]
AKAP1 OTIIB2JB moderate Altered Expression [803]
ANXA7 OTLMD0TK moderate Biomarker [804]
ARHGAP26 OTNGQU7A moderate Biomarker [805]
ARHGEF7 OT9BPJCL moderate Biomarker [806]
ASPG OT5E2EKR moderate Biomarker [807]
ATF5 OT03QCLM moderate Biomarker [808]
ATF6 OTAFHAVI moderate Biomarker [809]
ATG9A OTAZWZH7 moderate Altered Expression [810]
ATMIN OTEADE76 moderate Biomarker [811]
AVEN OTGIN5YK moderate Biomarker [812]
BAG3 OTVXYUDQ moderate Altered Expression [813]
BATF2 OT4XBZC9 moderate Biomarker [814]
BCL3 OT1M5B95 moderate Biomarker [280]
BIRC6 OTCQJAB0 moderate Biomarker [812]
BTG2 OTZF6K1H moderate Biomarker [815]
CAP1 OTYM8A2N moderate Biomarker [167]
CD151 OTF3UZS7 moderate Biomarker [816]
CD3D OTRBLP0R moderate Altered Expression [817]
CDH19 OTH31KJO moderate Biomarker [818]
CDSN OTQW4HV6 moderate Altered Expression [819]
CEBPD OTNBIPMY moderate Biomarker [820]
CHAF1A OTXSSY4H moderate Biomarker [388]
CREB3L2 OT09MHV0 moderate Altered Expression [821]
CREBRF OT2GK1HI moderate Altered Expression [822]
CTCF OT8ZB70U moderate Altered Expression [823]
DCHS1 OTW3GX62 moderate Biomarker [818]
DCTN6 OTI8PIN9 moderate Biomarker [753]
DDX6 OTKWXVDY moderate Biomarker [824]
DSTN OTMXO4YB moderate Altered Expression [42]
EIF3B OTF67VPH moderate Altered Expression [825]
ELK1 OTH9MXD6 moderate Altered Expression [826]
EMC6 OT9IHH51 moderate Biomarker [827]
ERCC1 OTNPYQHI moderate Genetic Variation [828]
FOXN1 OTE80D6I moderate Biomarker [829]
FOXO3 OTHXQG4P moderate Biomarker [830]
FTL OTYQA8A6 moderate Biomarker [831]
GAB2 OTBFN705 moderate Biomarker [832]
GABPB1 OTEXDEJN moderate Biomarker [833]
H4C1 OTB71W46 moderate Biomarker [834]
HACD1 OTEC7EP7 moderate Biomarker [167]
HAUS5 OTJNBV1W moderate Altered Expression [835]
HECTD1 OTJ95JJS moderate Biomarker [836]
HSDL2 OT4IN0MV moderate Biomarker [837]
IARS1 OT9WXH5N moderate Altered Expression [838]
IFI27 OTI2XGIT moderate Biomarker [753]
INSM1 OTG8RV8E moderate Biomarker [839]
ITSN1 OT8YF3S5 moderate Altered Expression [819]
JAG1 OT3LGT6K moderate Biomarker [840]
JMJD6 OTILR7E4 moderate Altered Expression [841]
KAT5 OTL7257A moderate Biomarker [842]
KCNH4 OTHJ8WTU moderate Altered Expression [826]
KCNH8 OT3I5FLB moderate Altered Expression [826]
KIF14 OTXHT4JM moderate Biomarker [843]
KIF3A OTMUBSSK moderate Biomarker [844]
LCP2 OT57KE22 moderate Biomarker [143]
LGALS8 OT71LJ8T moderate Biomarker [845]
LRP1B OT4YZG2N moderate Genetic Variation [846]
MFAP1 OTZN4FT3 moderate Biomarker [617]
MGAT5 OTU4DD4G moderate Biomarker [847]
MPZL2 OTKFNDUI moderate Biomarker [848]
MSH3 OTD3YPVL moderate Biomarker [193]
MSX1 OT5U41ZP moderate Biomarker [849]
MUC13 OTWKS9MF moderate Biomarker [850]
MXI1 OTUQ9E0D moderate Genetic Variation [145]
MYBPH OTQJBPUR moderate Altered Expression [851]
MYO1C OT69L39Y moderate Biomarker [852]
NAA30 OTE56C5T moderate Biomarker [853]
NAB2 OTG4BDF3 moderate Biomarker [854]
NDRG2 OT5L6KD7 moderate Altered Expression [855]
NFKBIZ OTU728KS moderate Biomarker [856]
NR2E1 OTW47GKM moderate Biomarker [562]
PAFAH1B1 OT9T2TCJ moderate Altered Expression [857]
PCBP2 OTXCN9CG moderate Biomarker [858]
PCDH8 OTDDOQM2 moderate Altered Expression [859]
PDCD4 OTZ6NXUX moderate Biomarker [860]
PFKM OT1QY9JM moderate Altered Expression [861]
PNOC OTJEAADN moderate Biomarker [175]
POU1F1 OTXT8A5C moderate Altered Expression [597]
PPP1R1C OTVH6BND moderate Altered Expression [862]
PRIMA1 OT9ITT3P moderate Biomarker [863]
PRMT8 OT3MRK62 moderate Biomarker [864]
PSMD9 OT6Y5CC3 moderate Biomarker [753]
PTBP3 OTVVYKIF moderate Biomarker [865]
PYCARD OT67RON3 moderate Biomarker [184]
RBBP4 OTG3BT3M moderate Biomarker [866]
REV3L OT0OP8EJ moderate Biomarker [867]
RHOC OTOLE1FT moderate Altered Expression [868]
RNF123 OTL59S8J moderate Biomarker [433]
RNF41 OTN1DQOY moderate Biomarker [188]
SAV1 OTSAEV92 moderate Altered Expression [869]
SCYL1 OTQ0IN7P moderate Biomarker [433]
SERP1 OT60XXUP moderate Altered Expression [870]
SERPINB6 OT7G55IK moderate Biomarker [167]
SKA1 OTDYJ12A moderate Biomarker [871]
SKI OT4KJ8F6 moderate Altered Expression [872]
SNAPC2 OTN0EL6L moderate Biomarker [873]
SNRPB OT3UJ4ZU moderate Biomarker [874]
SORBS1 OTWH8762 moderate Biomarker [167]
SOX7 OTOZOFAG moderate Altered Expression [875]
ST13 OTNML6UP moderate Altered Expression [563]
STAG2 OTR6X1Q7 moderate Genetic Variation [876]
STAT5B OTZVPEBT moderate Biomarker [877]
TAT OT2CJ91O moderate Biomarker [878]
TMPO OTL68EL4 moderate Biomarker [879]
TP73 OT0LUO47 moderate Altered Expression [77]
TSGA13 OT81V4LS moderate Altered Expression [880]
A1BG OTFVUGNQ Strong Biomarker [616]
ACP1 OTJ9CKLU Strong Biomarker [881]
ACTB OT1MCP2F Strong Biomarker [882]
ACTN4 OTCNZAJ5 Strong Biomarker [883]
ADAM23 OTVWT6JZ Strong Biomarker [884]
ADARB2 OTDJKS39 Strong Biomarker [885]
ADD3 OTDRSHAZ Strong Altered Expression [886]
ADGRB3 OT1EWGRW Strong Altered Expression [887]
ADGRE5 OTTSB84Q Strong Altered Expression [888]
ADGRL4 OTN1GAG7 Strong Biomarker [889]
AEBP1 OTBI1RZ6 Strong Altered Expression [890]
AGAP2 OTEYO9TM Strong Biomarker [891]
AIFM1 OTKPWB7Q Strong Altered Expression [892]
AIM2 OT86QUI8 Strong Posttranslational Modification [893]
AIMP1 OTTA5C3U Strong Biomarker [894]
AJUBA OTNW7YPK Strong Altered Expression [895]
ALDH3A1 OTAYZZE6 Strong Biomarker [896]
ALKBH2 OTSQW0BG Strong Biomarker [897]
AMFR OTQRX7LC Strong Genetic Variation [898]
AMH OT5FH4BD Strong Biomarker [899]
AMOTL2 OTRCTKV9 Strong Biomarker [320]
ANGPT4 OT881M3K Strong Biomarker [900]
ANGPTL2 OTB6JG41 Strong Biomarker [621]
ANKRD36B OT3MW415 Strong Biomarker [901]
ANKS4B OT1MREUS Strong Biomarker [621]
ANO6 OTTA5KQJ Strong Biomarker [902]
ANOS1 OTZJT4KN Strong Biomarker [903]
ANP32B OT3SQMLU Strong Biomarker [529]
APAF1 OTJWIVY0 Strong Biomarker [99]
API5 OTYX9YCZ Strong Altered Expression [904]
APLP2 OTTFE53M Strong Altered Expression [905]
APPL2 OT9S4C4K Strong Altered Expression [906]
AQP4 OTA9MYD5 Strong Altered Expression [907]
AQP8 OT99JKME Strong Altered Expression [908]
ARF4 OT3GMDHA Strong Biomarker [909]
ARHGAP1 OT0H2ZBZ Strong Altered Expression [910]
ARHGAP21 OT6XY8Y9 Strong Altered Expression [910]
ARHGAP24 OTCQCEZS Strong Altered Expression [77]
ARHGEF11 OTDOMEH6 Strong Altered Expression [911]
ARHGEF2 OTBQTFRT Strong Altered Expression [912]
ARHGEF26 OTX0U8PX Strong Altered Expression [912]
ARHGEF28 OT3F32IU Strong Altered Expression [488]
ARR3 OTRZ00CH Strong Biomarker [230]
ART1 OT7FBG5W Strong Altered Expression [913]
ASAP1 OT4DLRYY Strong Biomarker [487]
ASAP2 OTGEXULW Strong Biomarker [487]
ASCC1 OTH4VAP9 Strong Biomarker [806]
ASIC4 OT5POMCQ Strong Biomarker [214]
ASL OTI2NGQR Strong Biomarker [914]
ASS1 OT4ZMG0Q Strong Biomarker [914]
ATAD2B OTQMSTTC Strong Altered Expression [915]
ATF1 OT251CI0 Strong Altered Expression [254]
ATP1A3 OTM8EG6H Strong Altered Expression [907]
ATP6AP2 OT0IABVV Strong Altered Expression [916]
ATP6V0A2 OTJBDX0Y Strong Biomarker [917]
AXIN1 OTRGZGZ5 Strong Biomarker [918]
AZIN2 OT8OB7CG Strong Biomarker [919]
BAALC OTUZSRVF Strong Altered Expression [920]
BAD OT63ERYM Strong Biomarker [585]
BCAR1 OTKT2C2N Strong Biomarker [921]
BCL2L11 OTNQQWFJ Strong Altered Expression [922]
BCL2L13 OT2VRFTM Strong Biomarker [923]
BEX2 OT4G5SIC Strong Biomarker [924]
BHLHE22 OTZUQY5L Strong Altered Expression [925]
BHLHE40 OTITX14U Strong Altered Expression [926]
BHLHE41 OTY9GJ1Y Strong Biomarker [927]
BMPR1B OTGFN0OD Strong Biomarker [262]
BRCC3 OTK0ZN7Y Strong Altered Expression [928]
BRMS1L OTJIW47U Strong Biomarker [929]
BTRC OT2EZDGR Strong Biomarker [930]
BUB1B OT8KME51 Strong Altered Expression [931]
BUB3 OTU91HAU Strong Altered Expression [932]
C12orf75 OTFVI3EY Strong Biomarker [682]
C4BPA OTHNH6Y8 Strong Altered Expression [933]
C6orf47 OTMKBNDD Strong Biomarker [934]
CALM2 OTNYA92F Strong Altered Expression [652]
CAMTA1 OTAN1S5B Strong Biomarker [935]
CARD14 OTADQHOV Strong Altered Expression [933]
CAST OTBXZZGF Strong Posttranslational Modification [936]
CAV2 OT1FGRQX Strong Altered Expression [937]
CAVIN1 OTFO915U Strong Altered Expression [231]
CBFA2T2 OTNOIB23 Strong Biomarker [938]
CBLL2 OTB4AD3V Strong Altered Expression [792]
CCL8 OTCTWYN8 Strong Biomarker [939]
CCN3 OTOW5YL4 Strong Altered Expression [940]
CCNG2 OTII38K2 Strong Biomarker [941]
CCNO OT68CH0B Strong Biomarker [942]
CCR10 OT7ZWSSD Strong Altered Expression [943]
CD109 OTDADBM4 Strong Posttranslational Modification [944]
CD164 OTZ7FIU8 Strong Altered Expression [945]
CD68 OTOYEY3J Strong Biomarker [19]
CD93 OT6HZT6H Strong Biomarker [946]
CD99 OTPUZ5DE Strong Altered Expression [947]
CDC14B OTAESVOZ Strong Biomarker [948]
CDK20 OTOLNN68 Strong Altered Expression [563]
CDO1 OTLG1P77 Strong Biomarker [949]
CDS1 OT2F591M Strong Biomarker [950]
CEACAM7 OTKFDTZY Strong Biomarker [257]
CEBPZ OT11BATG Strong Biomarker [951]
CELF2 OTLJJ4VT Strong Biomarker [952]
CEP350 OT5Q3AEA Strong Biomarker [953]
CEP55 OTGSG2PA Strong Altered Expression [93]
CEP85L OTSHJFOT Strong Biomarker [954]
CH25H OT9S2BSW Strong Altered Expression [953]
CHD4 OTBDEHDP Strong Altered Expression [485]
CHD7 OTHNIZWZ Strong Altered Expression [955]
CHL1 OT6E6E8P Strong Biomarker [956]
CHSY1 OTB1XSSF Strong Altered Expression [387]
CIB1 OT4BVCRU Strong Altered Expression [433]
CIC OTFXCHNZ Strong Biomarker [957]
CLEC18B OTW1BFMQ Strong Altered Expression [958]
CLEC5A OT19WV30 Strong Altered Expression [959]
CLTC OTBFASMA Strong Biomarker [604]
CMTM1 OTKN7E89 Strong Biomarker [960]
CMTM3 OTS75IGC Strong Biomarker [960]
CNBP OTTGM9NK Strong Altered Expression [961]
COL11A2 OT3BQUBH Strong Biomarker [448]
COL3A1 OTT1EMLM Strong Biomarker [962]
COX5A OTP0961M Strong Altered Expression [963]
COX5B OTDP94F3 Strong Altered Expression [964]
COX7A2 OTVT146E Strong Altered Expression [965]
COX8A OTU0NR39 Strong Biomarker [966]
CPEB1 OTLCXC6H Strong Biomarker [967]
CPEB4 OTW1SCZW Strong Biomarker [968]
CPOX OTIAY121 Strong Altered Expression [963]
CPT1A OTI862QH Strong Altered Expression [969]
CPT1C OT8F1MBF Strong Altered Expression [969]
CRISPLD2 OTVSFHTL Strong Biomarker [970]
CTAG1B OTIQGW6U Strong Biomarker [269]
CTNNA1 OTFC725Z Strong Altered Expression [971]
CTNNA3 OT9Z0P1E Strong Altered Expression [971]
CUL1 OTXPE1UZ Strong Altered Expression [972]
CXCL14 OTM189TA Strong Biomarker [973]
CXCL6 OTFTCQ4O Strong Altered Expression [974]
CYB561 OT61GMNV Strong Biomarker [274]
CYC1 OT0962IM Strong Altered Expression [975]
CYGB OTX153DQ Strong Altered Expression [976]
DAB1 OTPL9MA3 Strong Biomarker [977]
DAPK2 OTWODUQG Strong Biomarker [978]
DAXX OTX6O7PL Strong Biomarker [979]
DBI OT884QY9 Strong Biomarker [980]
DBT OT4KZ5R9 Strong Biomarker [981]
DCDC2 OTSUFH1H Strong Biomarker [982]
DCTN4 OTM7C943 Strong Altered Expression [395]
DENR OTXP9HOY Strong Biomarker [978]
DEPP1 OTB36PHJ Strong Biomarker [983]
DGKI OTDZ602D Strong Posttranslational Modification [984]
DIAPH1 OTZBYPLH Strong Biomarker [985]
DIRAS3 OT3XHLQA Strong Biomarker [986]
DLC1 OTP8LMCR Strong Altered Expression [987]
DLD OT378CU9 Strong Biomarker [527]
DLX2 OTKC2DQ0 Strong Altered Expression [988]
DNAJC5 OTCZDXAL Strong Biomarker [989]
DNER OT2GH2E5 Strong Biomarker [428]
DOCK1 OTCFV3ON Strong Biomarker [678]
DOCK7 OTINNVQV Strong Biomarker [990]
DOCK9 OT84H8AD Strong Biomarker [991]
DOHH OTDRAT3F Strong Altered Expression [279]
DPF1 OTI4ZFP8 Strong Biomarker [992]
DPF2 OTL0JH2C Strong Biomarker [993]
DPYSL5 OT6F9T6F Strong Biomarker [994]
DRAM1 OTIJTXEN Strong Biomarker [995]
DSC3 OTYG47F8 Strong Biomarker [996]
DUSP2 OTH54FMR Strong Altered Expression [198]
DUSP6 OT4H6RKW Strong Altered Expression [997]
E2F5 OT1XWING Strong Altered Expression [998]
EBF3 OTB0IWLW Strong Genetic Variation [999]
ECHS1 OTS0593S Strong Biomarker [1000]
EDN3 OTN7Q9BE Strong Altered Expression [1001]
EFEMP1 OTZVUOOB Strong Biomarker [1002]
EFNB3 OT12WTXQ Strong Biomarker [303]
EGFLAM OTACZZJ0 Strong Biomarker [1003]
EIF3A OTFABY9G Strong Altered Expression [1004]
EIF3E OTI0WG98 Strong Biomarker [1005]
EIF3M OTVWEV60 Strong Altered Expression [1006]
ELOVL2 OTDAF6U3 Strong Biomarker [1007]
EMP1 OTSZHUHQ Strong Biomarker [1008]
EMP2 OTPS2H0L Strong Biomarker [1009]
EMP3 OTODMJ1D Strong Altered Expression [1010]
EMX2 OT0V8OYK Strong Altered Expression [1011]
ENDOG OT5IM7B3 Strong Biomarker [1012]
EPN3 OTNNYDT6 Strong Biomarker [1013]
EPS8 OTZ6ES6V Strong Biomarker [1014]
ERRFI1 OT7VZ2IZ Strong Biomarker [1015]
ESD OTUSIBPS Strong Altered Expression [1016]
ESPL1 OTMGEVOK Strong Biomarker [1017]
ETV2 OTP5URZ8 Strong Biomarker [1018]
ETV4 OT8C98UZ Strong Altered Expression [1019]
EXOSC3 OTNCF906 Strong Altered Expression [1020]
FABP7 OTRE2H4G Strong Biomarker [1021]
FAM107A OTBG61YZ Strong Biomarker [1022]
FBLN7 OT1XRDP6 Strong Altered Expression [207]
FBP1 OTQBANEP Strong Altered Expression [1023]
FCGR2C OTNLMNYB Strong Biomarker [1024]
FEN1 OT6QGG7O Strong Altered Expression [1025]
FERMT3 OTFQOT3C Strong Biomarker [1026]
FEZF2 OTU4TXIW Strong Biomarker [682]
FGF13 OTHNNVSG Strong Altered Expression [1027]
FGF9 OT2SKDGM Strong Biomarker [1028]
FHL2 OT0OAYWT Strong Biomarker [1029]
FLT3LG OTU0YGC4 Strong Biomarker [48]
FOCAD OT83QOSI Strong Altered Expression [1030]
FOSB OTW6C05J Strong Genetic Variation [1031]
FOXG1 OTAW57J4 Strong Biomarker [1032]
FOXK1 OTLZGS7J Strong Biomarker [1033]
FRAT1 OT1PS84E Strong Biomarker [1034]
FZD2 OT952ML1 Strong Altered Expression [1035]
GABPA OT9YB2SA Strong Biomarker [183]
GADD45A OTDRV63V Strong Genetic Variation [1036]
GADL1 OTJM4A0R Strong Biomarker [919]
GALNT14 OT9BSDDQ Strong Biomarker [1037]
GAS1 OTKJXG52 Strong Altered Expression [1038]
GGPS1 OTVEHG28 Strong Biomarker [316]
GHRH OT94U6MO Strong Altered Expression [1039]
GK5 OT65U8L1 Strong Altered Expression [1040]
GKN1 OT7ZYFQ9 Strong Biomarker [470]
GLIS2 OTOUUV1X Strong Biomarker [1041]
GLS2 OT08MSHL Strong Biomarker [1042]
GLUD1 OTXKOCUH Strong Posttranslational Modification [1043]
GOLGA4 OTCMEHNJ Strong Altered Expression [974]
GOLM1 OTOZSV6O Strong Biomarker [1044]
GOPC OTRBGH71 Strong Biomarker [490]
GPM6B OT8Q1582 Strong Biomarker [1045]
GPR158 OTYOC1RQ Strong Altered Expression [1046]
GPR37L1 OTOV08EV Strong Altered Expression [1047]
GPR65 OTCF5O4G Strong Altered Expression [1048]
GSC OT4DH7PR Strong Biomarker [84]
GTF2H1 OTCRXC6B Strong Altered Expression [395]
H2AX OT18UX57 Strong Biomarker [1049]
H3-3B OT9XHQ3C Strong Genetic Variation [1050]
HELLS OTVVV668 Strong Biomarker [287]
HEPACAM OT1MJ51D Strong Altered Expression [1051]
HEY1 OTJQL0I3 Strong Biomarker [1052]
HHIP OT77RQYS Strong Altered Expression [1053]
HLA-DRA OT7KZMP2 Strong Altered Expression [1054]
HLA-E OTX1CTFB Strong Altered Expression [1055]
HMMR OT4M0JTZ Strong Biomarker [1056]
HNRNPL OT0DJX74 Strong Biomarker [883]
HOPX OTBSR6C9 Strong Biomarker [1057]
HOXA9 OTKNK5H0 Strong Biomarker [1058]
HOXB1 OTGC0EKI Strong Genetic Variation [1059]
HOXB2 OTTD6HMV Strong Biomarker [1060]
HOXB3 OT9UC5PE Strong Genetic Variation [1059]
HOXB4 OTH1HRW5 Strong Genetic Variation [1059]
HOXB5 OTU74TB8 Strong Genetic Variation [1059]
HOXB6 OT3TFQ0U Strong Genetic Variation [1059]
HOXB8 OTKHOD17 Strong Biomarker [1061]
HOXB9 OTMVHQOU Strong Genetic Variation [1059]
HOXC6 OTBCRAZV Strong Altered Expression [1062]
HPCAL1 OTOBBFRD Strong Biomarker [1063]
HRG OTPLUFOG Strong Biomarker [1064]
HSPA1A OTKGIE76 Strong Biomarker [1065]
HSPA4 OT5HR0AR Strong Biomarker [1066]
HYOU1 OTBGBSOV Strong Biomarker [1067]
ID4 OTPMJ39I Strong Altered Expression [1068]
IFNA1 OTPMKY0L Strong Altered Expression [1069]
IGFBP4 OT2HZRBD Strong Biomarker [1070]
IGSF8 OTU22IKI Strong Biomarker [1071]
IKBKE OT5VYOSM Strong Posttranslational Modification [466]
IL17B OTS86H50 Strong Altered Expression [379]
IL18R1 OT83XMPQ Strong Altered Expression [288]
IL22RA1 OTGVKLBR Strong Altered Expression [1072]
IL34 OTZ15VVK Strong Biomarker [1073]
INA OT1D33T4 Strong Altered Expression [1074]
ING1 OTEZBRKW Strong Altered Expression [1075]
INPP5B OT0SC8W5 Strong Altered Expression [1076]
INPP5K OTQFLQKA Strong Altered Expression [1076]
INPPL1 OTCDAVBQ Strong Altered Expression [1076]
IQGAP1 OTZRWTGA Strong Altered Expression [320]
ITGA10 OTM0V5AO Strong Biomarker [1077]
ITGA2B OT4Y17PY Strong Biomarker [1078]
ITGA7 OTTBTAYW Strong Biomarker [1079]
ITGB5 OT21MF51 Strong Biomarker [1080]
ITIH4 OT460OO1 Strong Altered Expression [1081]
JUNB OTG2JXV5 Strong Altered Expression [1082]
JUND OTNKACJD Strong Altered Expression [1082]
KAT8 OT5LPQTR Strong Biomarker [1083]
KIF4A OT3UWL7D Strong Biomarker [1084]
KIF5B OTT34MT8 Strong Biomarker [1085]
KIF5C OT35570Y Strong Biomarker [1085]
KLF8 OTUC5CDB Strong Biomarker [1086]
KLF9 OTBFEJRQ Strong Biomarker [1087]
KMT2B OTMMAZQX Strong Biomarker [1088]
KMT2D OTTVHCLY Strong Biomarker [1088]
L2HGDH OTW6C712 Strong Genetic Variation [1089]
LAMA2 OTFROQWE Strong Biomarker [1090]
LAT OTZC1XZ1 Strong Biomarker [81]
LCMT1 OTRJQ16X Strong Genetic Variation [1091]
LEF1 OTWS5I5H Strong Biomarker [1092]
LHFPL3 OTG1EI22 Strong Biomarker [453]
LIG4 OT40DNXU Strong Altered Expression [1093]
LRG1 OTLD0KWA Strong Biomarker [1094]
LRIG1 OTY5HZN5 Strong Altered Expression [1095]
LRIG3 OT6TKZTU Strong Biomarker [1096]
LRRC4 OT7XJ70N Strong Biomarker [1097]
LZTR1 OTIDM6XO Strong Biomarker [1098]
MACC1 OTV3DLX0 Strong Altered Expression [1099]
MACF1 OTVIHD77 Strong Biomarker [918]
MAF1 OTKB0N8Q Strong Altered Expression [1100]
MAGED4B OTO37U7W Strong Altered Expression [405]
MAK16 OTD546E5 Strong Biomarker [1101]
MAP2 OT6UYT3X Strong Biomarker [1102]
MAP2K3 OTI2OREX Strong Biomarker [1103]
MAP2K6 OTK13JKC Strong Biomarker [762]
MAPK8IP2 OTDUHLN0 Strong Genetic Variation [1104]
MARCHF9 OTWF84QT Strong Genetic Variation [1105]
MARK4 OT6Z2TGV Strong Altered Expression [1106]
MAST2 OT85GLPP Strong Altered Expression [1107]
MATK OTVOJJLJ Strong Altered Expression [1108]
MBD2 OTUQPP0R Strong Biomarker [1109]
MCOLN2 OTU3V04B Strong Altered Expression [1110]
MCRS1 OT8K2X8P Strong Altered Expression [1111]
MED25 OTDBY87B Strong Altered Expression [1112]
METTL3 OTSXP1M3 Strong Biomarker [1113]
MGP OTZWU3FU Strong Altered Expression [1114]
MIB1 OT5C404P Strong Biomarker [420]
MIIP OT79EXZ7 Strong Biomarker [1115]
MIP OTEBLU3E Strong Biomarker [1081]
MMP19 OTLSTT2B Strong Biomarker [1116]
MMP28 OTHQZXM1 Strong Biomarker [1116]
MNX1 OTXP9FH1 Strong Biomarker [1117]
MPC1 OT6DYFUO Strong Genetic Variation [1118]
MPC2 OT0GHXGG Strong Biomarker [1119]
MPP1 OTA2ENZQ Strong Biomarker [1120]
MPRIP OT5FV5NS Strong Biomarker [1121]
MRPS30 OTDXIAGG Strong Biomarker [487]
MSH6 OT46FP09 Strong Altered Expression [1122]
MSN OTZJ4J6G Strong Altered Expression [1123]
MST1 OTOC4UNG Strong Posttranslational Modification [57]
MTPAP OT6HQ02S Strong Biomarker [487]
MUL1 OT2JC9YR Strong Altered Expression [792]
MXD1 OTS5CTHX Strong Biomarker [1124]
MXD3 OT4U88UP Strong Altered Expression [1125]
MYBL2 OTZ3JX8Q Strong Altered Expression [1126]
MZB1 OT071TET Strong Altered Expression [197]
NANS OTMQ2FUH Strong Biomarker [1127]
NCOR2 OTY917X0 Strong Biomarker [1128]
NCR3 OT20M764 Strong Biomarker [430]
NDN OTYBYJ82 Strong Biomarker [1129]
NECTIN1 OTTE5ZR6 Strong Biomarker [1130]
NEFL OTQESJV4 Strong Biomarker [1131]
NELL2 OTS4MJZ7 Strong Altered Expression [1132]
NEU1 OTH9BY8Y Strong Biomarker [1133]
NEU3 OTQ5PQOW Strong Altered Expression [1134]
NEU4 OTM16O9F Strong Altered Expression [1135]
NEURL1 OT2C4P70 Strong Biomarker [1133]
NFATC2 OTK5T6HZ Strong Altered Expression [1136]
NFIA OTDHQ9CG Strong Altered Expression [1137]
NFIB OTX94PD0 Strong Altered Expression [1137]
NGB OTW0SIUY Strong Altered Expression [1138]
NLRP12 OTGR132Z Strong Biomarker [893]
NME3 OT0CA0GF Strong Altered Expression [1139]
NMI OTYVG3NM Strong Biomarker [1140]
NOB1 OTW0YNSL Strong Altered Expression [784]
NOP53 OTA2YKO6 Strong Biomarker [1141]
NOVA1 OT6A9KHY Strong Biomarker [1142]
NR2F2 OTJFS67N Strong Altered Expression [1143]
NREP OT2AZPKK Strong Altered Expression [1144]
NTN4 OTDRRMP3 Strong Biomarker [1145]
NUDT1 OTZSES3W Strong Biomarker [1146]
NUDT21 OTZHKWAR Strong Biomarker [446]
NUP62 OTMN63DH Strong Altered Expression [395]
OCA2 OTDWIGBF Strong Biomarker [1147]
OCRL OTQ3L42N Strong Altered Expression [1076]
OIP5 OTI5C2DE Strong Altered Expression [286]
OLIG2 OTMCN6D3 Strong Biomarker [1148]
ORAI2 OTYISRYH Strong Biomarker [1149]
P4HB OTTYNYPF Strong Biomarker [1150]
PANK2 OTFBW889 Strong Biomarker [621]
PAPOLA OTPHD65D Strong Biomarker [487]
PATZ1 OT0X9WGR Strong Biomarker [1151]
PAX6 OTOC9876 Strong Altered Expression [1152]
PAX7 OTDMQRPO Strong Altered Expression [1153]
PCDH10 OT2GIT0E Strong Biomarker [1154]
PCLAF OTMVIOUU Strong Altered Expression [1155]
PDAP1 OTJSWMOD Strong Biomarker [487]
PDCD10 OTCHJTSF Strong Biomarker [1156]
PDE12 OTCRN5TB Strong Altered Expression [452]
PDIK1L OTISF4KG Strong Biomarker [1157]
PDLIM1 OT4EGCPG Strong Biomarker [1158]
PDLIM5 OTLQVV22 Strong Biomarker [404]
PDPN OTBUV19I Strong Altered Expression [1159]
PFN1 OTHTGA1H Strong Posttranslational Modification [1160]
PHF14 OTZT3GV1 Strong Altered Expression [1161]
PHF20 OTCBVH5P Strong Biomarker [1162]
PHF3 OTNOYLG9 Strong Altered Expression [305]
PHF6 OT8DXI40 Strong Altered Expression [1163]
PHLDB1 OTIRCB6I Strong Genetic Variation [737]
PHLPP1 OTIFXW8D Strong Altered Expression [1164]
PI15 OTPJL6ML Strong Altered Expression [970]
PID1 OT5YJ7FI Strong Biomarker [1165]
PIK3C3 OTLUM9L7 Strong Biomarker [1166]
PIK3R1 OT5BZ1J9 Strong Biomarker [938]
PIK3R2 OTZSUQK5 Strong Biomarker [938]
PIP4K2A OTO9JO9U Strong Biomarker [1167]
PKD1 OT5ALRZ5 Strong Altered Expression [1168]
PKD2 OTIXBU8H Strong Biomarker [1169]
PLAAT4 OTI66SAJ Strong Altered Expression [1170]
PLEC OTU4XDEG Strong Biomarker [1171]
PLEK OTB73XXA Strong Genetic Variation [930]
PLEKHM2 OT4ZYV73 Strong Altered Expression [1076]
PLK5 OTW5YPKM Strong Biomarker [1172]
PLPP3 OTSSF7BK Strong Biomarker [1173]
PLXNA4 OT5XKB3Q Strong Biomarker [1174]
PMEPA1 OTY8Z9UF Strong Biomarker [1175]
PNO1 OT010GIS Strong Biomarker [1101]
POLE OTFM3MMU Strong Genetic Variation [1176]
POLG2 OTDBMZJB Strong Biomarker [1120]
POLK OTKZ38JH Strong Altered Expression [516]
POLL OTZ24QGM Strong Altered Expression [516]
POMGNT1 OTBNOUZC Strong Biomarker [1177]
POTEF OTV3WXYE Strong Altered Expression [1178]
POU2F1 OTK7ELJ0 Strong Altered Expression [602]
POU5F1 OTDHHN7O Strong Biomarker [1179]
PPP1R12C OT9Q86JO Strong Biomarker [938]
PPP1R13B OTC88VQO Strong Biomarker [938]
PPP1R15A OTYG179K Strong Biomarker [934]
PPP1R1B OTSIJMQ9 Strong Biomarker [1180]
PPP2R5E OT8GPFT5 Strong Altered Expression [1181]
PRAP1 OT48QD82 Strong Altered Expression [1182]
PRDX1 OTZ3BEC4 Strong Altered Expression [1183]
PRELP OT9EEBUJ Strong Biomarker [1045]
PREX1 OTUTPVA9 Strong Biomarker [1092]
PRKD2 OTIFSVI8 Strong Biomarker [586]
PRMT2 OT63JZCI Strong Altered Expression [1184]
PROCR OTRHED17 Strong Altered Expression [1185]
PSG2 OT2EIXAI Strong Biomarker [257]
PSMB4 OTOJ9OHA Strong Biomarker [1186]
PSMD12 OTWICA51 Strong Biomarker [1120]
PSMG1 OTZ5I6UM Strong Altered Expression [198]
PTPA OTRGFOI7 Strong Altered Expression [1181]
PTPN12 OT5WA666 Strong Biomarker [1187]
PTPRF OTH5KF2D Strong Biomarker [1188]
PUM2 OT2H7NXV Strong Biomarker [225]
PVR OT3N91T7 Strong Altered Expression [1189]
PXN OTVMMUOF Strong Biomarker [1190]
PYGO2 OTZHB2OI Strong Altered Expression [1191]
RABGEF1 OTWC3Z3R Strong Biomarker [578]
RAD51B OTCJVRMY Strong Biomarker [1192]
RAD54L OTEGMAKG Strong Altered Expression [22]
RANBP2 OTFG5CVF Strong Biomarker [772]
RAP1A OT5RH6TI Strong Biomarker [578]
RASGRF1 OTNWJ7EN Strong Biomarker [990]
RASL10A OTEXTN6I Strong Altered Expression [1193]
RB1CC1 OTZK8PFX Strong Biomarker [1194]
RBM14 OTO9GMBD Strong Biomarker [1195]
RBMS3 OTFSC9MR Strong Biomarker [1101]
RCAN1 OT1MVXC7 Strong Biomarker [1196]
RDX OTNSYUN6 Strong Altered Expression [1197]
RECQL4 OT59LSW7 Strong Biomarker [1192]
RHBDD1 OTL5J132 Strong Biomarker [1198]
RIOK1 OT1OS3H3 Strong Altered Expression [264]
RIOK2 OTQODJ7F Strong Altered Expression [264]
RIOX1 OTN41QXP Strong Altered Expression [1199]
RIOX2 OT2YFPI2 Strong Biomarker [1200]
RIPK3 OTL1D484 Strong Biomarker [1121]
RMC1 OT7K8MTJ Strong Altered Expression [1201]
RMDN1 OTE1NB6U Strong Altered Expression [699]
RMDN2 OTK5WSFI Strong Altered Expression [699]
RNASEH2A OT8G3G7K Strong Posttranslational Modification [1202]
RND3 OTXMXPIH Strong Biomarker [1203]
RNF138 OTPU0CO4 Strong Biomarker [1204]
ROBO3 OTPVG40S Strong Biomarker [277]
RPL36A OT1LYV85 Strong Biomarker [1015]
RPS3 OT0K3TMH Strong Biomarker [1204]
RRAD OTW2O4GD Strong Biomarker [1205]
RTKN OTSS8XR6 Strong Altered Expression [657]
RTL10 OTHGB81W Strong Altered Expression [1206]
S100A1 OT1F2G4J Strong Biomarker [1207]
S100A10 OTI71243 Strong Altered Expression [1020]
S100A11 OTI57KDN Strong Biomarker [1208]
SART1 OTHMOGO1 Strong Genetic Variation [1209]
SCG5 OTXSJMT1 Strong Biomarker [1210]
SCNN1A OTE2KVZV Strong Biomarker [1211]
SCO1 OTC45UGB Strong Biomarker [1212]
SEMA3B OTCZCPMS Strong Altered Expression [1213]
SEMA3C OTEGUY7F Strong Biomarker [1214]
SEMA3D OTD5TJV1 Strong Altered Expression [1215]
SEMA3E OTD4S36H Strong Altered Expression [1215]
SEMA6A OTDQ7QAW Strong Biomarker [1216]
SEMA6B OT3VVVUO Strong Altered Expression [1217]
SEPTIN14 OTCM6DDO Strong Biomarker [1218]
SEPTIN7 OTJI08YX Strong Altered Expression [1219]
SERPINB1 OT5RDUFO Strong Altered Expression [1220]
SERPINE2 OTYF5340 Strong Biomarker [1221]
SESN2 OT889IXY Strong Biomarker [645]
SGSM3 OTIB1P8A Strong Altered Expression [1222]
SH3GL3 OTX6BOCN Strong Altered Expression [1223]
SHC1 OT1J5IRN Strong Biomarker [1224]
SHPRH OTKCBWWS Strong Altered Expression [1225]
SIAH1 OT29A838 Strong Biomarker [359]
SIX3 OTP5E3VU Strong Altered Expression [1226]
SLAMF1 OTBTT3ZQ Strong Altered Expression [1227]
SLC12A9 OTR7VRAK Strong Altered Expression [256]
SLC22A18 OT9C3KR4 Strong Altered Expression [1228]
SLC2A4RG OTW3LX8D Strong Genetic Variation [1229]
SLC35F1 OTRXHR2P Strong Biomarker [1230]
SLFN5 OTT1AESL Strong Altered Expression [1069]
SLTM OT0VRZA6 Strong Altered Expression [489]
SLURP1 OT89YD2E Strong Biomarker [1231]
SMARCA2 OTSGJ8SV Strong Biomarker [1232]
SMARCAL1 OTTKXLUZ Strong Genetic Variation [1233]
SMARCB1 OT2LP7LJ Strong Biomarker [1234]
SMC1A OT9ZMRK9 Strong Biomarker [1235]
SMN2 OT54RLO1 Strong Biomarker [508]
SMR3B OTL5HNM8 Strong Biomarker [481]
SNAI3 OTG9DI66 Strong Altered Expression [1236]
SNED1 OTBQVXY5 Strong Biomarker [1237]
SNRPN OTQB1ID1 Strong Altered Expression [1223]
SNW1 OTKWG3PS Strong Altered Expression [1076]
SOAT1 OTB4Y5RJ Strong Biomarker [194]
SOCS6 OT2O5ZBK Strong Biomarker [441]
SOHLH1 OT3RBLSK Strong Biomarker [1238]
SOS1 OTTCWXC3 Strong Biomarker [1239]
SOX1 OTVI1RAR Strong Altered Expression [1240]
SOX17 OT9H4WWE Strong Altered Expression [1241]
SOX3 OT1CRCOB Strong Biomarker [1242]
SP100 OTN8SD5W Strong Altered Expression [1243]
SPAG4 OTVXS2SM Strong Biomarker [1244]
SPAG9 OT45AHMB Strong Altered Expression [1245]
SPARCL1 OT74DWMV Strong Altered Expression [1246]
SPG7 OT8OY9ST Strong Biomarker [230]
SPHKAP OT5RHUYJ Strong Altered Expression [1076]
SPINT2 OTQV7BKQ Strong Posttranslational Modification [1247]
SRRM2 OTSIMMC9 Strong Biomarker [1101]
SRRT OTMYPSWV Strong Biomarker [1248]
SRSF3 OTOFT707 Strong Biomarker [1249]
SSBP2 OTYG1G80 Strong Biomarker [1250]
ST6GAL1 OT7US3NO Strong Altered Expression [1251]
ST8SIA1 OTGND2YZ Strong Altered Expression [1252]
STAT2 OTO9G2RZ Strong Altered Expression [1253]
STAT5A OTBSJGN3 Strong Biomarker [1254]
STEAP3 OTS9GZK5 Strong Biomarker [1255]
STING1 OTDAP4G0 Strong Biomarker [299]
STIP1 OT7TXLOX Strong Altered Expression [1256]
STMN3 OT20F289 Strong Altered Expression [1257]
SUGP1 OT7W0EB8 Strong Altered Expression [1258]
SWAP70 OTPHT2QD Strong Altered Expression [1259]
SYBU OT3FQV7N Strong Altered Expression [699]
SYNJ1 OTTE02XC Strong Altered Expression [1076]
SYNJ2 OTLRHXP1 Strong Altered Expression [1076]
SYNM OTOI8TRJ Strong Biomarker [1260]
SYT7 OTBWAOWY Strong Altered Expression [1261]
TAX1BP3 OTQ6IB4T Strong Altered Expression [657]
TBPL1 OT4I143E Strong Biomarker [518]
TCFL5 OTJL4348 Strong Biomarker [1262]
TCHP OTVDMHSY Strong Biomarker [204]
TCTN1 OTG5KEV8 Strong Biomarker [1263]
TEAD1 OTK6971C Strong Biomarker [1264]
TENM1 OTSKSU4V Strong Biomarker [1265]
TERF2IP OT3M5P3G Strong Biomarker [578]
TET3 OT76U3YF Strong Biomarker [1266]
TFAM OTXXV5V7 Strong Altered Expression [1267]
TFEB OTJUJJQY Strong Biomarker [1268]
TFPI2 OTZCRWOR Strong Altered Expression [1269]
THY1 OTVONVTB Strong Biomarker [1270]
TIGAR OTR7NMRJ Strong Biomarker [1271]
TIMP2 OT8S1RRP Strong Biomarker [1272]
TIMP4 OT8A68SW Strong Altered Expression [1273]
TLCD3B OTM6EPUS Strong Biomarker [923]
TLK2 OTZ09CG8 Strong Altered Expression [85]
TM7SF2 OTILU5S7 Strong Genetic Variation [1274]
TMEM71 OTA7W26O Strong Altered Expression [1275]
TNN OTQK2AMX Strong Altered Expression [1276]
TNS2 OTP72P0F Strong Altered Expression [1277]
TPM3 OT5RU5G6 Strong Biomarker [1278]
TPR OTUBBA4W Strong Biomarker [1279]
TRAF2 OT1MEZZN Strong Biomarker [760]
TRAP1 OTNG0L8J Strong Biomarker [498]
TREH OTJE0NOY Strong Genetic Variation [1280]
TRIB2 OTHSX3MX Strong Biomarker [407]
TRIM13 OTQIUACB Strong Biomarker [230]
TRIM14 OTLQKUG0 Strong Altered Expression [1281]
TRIM45 OTFDQT4E Strong Biomarker [1282]
TRIM8 OTS6JFR0 Strong Altered Expression [792]
TRIOBP OTGB5WHC Strong Altered Expression [1283]
TRIP6 OTIPA4ZR Strong Biomarker [1284]
TSHZ3 OTAN7RY5 Strong Altered Expression [1285]
TSPAN31 OT8WQ83R Strong Biomarker [1127]
TSPAN8 OT1F68WQ Strong Biomarker [1286]
ACOT7 OT7C68YV Definitive Biomarker [552]
ACTBL2 OTD6B81U Definitive Biomarker [552]
ACTG2 OTRDWUO0 Definitive Biomarker [552]
ADGRE3 OTYNAQ75 Definitive Biomarker [1287]
ARL4C OTQ3QNNU Definitive Biomarker [1288]
ATP23 OT303R2T Definitive Altered Expression [1289]
AXIN2 OTRMGQNU Definitive Altered Expression [1290]
BNIP3L OTJKOMXE Definitive Biomarker [1291]
BRD8 OTIKS3PC Definitive Biomarker [581]
CAMKMT OTLJBRUW Definitive Biomarker [1292]
CAPG OTJ86KI6 Definitive Altered Expression [1293]
CCT2 OTW1VV4E Definitive Biomarker [1294]
CCT3 OTL6EOS1 Definitive Biomarker [1294]
CCT5 OTPZ38BT Definitive Biomarker [1294]
CCT7 OTQNM3CY Definitive Biomarker [1294]
CDKN3 OTBE3H07 Definitive Altered Expression [587]
CHTOP OTMMNZ65 Definitive Biomarker [1295]
CMYA5 OTYV0RME Definitive Biomarker [1296]
CREB3 OT9617UO Definitive Biomarker [1297]
CRLF3 OTT9TMXN Definitive Altered Expression [563]
CTNND1 OTUMPSHR Definitive Biomarker [581]
DEFB126 OT9NHGQE Definitive Biomarker [574]
DHX33 OTREUESJ Definitive Biomarker [1298]
DIO2 OTGPNSLH Definitive Genetic Variation [566]
DIP2A OTXPTR8R Definitive Biomarker [1299]
DLGAP1 OTF2PUUI Definitive Biomarker [1300]
DPP3 OTUIVL1C Definitive Altered Expression [1301]
DTX1 OTYX91DX Definitive Biomarker [1302]
DUSP26 OTI7WIYN Definitive Altered Expression [1303]
E2F6 OT2PN28R Definitive Biomarker [1304]
EIF5B OTZTT22W Definitive Biomarker [1305]
ELK4 OTVSSEOE Definitive Altered Expression [1306]
FA2H OT8HA13U Definitive Biomarker [623]
FBXO16 OTTEJJVJ Definitive Biomarker [1307]
FHL5 OT6C00Z1 Definitive Biomarker [552]
FOXP2 OTVX6A59 Definitive Biomarker [1308]
FRZB OTTO3DPY Definitive Biomarker [675]
FZD6 OTBCPII8 Definitive Biomarker [1309]
GAB1 OTQKE6V4 Definitive Biomarker [990]
GDE1 OTU6FSBF Definitive Altered Expression [146]
GINS3 OT8NVXTD Definitive Biomarker [1310]
GMFB OTR1JN1D Definitive Biomarker [1311]
HNRNPU OTLQN1E2 Definitive Biomarker [581]
HOXA10 OTB6GQ09 Definitive Posttranslational Modification [1312]
HOXC10 OT5WF17M Definitive Altered Expression [1313]
IER3 OTZJI5FZ Definitive Altered Expression [1314]
IGF2BP2 OT4ZSEEE Definitive Biomarker [1315]
IGSF1 OT3XD6U2 Definitive Biomarker [581]
IMMP2L OT9WGAFD Definitive Biomarker [1315]
IRF9 OTK4MYQJ Definitive Altered Expression [563]
ITGA9 OTHN1IKA Definitive Altered Expression [1316]
ITGB4 OT28UK84 Definitive Biomarker [1317]
KPNA2 OTU7FOE6 Definitive Altered Expression [1318]
KRIT1 OT58AP1I Definitive Biomarker [1292]
MVP OTJGHJRB Definitive Altered Expression [1319]
NAA25 OTS3QVF1 Definitive Biomarker [581]
NAPSA OT6F8IAL Definitive Altered Expression [587]
NEIL3 OTBCI2NS Definitive Biomarker [1320]
NEO1 OTGJ1997 Definitive Biomarker [1321]
NFAT5 OTKIE59S Definitive Biomarker [1322]
NSUN5 OTBN7RS8 Definitive Biomarker [581]
NUP43 OTDF5K8Y Definitive Altered Expression [563]
PDK4 OTCMHMBZ Definitive Altered Expression [1323]
PGK1 OT6V1ICH Definitive Altered Expression [1324]
PITX1 OTA0UN4C Definitive Altered Expression [575]
POTEM OT7L2HGH Definitive Biomarker [552]
PROX1 OT68R6IO Definitive Altered Expression [1325]
PSMC6 OTG8997V Definitive Altered Expression [563]
PTF1A OT7SWA57 Definitive Altered Expression [563]
PTPRT OTV5TXNN Definitive Altered Expression [1326]
RAB40B OTCA9ZF5 Definitive Biomarker [1327]
RAI14 OT6USGBK Definitive Biomarker [1328]
RAP1B OTHEIIMM Definitive Biomarker [1329]
RECQL OTPCH3JH Definitive Biomarker [1330]
RFC4 OTWALD2R Definitive Altered Expression [1331]
RFX1 OTZUDMPR Definitive Biomarker [1332]
RIN2 OTCY73U9 Definitive Genetic Variation [1333]
RNF168 OT6AZXX8 Definitive Altered Expression [178]
RPS15A OT0BUA12 Definitive Biomarker [1334]
RYBP OTZZ4P2Z Definitive Altered Expression [1335]
SERPINA3 OT9BP2S0 Definitive Biomarker [1336]
SERPINI1 OTUJHIJW Definitive Biomarker [574]
SH3GL2 OTOE443G Definitive Biomarker [1337]
SHC3 OT305NPA Definitive Altered Expression [1338]
SIGLEC9 OTZC7SIM Definitive Biomarker [1339]
SLN OTERIU75 Definitive Biomarker [1340]
SPAST OTIF3AJI Definitive Biomarker [925]
SPPL3 OT2HLJF6 Definitive Biomarker [1315]
STIM1 OT8CLQ1W Definitive Biomarker [1341]
SUMO1 OTJFD4P5 Definitive Biomarker [1342]
TCP1 OT1MGUX9 Definitive Biomarker [1294]
TES OTL8PP6V Definitive Biomarker [555]
TMEM18 OT05YQ1E Definitive Altered Expression [1343]
TNFAIP8L3 OTHSBS1B Definitive Biomarker [1344]
TNFRSF10C OTVHOL9B Definitive Biomarker [280]
TPI1 OT14KP4B Definitive Biomarker [1345]
TRADD OTBOSJHO Definitive Biomarker [1346]
TRIM48 OT2L4STK Definitive Altered Expression [1347]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1018 DOT(s)

References

1 5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patients. Neurooncol Adv. 2021 Mar 26;3(1):vdab047.
2 Lomustine and Bevacizumab in Progressive Glioblastoma. N Engl J Med. 2017 Nov 16;377(20):1954-1963.
3 Irinotecan FDA Label
4 Vorinostat FDA Label
5 ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.Int J Mol Sci. 2019 Nov 23;20(23):5886. doi: 10.3390/ijms20235886.
6 Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.PLoS One. 2017 Jan 12;12(1):e0169566. doi: 10.1371/journal.pone.0169566. eCollection 2017.
7 Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.Int J Cancer. 2006 Jan 1;118(1):55-61. doi: 10.1002/ijc.21258.
8 The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.Adv Exp Med Biol. 2017;966:1-14. doi: 10.1007/5584_2016_201.
9 High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.Oncol Rep. 2017 May;37(5):2865-2874. doi: 10.3892/or.2017.5528. Epub 2017 Mar 24.
10 BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.Sci Rep. 2017 Dec 18;7(1):17740. doi: 10.1038/s41598-017-17062-1.
11 Multistage Ultraviolet Photodissociation Mass Spectrometry To Characterize Single Amino Acid Variants of Human Mitochondrial BCAT2.Anal Chem. 2018 Aug 21;90(16):9904-9911. doi: 10.1021/acs.analchem.8b02099. Epub 2018 Aug 1.
12 Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma.Mol Cancer Ther. 2018 Dec;17(12):2598-2609. doi: 10.1158/1535-7163.MCT-18-0533. Epub 2018 Sep 25.
13 Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.Am J Pathol. 2002 Apr;160(4):1279-92. doi: 10.1016/S0002-9440(10)62555-2.
14 A positive feedback loop involving nuclear factor IB and calpain 1 suppresses glioblastoma cell migration.J Biol Chem. 2019 Aug 23;294(34):12638-12654. doi: 10.1074/jbc.RA119.008291. Epub 2019 Jul 1.
15 MEG-3-mediated Wnt/-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma.Oncol Lett. 2018 Sep;16(3):2797-2804. doi: 10.3892/ol.2018.9048. Epub 2018 Jun 28.
16 Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.Radiol Oncol. 2019 Nov 20;53(4):397-406. doi: 10.2478/raon-2019-0057.
17 Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with (99m)Tc and (177)Lu as Potential Receptor Radiopharmaceuticals.Molecules. 2018 Oct 5;23(10):2542. doi: 10.3390/molecules23102542.
18 B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma.Lab Invest. 2019 Jul;99(8):1117-1129. doi: 10.1038/s41374-019-0238-5. Epub 2019 Mar 26.
19 Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma.Oncoimmunology. 2018 Aug 27;7(11):e1507668. doi: 10.1080/2162402X.2018.1507668. eCollection 2018.
20 Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.Oncoimmunology. 2017 Dec 12;7(3):e1407899. doi: 10.1080/2162402X.2017.1407899. eCollection 2018.
21 A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in Glioblastoma.Cancer Res. 2018 Nov 15;78(22):6509-6522. doi: 10.1158/0008-5472.CAN-18-1697. Epub 2018 Oct 2.
22 CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma.Transl Oncol. 2018 Apr;11(2):300-306. doi: 10.1016/j.tranon.2018.01.003. Epub 2018 Feb 4.
23 Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma.Nat Commun. 2019 Jul 2;10(1):2910. doi: 10.1038/s41467-019-10993-5.
24 The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.J Exp Clin Cancer Res. 2019 Oct 21;38(1):420. doi: 10.1186/s13046-019-1434-2.
25 Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.Biochem Biophys Res Commun. 2018 Sep 5;503(2):888-894. doi: 10.1016/j.bbrc.2018.06.092. Epub 2018 Jun 21.
26 NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells-A Potential Target for Adjuvant Radiotherapy.Cancers (Basel). 2019 Apr 9;11(4):503. doi: 10.3390/cancers11040503.
27 Suppression of astrocytic autophagy by B-crystallin contributes to -synuclein inclusion formation.Transl Neurodegener. 2019 Jan 18;8:3. doi: 10.1186/s40035-018-0143-7. eCollection 2019.
28 Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival.Sci Rep. 2018 Sep 11;8(1):13621. doi: 10.1038/s41598-018-31864-x.
29 MSI2-TGF-/TGF- R1/SMAD3 positive feedback regulation in glioblastoma.Cancer Chemother Pharmacol. 2019 Aug;84(2):415-425. doi: 10.1007/s00280-019-03892-5. Epub 2019 Jun 27.
30 Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.Neuro Oncol. 2018 Jan 22;20(2):192-202. doi: 10.1093/neuonc/nox119.
31 MKP1 phosphatase is recruited by CXCL12 in glioblastoma cells and plays a role in DNA strand breaks repair.Carcinogenesis. 2020 Jun 17;41(4):417-429. doi: 10.1093/carcin/bgz151.
32 DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme.Cancer Res. 2017 Jan 1;77(1):198-206. doi: 10.1158/0008-5472.CAN-16-1151. Epub 2016 Oct 28.
33 EphA3 is up-regulated by epidermal growth factor and promotes formation of glioblastoma cell aggregates.Biochem Biophys Res Commun. 2019 Jan 15;508(3):715-721. doi: 10.1016/j.bbrc.2018.12.002. Epub 2018 Dec 6.
34 FABP4 accelerates glioblastoma cell growth and metastasis through Wnt10b signalling.Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7807-7818. doi: 10.26355/eurrev_201811_16405.
35 Delta-6-desaturase inhibitor enhances radiation therapy in glioblastoma in vitro and in vivo.Cancer Manag Res. 2018 Dec 7;10:6779-6790. doi: 10.2147/CMAR.S185601. eCollection 2018.
36 Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer.Int J Biol Sci. 2017 Jun 1;13(6):804-814. doi: 10.7150/ijbs.19398. eCollection 2017.
37 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.Clin Nucl Med. 2020 Jan;45(1):e61-e62. doi: 10.1097/RLU.0000000000002668.
38 Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.Neuro Oncol. 2018 Jul 5;20(8):1055-1067. doi: 10.1093/neuonc/noy012.
39 BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma.Cell Death Differ. 2018 Nov;25(10):1808-1822. doi: 10.1038/s41418-018-0149-9. Epub 2018 Jul 5.
40 YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.Oncogene. 2018 Oct;37(41):5492-5507. doi: 10.1038/s41388-018-0301-5. Epub 2018 Jun 11.
41 Glioblastoma invasion and NMDA receptors: A novel prospect.Physiol Int. 2019 Sep 1;106(3):250-260. doi: 10.1556/2060.106.2019.22. Epub 2019 Sep 30.
42 Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.Int J Biochem Cell Biol. 2015 Aug;65:222-9. doi: 10.1016/j.biocel.2015.06.011. Epub 2015 Jun 14.
43 DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.PLoS One. 2018 Jun 4;13(6):e0198364. doi: 10.1371/journal.pone.0198364. eCollection 2018.
44 HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells.Cell Cycle. 2019 Jul;18(13):1446-1457. doi: 10.1080/15384101.2019.1618541. Epub 2019 May 22.
45 Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.Cancer Res Treat. 2017 Apr;49(2):387-398. doi: 10.4143/crt.2016.106. Epub 2016 Jul 19.
46 Molecular mechanism of point mutation-induced Monopolar spindle 1 (Mps1/TTK) inhibitor resistance revealed by a comprehensive molecular modeling study.PeerJ. 2019 Jan 21;7:e6299. doi: 10.7717/peerj.6299. eCollection 2019.
47 Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis.Sci Rep. 2018 Oct 30;8(1):16022. doi: 10.1038/s41598-018-34242-9.
48 CD103(+) Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model.Oncol Res. 2018 Mar 5;26(2):173-182. doi: 10.3727/096504017X14841698396865. Epub 2017 Jan 20.
49 Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.Cell Death Dis. 2019 Mar 29;10(4):292. doi: 10.1038/s41419-019-1387-6.
50 LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.BMC Cancer. 2018 Jul 6;18(1):722. doi: 10.1186/s12885-018-4649-2.
51 LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.J Pathol. 2019 Feb;247(2):228-240. doi: 10.1002/path.5186. Epub 2019 Jan 10.
52 Mutations in the mitotic check point gene, MAD1L1, in human cancers.Oncogene. 2001 May 31;20(25):3301-5. doi: 10.1038/sj.onc.1204421.
53 Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.J Neurochem. 2020 Jan;152(2):221-234. doi: 10.1111/jnc.14849. Epub 2019 Aug 25.
54 MerTK as a therapeutic target in glioblastoma. Neuro Oncol. 2018 Jan 10;20(1):92-102.
55 Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.Nucleic Acids Res. 2018 Nov 30;46(21):11396-11404. doi: 10.1093/nar/gky921.
56 Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.J Neurosurg. 2019 Apr 5;132(5):1435-1446. doi: 10.3171/2019.1.JNS182938.
57 Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma: An Alternative Detection Method for a Heterogeneous Process.Am J Clin Pathol. 2017 Oct 1;148(4):296-307. doi: 10.1093/ajcp/aqx073.
58 Human cytomegalovirus ie2 affects the migration of glioblastoma by mediating the different splicing patterns of RON through hnRNP A2B1.Neuroreport. 2019 Aug 14;30(12):805-811. doi: 10.1097/WNR.0000000000001277.
59 Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15550-15559. doi: 10.1073/pnas.1902847116. Epub 2019 Jun 24.
60 Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin.J Cell Physiol. 2018 May;233(5):4091-4105. doi: 10.1002/jcp.26205. Epub 2017 Dec 18.
61 miR-93-5p suppresses cellular senescence by directly targeting Bcl-w and p21.Biochem Biophys Res Commun. 2018 Nov 10;505(4):1134-1140. doi: 10.1016/j.bbrc.2018.10.010. Epub 2018 Oct 11.
62 Downregulation of Oxytocin Receptor Decreases the Length of Projections Stimulated by Retinoic Acid in the U-87MG Cells.Neurochem Res. 2017 Apr;42(4):1006-1014. doi: 10.1007/s11064-016-2133-4. Epub 2016 Dec 19.
63 The human poly(ADP-ribose) glycohydrolase maps to chromosome 10q11.23-21.1 by fluorescence in situ hybridization.Hum Cell. 1998 Dec;11(4):243-6.
64 PARP3 interacts with FoxM1 to confer glioblastoma cell radioresistance.Tumour Biol. 2015 Nov;36(11):8617-24. doi: 10.1007/s13277-015-3554-4. Epub 2015 Jun 4.
65 Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).J Neuropathol Exp Neurol. 2019 Sep 1;78(9):865-870. doi: 10.1093/jnen/nlz067.
66 Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.Neurosurg Rev. 2019 Jun;42(2):351-369. doi: 10.1007/s10143-018-0953-1. Epub 2018 Feb 17.
67 Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma.Oncol Rep. 2017 Nov;38(5):2919-2926. doi: 10.3892/or.2017.5937. Epub 2017 Sep 4.
68 Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.J Neuropathol Exp Neurol. 2010 Jun;69(6):582-92. doi: 10.1097/NEN.0b013e3181e008fe.
69 Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.Oncotarget. 2017 Apr 4;8(14):23401-23413. doi: 10.18632/oncotarget.15581.
70 A novel role of the mitochondrial permeability transition pore in (-)-gossypol-induced mitochondrial dysfunction.Mech Ageing Dev. 2018 Mar;170:45-58. doi: 10.1016/j.mad.2017.06.004. Epub 2017 Jul 3.
71 PKC depletion initiates mitotic slippage-induced senescence in glioblastoma.Cell Cycle. 2015;14(18):2938-48. doi: 10.1080/15384101.2015.1071744.
72 A dimeric bicyclic RGD ligand displays enhanced integrin binding affinity and strong biological effects on U-373 MG glioblastoma cells.Org Biomol Chem. 2019 Oct 21;17(39):8913-8917. doi: 10.1039/c9ob01811e. Epub 2019 Sep 26.
73 Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.Oncotarget. 2017 Mar 14;8(11):18031-18049. doi: 10.18632/oncotarget.14949.
74 AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.Cancer Res. 2013 Sep 1;73(17):5519-31. doi: 10.1158/0008-5472.CAN-13-0280. Epub 2013 Jun 28.
75 Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.Cancer Res Treat. 2018 Jul;50(3):1009-1022. doi: 10.4143/crt.2017.315. Epub 2017 Nov 10.
76 HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF- Pathway.ACS Chem Neurosci. 2017 Jan 18;8(1):128-134. doi: 10.1021/acschemneuro.6b00253. Epub 2016 Oct 12.
77 SIRT2-mediated inactivation of p73 is required for glioblastoma tumorigenicity.EMBO Rep. 2018 Nov;19(11):e45587. doi: 10.15252/embr.201745587. Epub 2018 Sep 13.
78 Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications.Oncotarget. 2019 Jun 18;10(40):4038-4052. doi: 10.18632/oncotarget.27005. eCollection 2019 Jun 18.
79 Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.Biochim Biophys Acta. 2015 Jun;1850(6):1197-205. doi: 10.1016/j.bbagen.2015.01.017. Epub 2015 Jan 31.
80 Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.J Neurooncol. 2018 Apr;137(2):429-438. doi: 10.1007/s11060-017-2735-y. Epub 2018 Jan 27.
81 New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.Sci Rep. 2019 Feb 27;9(1):2878. doi: 10.1038/s41598-019-40013-x.
82 Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.PLoS One. 2019 Feb 27;14(2):e0212581. doi: 10.1371/journal.pone.0212581. eCollection 2019.
83 Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.Oncogene. 2019 Feb;38(8):1151-1165. doi: 10.1038/s41388-018-0504-9. Epub 2018 Sep 24.
84 Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates.Int J Mol Sci. 2018 May 4;19(5):1369. doi: 10.3390/ijms19051369.
85 TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.Cancer Biol Ther. 2019;20(1):101-108. doi: 10.1080/15384047.2018.1507257. Epub 2018 Sep 12.
86 Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation. Biochem Biophys Res Commun. 2017 Jun 17;488(1):136-140.
87 The Critical Role of SRPK1 in EMT of Human Glioblastoma in the Spinal Cord.Mol Neurobiol. 2017 Apr;54(3):1818-1824. doi: 10.1007/s12035-016-9784-7. Epub 2016 Feb 18.
88 Epigenetic downregulation of STAT6 increases HIF-1 expression via mTOR/S6K/S6, leading to enhanced hypoxic viability of glioma cells.Acta Neuropathol Commun. 2019 Sep 17;7(1):149. doi: 10.1186/s40478-019-0798-z.
89 MiR-184 Retarded the Proliferation, Invasiveness and Migration of Glioblastoma Cells by Repressing Stanniocalcin-2.Pathol Oncol Res. 2018 Oct;24(4):853-860. doi: 10.1007/s12253-017-0298-z. Epub 2017 Sep 8.
90 Essential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism.Nucleic Acids Res. 2017 Jun 20;45(11):6793-6804. doi: 10.1093/nar/gkx239.
91 Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.J Control Release. 2018 May 10;277:89-101. doi: 10.1016/j.jconrel.2018.03.006. Epub 2018 Mar 6.
92 Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.Pathol Oncol Res. 2019 Jan;25(1):59-69. doi: 10.1007/s12253-017-0312-5. Epub 2017 Sep 30.
93 Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.Biomed Res Int. 2019 Apr 15;2019:6581576. doi: 10.1155/2019/6581576. eCollection 2019.
94 Identification of the role of TRPM8 in glioblastoma and its effect on proliferation, apoptosis and invasion of the U251 human glioblastoma cell line.Oncol Rep. 2019 Oct;42(4):1517-1526. doi: 10.3892/or.2019.7260. Epub 2019 Aug 5.
95 The Transient Receptor Potential Vanilloid Type-2(TRPV2) Ion Channels in Neurogenesis andGliomagenesis: Cross-Talk between TranscriptionFactors and Signaling Molecules.Cancers (Basel). 2019 Mar 6;11(3):322. doi: 10.3390/cancers11030322.
96 Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.J Exp Med. 2017 Jan;214(1):245-267. doi: 10.1084/jem.20151673. Epub 2016 Dec 6.
97 USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.Biochem Biophys Res Commun. 2017 Oct 7;492(1):48-54. doi: 10.1016/j.bbrc.2017.08.040. Epub 2017 Aug 12.
98 Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.Cancer Immunol Immunother. 2018 Nov;67(11):1777-1788. doi: 10.1007/s00262-018-2232-y. Epub 2018 Aug 22.
99 High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.Arq Neuropsiquiatr. 2017 Dec;75(12):875-880. doi: 10.1590/0004-282X20170156.
100 Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems.Sci Rep. 2018 Oct 18;8(1):15383. doi: 10.1038/s41598-018-33784-2.
101 PREX1 integrates G protein-coupled receptor and phosphoinositide 3-kinase signaling to promote glioblastoma invasion.Oncotarget. 2017 Jan 31;8(5):8559-8573. doi: 10.18632/oncotarget.14348.
102 Oligodendrocytes Up-regulate the Invasive Activity of Glioblastoma Cells via the Angiopoietin-2 Signaling Pathway.Anticancer Res. 2019 Feb;39(2):577-584. doi: 10.21873/anticanres.13150.
103 Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis.Onco Targets Ther. 2018 Mar 20;11:1583-1593. doi: 10.2147/OTT.S160813. eCollection 2018.
104 Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma.Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10703-8. doi: 10.1073/pnas.0712034105. Epub 2008 Jul 31.
105 Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma.Bioorg Med Chem Lett. 2019 Aug 15;29(16):2294-2301. doi: 10.1016/j.bmcl.2019.06.021. Epub 2019 Jun 26.
106 Inhibition of Chloride Intracellular Channel 1 (CLIC1) as Biguanide Class-Effect to Impair Human Glioblastoma Stem Cell Viability.Front Pharmacol. 2018 Aug 21;9:899. doi: 10.3389/fphar.2018.00899. eCollection 2018.
107 Wild type p53-dependent transcriptional upregulation of cathepsin L expression is mediated by C/EBPα in human glioblastoma cells.Biol Chem. 2010 Sep;391(9):1031-40. doi: 10.1515/BC.2010.103.
108 Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.Neuro Oncol. 2010 Jun;12(6):528-39. doi: 10.1093/neuonc/nop060. Epub 2010 Feb 14.
109 Acidic pH with coordinated reduction of basic fibroblast growth factor maintains the glioblastoma stem cell-like phenotype invitro.J Biosci Bioeng. 2017 May;123(5):634-641. doi: 10.1016/j.jbiosc.2016.12.006. Epub 2017 Jan 4.
110 Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells.FEBS Lett. 2008 Mar 5;582(5):799-804. doi: 10.1016/j.febslet.2008.01.061. Epub 2008 Feb 11.
111 Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.J Neuropathol Exp Neurol. 2008 May;67(5):456-69. doi: 10.1097/NEN.0b013e318170f892.
112 HOXB13 promotes proliferation, migration, and invasion of glioblastoma through transcriptional upregulation of lncRNA HOXC-AS3.J Cell Biochem. 2019 Sep;120(9):15527-15537. doi: 10.1002/jcb.28819. Epub 2019 May 6.
113 mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.Oncogene. 2018 Feb 8;37(6):732-743. doi: 10.1038/onc.2017.360. Epub 2017 Oct 23.
114 Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management.Biochim Biophys Acta Gen Subj. 2019 Jul;1863(7):1196-1209. doi: 10.1016/j.bbagen.2019.04.015. Epub 2019 Apr 25.
115 Serum amyloid A1 in combination with integrin V3 increases glioblastoma cells mobility and progression.Mol Oncol. 2018 May;12(5):756-771. doi: 10.1002/1878-0261.12196. Epub 2018 Apr 17.
116 T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells.J Immunother Cancer. 2019 Jul 9;7(1):171. doi: 10.1186/s40425-019-0642-9.
117 Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression.BMC Cancer. 2019 Sep 12;19(1):911. doi: 10.1186/s12885-019-6091-5.
118 Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy.Sci Rep. 2017 Apr 27;7(1):1217. doi: 10.1038/s41598-017-01279-1.
119 The Up-Regulation of Oxidative Stress as a Potential Mechanism of Novel MAO-B Inhibitors for Glioblastoma Treatment.Molecules. 2019 May 25;24(10):2005. doi: 10.3390/molecules24102005.
120 Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.Oncotarget. 2018 Apr 3;9(25):17951-17970. doi: 10.18632/oncotarget.24885. eCollection 2018 Apr 3.
121 Rapamycin promotes differentiation increasing III-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells.Oncotarget. 2017 May 2;8(18):29574-29599. doi: 10.18632/oncotarget.15906.
122 Anti-CD133 Antibody-Targeted Therapeutic Immunomagnetic Albumin Microbeads Loaded with Vincristine-Assisted to Enhance Anti-Glioblastoma Treatment.Mol Pharm. 2019 Nov 4;16(11):4582-4593. doi: 10.1021/acs.molpharmaceut.9b00704. Epub 2019 Oct 15.
123 Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.Oncogene. 2017 Sep 21;36(38):5369-5381. doi: 10.1038/onc.2017.134. Epub 2017 May 15.
124 The proton-coupled oligopeptide transporters PEPT2, PHT1 and PHT2 mediate the uptake of carnosine in glioblastoma cells.Amino Acids. 2019 Jul;51(7):999-1008. doi: 10.1007/s00726-019-02739-w. Epub 2019 May 9.
125 Protein Expression and Functional Relevance of Efflux and Uptake Drug Transporters at the Blood-Brain Barrier of Human Brain and Glioblastoma.Clin Pharmacol Ther. 2020 May;107(5):1116-1127. doi: 10.1002/cpt.1710. Epub 2019 Dec 10.
126 Prognostic value of stem cell markers in glioblastoma.Biomarkers. 2019 Nov;24(7):677-683. doi: 10.1080/1354750X.2019.1652345. Epub 2019 Sep 8.
127 RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes.Nucleic Acids Res. 2018 Apr 20;46(7):e39. doi: 10.1093/nar/gky015.
128 Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin 51 by the Tenascin-C-Derived Peptide TNIIIA2.Mol Cancer Ther. 2019 Sep;18(9):1649-1658. doi: 10.1158/1535-7163.MCT-18-1251. Epub 2019 Jun 12.
129 Induction Of XLF And 53BP1 Expression Is Associated With Temozolomide Resistance In Glioblastoma Cells.Onco Targets Ther. 2019 Nov 25;12:10139-10151. doi: 10.2147/OTT.S221025. eCollection 2019.
130 ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143.J Photochem Photobiol B. 2018 Jan;178:182-191. doi: 10.1016/j.jphotobiol.2017.10.035. Epub 2017 Oct 28.
131 Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas.Cancer Med. 2016 Dec;5(12):3532-3543. doi: 10.1002/cam4.940. Epub 2016 Nov 23.
132 Clinical significance of angiopoietin-like protein 3 expression in patients with glioblastoma.Neoplasma. 2016;63(1):93-8. doi: 10.4149/neo_2016_011.
133 Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging.Sci Rep. 2019 Nov 12;9(1):16613. doi: 10.1038/s41598-019-53147-9.
134 Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.Cell Oncol (Dordr). 2017 Aug;40(4):389-399. doi: 10.1007/s13402-017-0329-5. Epub 2017 Jun 19.
135 MicroRNA-613 is downregulated in HCMV-positive glioblastoma and inhibits tumour progression by targeting arginase-2.Tumour Biol. 2017 Jul;39(7):1010428317712512. doi: 10.1177/1010428317712512.
136 Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells.J Neurooncol. 2019 Jun;143(2):231-240. doi: 10.1007/s11060-019-03164-5. Epub 2019 Apr 22.
137 BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53.Sci Rep. 2016 Dec 21;6:39743. doi: 10.1038/srep39743.
138 The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma.Nat Commun. 2019 Jan 25;10(1):442. doi: 10.1038/s41467-019-08390-z.
139 LOX expression and functional analysis in astrocytomas and impact of IDH1 mutation.PLoS One. 2015 Mar 19;10(3):e0119781. doi: 10.1371/journal.pone.0119781. eCollection 2015.
140 Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.Sci Rep. 2017 Jun 27;7(1):4292. doi: 10.1038/s41598-017-04612-w.
141 An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.Neuro Oncol. 2016 Jul;18(7):950-61. doi: 10.1093/neuonc/nov315. Epub 2016 Jan 10.
142 Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-1-dependent activation of Smad/ERK signaling.Cell Death Dis. 2017 Jun 15;8(6):e2885. doi: 10.1038/cddis.2017.248.
143 The PPI network and clusters analysis in glioblastoma.Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4784-90.
144 Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours.J Neurooncol. 2019 Jun;143(2):187-196. doi: 10.1007/s11060-019-03156-5. Epub 2019 Apr 19.
145 Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma.Oncotarget. 2016 Jul 19;7(29):45027-45041. doi: 10.18632/oncotarget.7801.
146 Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.Oncogene. 2017 Oct 19;36(42):5861-5873. doi: 10.1038/onc.2017.182. Epub 2017 Jun 19.
147 CCAAT/enhancer binding protein negatively regulates progesterone receptor expression in human glioblastoma cells.Mol Cell Endocrinol. 2017 Jan 5;439:317-327. doi: 10.1016/j.mce.2016.09.018. Epub 2016 Sep 20.
148 Claudin 4-targeted nanographene phototherapy using a Clostridium perfringens enterotoxin peptide-photosensitizer conjugate.Acta Pharmacol Sin. 2017 Jun;38(6):954-962. doi: 10.1038/aps.2017.46. Epub 2017 May 29.
149 Casein kinase 2 regulates glioblastoma brain tumor-initiating cell growth through the -catenin pathway.Oncogene. 2015 Jul;34(28):3688-99. doi: 10.1038/onc.2014.299. Epub 2014 Sep 22.
150 Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.PLoS One. 2019 Jan 9;14(1):e0210608. doi: 10.1371/journal.pone.0210608. eCollection 2019.
151 Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine--lyase function.Oncol Rep. 2015 Mar;33(3):1465-74. doi: 10.3892/or.2015.3712. Epub 2015 Jan 13.
152 Cathepsin B contributes to radioresistance by enhancing homologous recombination in glioblastoma.Biomed Pharmacother. 2018 Nov;107:390-396. doi: 10.1016/j.biopha.2018.08.007. Epub 2018 Aug 9.
153 Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells.Oncotarget. 2016 Nov 15;7(46):74602-74611. doi: 10.18632/oncotarget.12980.
154 Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.J Histochem Cytochem. 2018 Mar;66(3):155-173. doi: 10.1369/0022155417749174. Epub 2018 Jan 3.
155 DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.Tumour Biol. 2017 Jul;39(7):1010428317716248. doi: 10.1177/1010428317716248.
156 An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8247-E8256. doi: 10.1073/pnas.1610921114. Epub 2016 Dec 7.
157 Expression and prognostic value of JAM-A in gliomas.J Neurooncol. 2017 Oct;135(1):107-117. doi: 10.1007/s11060-017-2555-0. Epub 2017 Jul 4.
158 CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.Oncotarget. 2015 Mar 20;6(8):5889-902. doi: 10.18632/oncotarget.3334.
159 A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.Biol Psychiatry. 2010 May 1;67(9):855-63. doi: 10.1016/j.biopsych.2009.10.032. Epub 2009 Dec 22.
160 Concurrent activation of (2)-adrenergic receptor and blockage of GPR55 disrupts pro-oncogenic signaling in glioma cells.Cell Signal. 2017 Aug;36:176-188. doi: 10.1016/j.cellsig.2017.05.006. Epub 2017 May 8.
161 Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.J Neurooncol. 2015 Oct;125(1):33-41. doi: 10.1007/s11060-015-1886-y. Epub 2015 Aug 14.
162 Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71.Cancer Lett. 2015 Feb 28;357(2):602-11. doi: 10.1016/j.canlet.2014.12.030. Epub 2014 Dec 16.
163 STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.J Neurosurg. 2014 Aug;121(2):374-83. doi: 10.3171/2014.4.JNS131198. Epub 2014 May 30.
164 Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion.Trends Mol Med. 2017 Sep;23(9):773-776. doi: 10.1016/j.molmed.2017.07.008. Epub 2017 Jul 31.
165 Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation.Clin Cancer Res. 2016 Jul 15;22(14):3513-23. doi: 10.1158/1078-0432.CCR-15-2308. Epub 2016 Mar 2.
166 Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.Br J Cancer. 2017 Jun 6;116(12):1572-1584. doi: 10.1038/bjc.2017.126. Epub 2017 May 11.
167 A Novel Micro Cold Atmospheric Plasma Device for Glioblastoma Both In Vitro and In Vivo.Cancers (Basel). 2017 May 30;9(6):61. doi: 10.3390/cancers9060061.
168 Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.Cancer Lett. 2015 Jan 28;356(2 Pt B):496-505. doi: 10.1016/j.canlet.2014.09.045. Epub 2014 Oct 6.
169 Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors.J Control Release. 2019 May 10;301:28-41. doi: 10.1016/j.jconrel.2019.02.021. Epub 2019 Mar 4.
170 EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.Mol Cancer Res. 2017 Aug;15(8):1085-1095. doi: 10.1158/1541-7786.MCR-16-0318. Epub 2017 May 9.
171 miR?6 inhibits EMT by targeting AEG? in glioblastoma cancer cells.Mol Med Rep. 2018 Feb;17(2):2964-2972. doi: 10.3892/mmr.2017.8227. Epub 2017 Dec 8.
172 MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.Mol Oncol. 2016 Nov;10(9):1387-1403. doi: 10.1016/j.molonc.2016.07.007. Epub 2016 Jul 28.
173 Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.J Clin Invest. 2017 Aug 1;127(8):3075-3089. doi: 10.1172/JCI89092. Epub 2017 Jul 24.
174 Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma.J Neurooncol. 2015 Oct;125(1):55-63. doi: 10.1007/s11060-015-1889-8. Epub 2015 Aug 22.
175 Nociceptin/orphanin FQ antagonizes lipopolysaccharide-stimulated proliferation, migration and inflammatory signaling in human glioblastoma U87 cells.Biochem Pharmacol. 2017 Sep 15;140:89-104. doi: 10.1016/j.bcp.2017.05.021. Epub 2017 Jun 2.
176 Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.Tumour Biol. 2017 Mar;39(3):1010428317695921. doi: 10.1177/1010428317695921.
177 Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.Cell Rep. 2015 Dec 22;13(11):2425-2439. doi: 10.1016/j.celrep.2015.11.021. Epub 2015 Dec 7.
178 A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.Cell Rep. 2019 Sep 17;28(12):3199-3211.e5. doi: 10.1016/j.celrep.2019.08.031.
179 miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.Cell Biol Int. 2018 May;42(5):506-514. doi: 10.1002/cbin.10924. Epub 2018 Jan 25.
180 Construction and analysis of dynamic transcription factor regulatory networks in the progression of glioma.Sci Rep. 2015 Nov 3;5:15953. doi: 10.1038/srep15953.
181 Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions.BMC Cancer. 2018 May 3;18(1):524. doi: 10.1186/s12885-018-4440-4.
182 Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-B signaling pathway.Oncogene. 2018 Jun;37(23):3070-3087. doi: 10.1038/s41388-018-0182-7. Epub 2018 Mar 14.
183 Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.Oncogene. 2019 Dec;38(50):7473-7490. doi: 10.1038/s41388-019-0956-6. Epub 2019 Aug 23.
184 Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. Neuroreport. 2004 Mar 22;15(4):575-8.
185 New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.Front Pharmacol. 2017 Dec 12;8:905. doi: 10.3389/fphar.2017.00905. eCollection 2017.
186 DR5 related autophagy can promote apoptosis in gliomas after irradiation.Biochem Biophys Res Commun. 2020 Feb 19;522(4):910-916. doi: 10.1016/j.bbrc.2019.11.161. Epub 2019 Dec 3.
187 OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.Mol Cancer. 2015 Feb 15;14:41. doi: 10.1186/s12943-015-0307-3.
188 Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.Oncogene. 2017 Sep 7;36(36):5158-5167. doi: 10.1038/onc.2017.126. Epub 2017 May 8.
189 Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma.Front Oncol. 2017 Jul 11;7:146. doi: 10.3389/fonc.2017.00146. eCollection 2017.
190 WNK1 kinase and its partners Akt, SGK1 and NBC-family Na(+)/HCO3(-) cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling.Oncotarget. 2018 Jun 5;9(43):27197-27219. doi: 10.18632/oncotarget.25509. eCollection 2018 Jun 5.
191 Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness.Cancers (Basel). 2019 Mar 22;11(3):406. doi: 10.3390/cancers11030406.
192 Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide.Int J Cardiol. 2019 Dec 15;297:111-117. doi: 10.1016/j.ijcard.2019.08.043. Epub 2019 Aug 22.
193 Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.J Nanobiotechnology. 2018 Apr 13;16(1):38. doi: 10.1186/s12951-018-0365-y.
194 Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution.ACS Omega. 2019 Oct 2;4(16):16943-16955. doi: 10.1021/acsomega.9b02307. eCollection 2019 Oct 15.
195 Metalloproteinases ADAM10 and ADAM17 Mediate Migration and Differentiation in Glioblastoma Sphere-Forming Cells.Mol Neurobiol. 2017 Jul;54(5):3893-3905. doi: 10.1007/s12035-016-0053-6. Epub 2016 Aug 19.
196 FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.Cell Death Dis. 2018 May 1;9(5):469. doi: 10.1038/s41419-018-0482-4.
197 The differential effects of neuroleptic drugs and PACAP on the expression of BDNF mRNA and protein in a human glioblastoma cell line. Acta Neurobiol Exp (Wars). 2017;77(3):205-213.
198 Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors. Neurochem Res. 2017 Apr;42(4):943-952. doi: 10.1007/s11064-016-2127-2. Epub 2016 Nov 30.
199 Interleukin-1 promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production.Cell Death Dis. 2014 Jan 23;5(1):e1020. doi: 10.1038/cddis.2013.562.
200 Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.J Nucl Med. 2010 Feb;51(2):251-258. doi: 10.2967/jnumed.109.069831.
201 Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma.Br J Cancer. 2004 Mar 8;90(5):1059-68. doi: 10.1038/sj.bjc.6601646.
202 Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.Neuropathol Appl Neurobiol. 2018 Feb;44(2):185-206. doi: 10.1111/nan.12428. Epub 2017 Sep 5.
203 Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.Oncogene. 2019 Sep;38(39):6630-6646. doi: 10.1038/s41388-019-0882-7. Epub 2019 Aug 2.
204 A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1.Mol Cancer. 2019 Aug 30;18(1):131. doi: 10.1186/s12943-019-1056-5.
205 ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2.J Exp Clin Cancer Res. 2019 Apr 15;38(1):163. doi: 10.1186/s13046-019-1159-2.
206 Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819846636. doi: 10.1177/1533033819846636.
207 Fibulin-7 is overexpressed in glioblastomas and modulates glioblastoma neovascularization through interaction with angiopoietin-1.Int J Cancer. 2019 Oct 15;145(8):2157-2169. doi: 10.1002/ijc.32306. Epub 2019 Apr 15.
208 ANGPTL4 Induces TMZ Resistance of Glioblastoma by Promoting Cancer Stemness Enrichment via the EGFR/AKT/4E-BP1 Cascade.Int J Mol Sci. 2019 Nov 11;20(22):5625. doi: 10.3390/ijms20225625.
209 The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.J Exp Clin Cancer Res. 2019 Mar 21;38(1):133. doi: 10.1186/s13046-019-1132-0.
210 Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.Cancer Res. 2019 May 1;79(9):2298-2313. doi: 10.1158/0008-5472.CAN-18-0881. Epub 2019 Feb 4.
211 AQP9 expression in glioblastoma multiforme tumors is limited to a small population of astrocytic cells and CD15(+)/CalB(+) leukocytes.PLoS One. 2013 Sep 25;8(9):e75764. doi: 10.1371/journal.pone.0075764. eCollection 2013.
212 Downregulation of -arrestin 1 suppresses glioblastoma cell malignant progression vis inhibition of Src signaling.Exp Cell Res. 2017 Aug 1;357(1):51-58. doi: 10.1016/j.yexcr.2017.04.023. Epub 2017 Apr 22.
213 Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration.J Biol Chem. 2009 Sep 4;284(36):24526-41. doi: 10.1074/jbc.M109.037390. Epub 2009 Jun 26.
214 Integration of gene expression and methylation to unravel biological networks in glioblastoma patients.Genet Epidemiol. 2017 Feb;41(2):136-144. doi: 10.1002/gepi.22028. Epub 2016 Dec 26.
215 microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells.Cancer Biol Ther. 2013 Jul;14(7):574-86. doi: 10.4161/cbt.24597. Epub 2013 May 10.
216 Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.Pathol Res Pract. 2019 Nov;215(11):152617. doi: 10.1016/j.prp.2019.152617. Epub 2019 Aug 23.
217 Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.CNS Neurosci Ther. 2020 Jul;26(7):777. doi: 10.1111/cns.13227. Epub 2019 Oct 2.
218 miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.Tumour Biol. 2014 Jul;35(7):6293-302. doi: 10.1007/s13277-014-1821-4. Epub 2014 Mar 19.
219 Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens.J Pharmacol Exp Ther. 2011 Dec;339(3):851-8. doi: 10.1124/jpet.111.184879. Epub 2011 Aug 31.
220 Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.Biomed Res Int. 2018 Oct 18;2018:6953506. doi: 10.1155/2018/6953506. eCollection 2018.
221 BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.Sci Rep. 2017 Aug 24;7(1):9350. doi: 10.1038/s41598-017-09503-8.
222 Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.Oncotarget. 2015 May 10;6(13):10950-63. doi: 10.18632/oncotarget.3459.
223 PI3K and STAT3: a new alliance.Cancer Discov. 2011 Nov;1(6):481-6. doi: 10.1158/2159-8290.CD-11-0218.
224 Reshaping acetylated peptide selectivity between human BET Brd2 bromodomains BD-I and BD-II in glioblastoma by rationally grafting secondary anchor residues.Gen Physiol Biophys. 2018 Jul;37(4):411-419. doi: 10.4149/gpb_2017063. Epub 2018 Jun 29.
225 PUM2 Promotes Glioblastoma Cell Proliferation and Migration via Repressing BTG1 Expression.Cell Struct Funct. 2019;44(1):29-39. doi: 10.1247/csf.18030.
226 Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.J Neurosurg. 2019 Oct 18;133(6):1683-1694. doi: 10.3171/2019.7.JNS191376.
227 RETRACTED: Serine/threonine kinase BUB1 promotes proliferation and radio-resistance in glioblastoma.Pathol Res Pract. 2019 Aug;215(8):152508. doi: 10.1016/j.prp.2019.152508. Epub 2019 Jun 20.
228 Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma.Neuro Oncol. 2019 Nov 4;21(11):1436-1446. doi: 10.1093/neuonc/noz117.
229 Transcriptomic analysis unveils correlations between regulative apoptotic caspases and genes of cholesterol homeostasis in human brain.PLoS One. 2014 Oct 16;9(10):e110610. doi: 10.1371/journal.pone.0110610. eCollection 2014.
230 CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.Front Immunol. 2019 Nov 14;10:2683. doi: 10.3389/fimmu.2019.02683. eCollection 2019.
231 Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.J Neurooncol. 2019 Jun;143(2):207-220. doi: 10.1007/s11060-019-03161-8. Epub 2019 Apr 4.
232 Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.Neoplasia. 2015 Jun;17(6):518-24. doi: 10.1016/j.neo.2015.06.003.
233 The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.Am J Cancer Res. 2017 Jan 1;7(1):64-76. eCollection 2017.
234 The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):241-252. doi: 10.26355/eurrev_201901_16770.
235 Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma.J Cell Physiol. 2017 Dec;232(12):3622-3630. doi: 10.1002/jcp.25831. Epub 2017 Mar 27.
236 PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma.Sci Rep. 2017 Aug 7;7(1):7391. doi: 10.1038/s41598-017-07745-0.
237 Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activity.J Virol. 2012 Sep;86(17):9369-83. doi: 10.1128/JVI.07181-11. Epub 2012 Jun 20.
238 Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.Biochem Pharmacol. 2007 May 15;73(10):1528-36. doi: 10.1016/j.bcp.2007.01.022. Epub 2007 Jan 21.
239 MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.Neuro Oncol. 2012 Mar;14(3):278-87. doi: 10.1093/neuonc/nor216. Epub 2012 Jan 4.
240 Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.Mol Carcinog. 2019 Aug;58(8):1502-1511. doi: 10.1002/mc.23034. Epub 2019 May 2.
241 CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.J Neuroimmunol. 2012 May 15;246(1-2):10-7. doi: 10.1016/j.jneuroim.2012.02.009. Epub 2012 Mar 16.
242 Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137.
243 PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review.Crit Rev Oncol Hematol. 2019 Mar;135:128-134. doi: 10.1016/j.critrevonc.2018.12.002. Epub 2019 Feb 1.
244 CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.Cancer Med. 2020 Jan;9(1):350-360. doi: 10.1002/cam4.2714. Epub 2019 Nov 19.
245 Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.Cancer Res. 2019 May 15;79(10):2697-2708. doi: 10.1158/0008-5472.CAN-18-3125. Epub 2019 Mar 21.
246 Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.J Neuropathol Exp Neurol. 2017 Aug 1;76(8):697-708. doi: 10.1093/jnen/nlx051.
247 Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.Oncotarget. 2016 Jan 5;7(1):593-609. doi: 10.18632/oncotarget.5477.
248 A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.Cell Rep. 2015 Jun 23;11(11):1809-21. doi: 10.1016/j.celrep.2015.05.027. Epub 2015 Jun 11.
249 A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells.Brain Tumor Pathol. 2011 Jul;28(3):209-14. doi: 10.1007/s10014-011-0037-1. Epub 2011 May 27.
250 Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1516-1524. doi: 10.1016/j.bbadis.2019.03.001. Epub 2019 Mar 13.
251 CDH2 expression is of prognostic significance in glioma and predicts the efficacy of temozolomide therapy in patients with glioblastoma.Oncol Lett. 2018 May;15(5):7415-7422. doi: 10.3892/ol.2018.8227. Epub 2018 Mar 9.
252 CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.Neuro Oncol. 2013 Jul;15(7):865-79. doi: 10.1093/neuonc/not029. Epub 2013 May 3.
253 Estrogen-related receptor activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma.FASEB J. 2019 Dec;33(12):13476-13491. doi: 10.1096/fj.201901075R. Epub 2019 Sep 28.
254 Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.Cancer Res. 2008 Sep 15;68(18):7650-60. doi: 10.1158/0008-5472.CAN-08-1137.
255 Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.Cell Cycle. 2012 Mar 15;11(6):1202-16. doi: 10.4161/cc.11.6.19663. Epub 2012 Mar 15.
256 P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo.J Agric Food Chem. 2013 Mar 20;61(11):2811-9. doi: 10.1021/jf400542m. Epub 2013 Mar 7.
257 CEA-negative glioblastoma and melanoma cells are sensitive to cytosine deaminase/5-fluorocytosine therapy directed by the carcinoembryonic antigen promoter.Acta Biochim Pol. 2004;51(3):723-32.
258 Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.Cell Death Dis. 2019 Feb 11;10(2):118. doi: 10.1038/s41419-019-1383-x.
259 Role of GalNAc4S-6ST in astrocytic tumor progression.PLoS One. 2013;8(1):e54278. doi: 10.1371/journal.pone.0054278. Epub 2013 Jan 17.
260 Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions.Exp Hematol. 2000 Dec;28(12):1441-50. doi: 10.1016/s0301-472x(00)00546-4.
261 Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.Clin Cancer Res. 2012 Jul 1;18(13):3628-36. doi: 10.1158/1078-0432.CCR-12-0339. Epub 2012 May 15.
262 Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.Cancer Cell. 2008 Jan;13(1):69-80. doi: 10.1016/j.ccr.2007.12.005.
263 [(68)Ga]RGD Versus [(18)F]FDG PET Imaging in Monitoring Treatment Response of a Mouse Model of Human Glioblastoma Tumor with Bevacizumab and/or Temozolomide.Mol Imaging Biol. 2019 Apr;21(2):297-305. doi: 10.1007/s11307-018-1224-9.
264 A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma.PLoS Genet. 2013;9(2):e1003253. doi: 10.1371/journal.pgen.1003253. Epub 2013 Feb 14.
265 NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy. Int J Oncol. 2000 Feb;16(2):295-303.
266 MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.Brain Pathol. 2013 Jul;23(4):426-39. doi: 10.1111/bpa.12015. Epub 2013 Jan 10.
267 Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.Oncogene. 2017 Oct 26;36(43):6049-6058. doi: 10.1038/onc.2017.261. Epub 2017 Jul 31.
268 Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.Clin Cancer Res. 2013 Dec 1;19(23):6484-94. doi: 10.1158/1078-0432.CCR-13-0265. Epub 2013 Sep 13.
269 Current Trends in Clinical Development of Gene and Cellular Therapeutic Products for Cancer in Japan.Clin Ther. 2019 Jan;41(1):174-184.e3. doi: 10.1016/j.clinthera.2018.11.003. Epub 2018 Dec 7.
270 Cathepsin L silencing increases As(2)O(3) toxicity in malignantly transformed pilocytic astrocytoma MPA58 cells by activating caspases 3/7.Exp Cell Res. 2017 Jul 1;356(1):64-73. doi: 10.1016/j.yexcr.2017.04.013. Epub 2017 Apr 12.
271 Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.Toxicol Lett. 2014 Aug 4;228(3):248-59. doi: 10.1016/j.toxlet.2014.05.015. Epub 2014 May 27.
272 Macrophage exclusion after radiation therapy (MERT): A new and effective way to increase the therapeutic ratio of radiotherapy.Radiother Oncol. 2020 Mar;144:159-164. doi: 10.1016/j.radonc.2019.11.020. Epub 2019 Dec 5.
273 Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.EMBO Mol Med. 2020 Jan 9;12(1):e10924. doi: 10.15252/emmm.201910924. Epub 2019 Nov 28.
274 Mouse cytochrome b561: cDNA cloning and expression in rat brain, mouse embryos, and human glioma cell lines.DNA Cell Biol. 1998 Sep;17(9):771-7. doi: 10.1089/dna.1998.17.771.
275 Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.Cell Tissue Res. 2020 Jan;379(1):147-155. doi: 10.1007/s00441-019-03127-2. Epub 2019 Nov 26.
276 The synergistic effect of DZNEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells.Int J Oncol. 2020 Jan;56(1):283-300. doi: 10.3892/ijo.2019.4905. Epub 2019 Oct 30.
277 Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.Stem Cells. 2013 Jun;31(6):1064-74. doi: 10.1002/stem.1350.
278 Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.World Neurosurg. 2019 Aug;128:e195-e208. doi: 10.1016/j.wneu.2019.04.089. Epub 2019 Apr 16.
279 Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.PLoS One. 2012;7(8):e43468. doi: 10.1371/journal.pone.0043468. Epub 2012 Aug 21.
280 B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.Int J Oncol. 2016 Dec;49(6):2471-2479. doi: 10.3892/ijo.2016.3729. Epub 2016 Oct 12.
281 Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth.Oncotarget. 2017 Jun 20;8(25):40115-40131. doi: 10.18632/oncotarget.16969.
282 Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.Cancer Invest. 2019;37(3):144-155. doi: 10.1080/07357907.2019.1582060. Epub 2019 Mar 25.
283 Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.J Mol Neurosci. 2019 Nov;69(3):391-398. doi: 10.1007/s12031-019-01368-y. Epub 2019 Jul 2.
284 Biological activity of weekly ONC201 in adult recurrent glioblastoma patients.Neuro Oncol. 2020 Jan 11;22(1):94-102. doi: 10.1093/neuonc/noz164.
285 Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1A.Bioorg Med Chem. 2018 Dec 1;26(22):5852-5869. doi: 10.1016/j.bmc.2018.10.034. Epub 2018 Oct 28.
286 Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.Neuro Oncol. 2018 Aug 2;20(9):1173-1184. doi: 10.1093/neuonc/noy037.
287 Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.JCI Insight. 2019 Apr 4;4(7):e126140. doi: 10.1172/jci.insight.126140. eCollection 2019 Apr 4.
288 Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation.Acta Neuropathol. 2002 Feb;103(2):171-8. doi: 10.1007/s004010100448. Epub 2001 Nov 22.
289 The endothelin system in human glioblastoma.Lab Invest. 2000 Nov;80(11):1681-9. doi: 10.1038/labinvest.3780178.
290 Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells.Oncotarget. 2016 Oct 25;7(43):69770-69782. doi: 10.18632/oncotarget.11974.
291 Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-.Cell Death Dis. 2014 Jul 10;5(7):e1322. doi: 10.1038/cddis.2014.295.
292 A cellular screening assay to test the ability of PKR to induce cell death in mammalian cells.Mol Ther. 2005 Nov;12(5):969-75. doi: 10.1016/j.ymthe.2005.06.442. Epub 2005 Aug 8.
293 GCN2 is essential for CD8(+) T cell survival and function in murine models of malignant glioma.Cancer Immunol Immunother. 2020 Jan;69(1):81-94. doi: 10.1007/s00262-019-02441-6. Epub 2019 Dec 16.
294 Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Oncogene. 2018 Feb 1;37(5):651-662. doi: 10.1038/onc.2017.372. Epub 2017 Oct 9.
295 Inhibiting 4EBP1 in Glioblastoma.Clin Cancer Res. 2018 Jan 1;24(1):14-21. doi: 10.1158/1078-0432.CCR-17-0042. Epub 2017 Jul 10.
296 LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.CNS Neurosci Ther. 2020 Jan;26(1):66-75. doi: 10.1111/cns.13152. Epub 2019 May 17.
297 Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.Sci Rep. 2018 Apr 11;8(1):5805. doi: 10.1038/s41598-018-24046-2.
298 CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.Nature. 2014 Jun 19;510(7505):412-6. doi: 10.1038/nature13261. Epub 2014 May 11.
299 Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer.J Med Chem. 2019 Oct 24;62(20):9254-9269. doi: 10.1021/acs.jmedchem.9b01213. Epub 2019 Oct 3.
300 Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.Nat Neurosci. 2019 May;22(5):729-740. doi: 10.1038/s41593-019-0370-y. Epub 2019 Apr 8.
301 Simultaneous targeting of Eph receptors in glioblastoma.Oncotarget. 2016 Sep 13;7(37):59860-59876. doi: 10.18632/oncotarget.10978.
302 The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.Cell Signal. 2019 Oct;62:109329. doi: 10.1016/j.cellsig.2019.05.014. Epub 2019 May 29.
303 Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.Oncotarget. 2017 Apr 4;8(14):23750-23759. doi: 10.18632/oncotarget.16077.
304 cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.J Neurooncol. 2020 Jan;146(1):9-23. doi: 10.1007/s11060-019-03348-z. Epub 2019 Nov 28.
305 PHF3 expression is frequently reduced in glioma.Cytogenet Cell Genet. 2001;94(3-4):131-6. doi: 10.1159/000048804.
306 Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.PLoS One. 2018 Jan 17;13(1):e0190664. doi: 10.1371/journal.pone.0190664. eCollection 2018.
307 High epiregulin expression in human U87 glioma cells relies on IRE1 and promotes autocrine growth through EGF receptor.BMC Cancer. 2013 Dec 13;13:597. doi: 10.1186/1471-2407-13-597.
308 Dual IRE1 RNase functions dictate glioblastoma development.EMBO Mol Med. 2018 Mar;10(3):e7929. doi: 10.15252/emmm.201707929.
309 Np73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.Neuro Oncol. 2020 Mar 5;22(3):345-356. doi: 10.1093/neuonc/noz190.
310 Expression of factor X in both the rat brain and cells of the central nervous system.FEBS Lett. 1999 Dec 17;463(3):387-9. doi: 10.1016/s0014-5793(99)01657-9.
311 Dynamic MR imaging for functional vascularization depends on tissue factor signaling in glioblastoma.Cancer Biol Ther. 2018 May 4;19(5):416-426. doi: 10.1080/15384047.2018.1423924. Epub 2018 Feb 6.
312 miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP- in glioblastoma.Oncol Lett. 2018 May;15(5):7563-7570. doi: 10.3892/ol.2018.8301. Epub 2018 Mar 20.
313 Translational PBPK Modeling of the Protein Therapeutic and CD95L Inhibitor Asunercept to Develop Dose Recommendations for Its First Use in Pediatric Glioblastoma Patients.Pharmaceutics. 2019 Apr 1;11(4):152. doi: 10.3390/pharmaceutics11040152.
314 FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.Int J Cancer. 2018 Feb 15;142(4):805-812. doi: 10.1002/ijc.31092. Epub 2017 Oct 17.
315 IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcRIIB phosphorylation in glioblastoma.PLoS One. 2019 Sep 27;14(9):e0222999. doi: 10.1371/journal.pone.0222999. eCollection 2019.
316 Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.Exp Mol Med. 2018 Oct 17;50(10):1-12. doi: 10.1038/s12276-018-0166-2.
317 Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.J Clin Invest. 1996 Sep 1;98(5):1165-73. doi: 10.1172/JCI118900.
318 Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.Br J Cancer. 2011 Mar 1;104(5):798-807. doi: 10.1038/bjc.2011.12. Epub 2011 Feb 8.
319 FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated.Mol Immunol. 1999 Sep-Oct;36(13-14):809-18. doi: 10.1016/s0161-5890(99)00101-7.
320 IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.J Histochem Cytochem. 2019 Jul;67(7):481-494. doi: 10.1369/0022155419833334. Epub 2019 Feb 22.
321 Fms related tyrosine kinase 1 (Flt1) functions as an oncogene and regulates glioblastoma cell metastasis by regulating sonic hedgehog signaling.Am J Cancer Res. 2017 May 1;7(5):1164-1176. eCollection 2017.
322 The chloroethylating anticancer drug ACNU induces FRA1 that is involved in drug resistance of glioma cells.Biochim Biophys Acta. 2012 Jul;1823(7):1199-207. doi: 10.1016/j.bbamcr.2012.05.008. Epub 2012 May 15.
323 FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.Oncol Res. 2013;21(2):111-20. doi: 10.3727/096504013X13814233062171.
324 FOXO1 is crucial in glioblastoma cell tumorigenesis and regulates the expression of SIRT1 to suppress senescence in the brain.Mol Med Rep. 2018 Feb;17(2):2535-2542. doi: 10.3892/mmr.2017.8146. Epub 2017 Nov 23.
325 Identification of oligomer proanthocyanidins (F2) isolated from grape seeds as a formyl peptide receptor 1 partial agonist.Int Immunopharmacol. 2013 Apr;15(4):756-63. doi: 10.1016/j.intimp.2013.03.007. Epub 2013 Mar 21.
326 Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells.PLoS One. 2018 Jun 4;13(6):e0198508. doi: 10.1371/journal.pone.0198508. eCollection 2018.
327 Expression of activin A and follistatin in glioblastoma and their effects on U87 in vitro.J Int Med Res. 2010 Jul-Aug;38(4):1343-53. doi: 10.1177/147323001003800416.
328 Novel positioning from obesity to cancer: FTO, an m(6)A RNA demethylase, regulates tumour progression.J Cancer Res Clin Oncol. 2019 Jan;145(1):19-29. doi: 10.1007/s00432-018-2796-0. Epub 2018 Nov 21.
329 Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.Front Cell Dev Biol. 2019 Oct 2;7:217. doi: 10.3389/fcell.2019.00217. eCollection 2019.
330 Cell surface Nestin is a biomarker for glioma stem cells.Biochem Biophys Res Commun. 2013 Apr 19;433(4):496-501. doi: 10.1016/j.bbrc.2013.03.021. Epub 2013 Mar 21.
331 Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway.Int J Mol Med. 2002 Feb;9(2):107-12.
332 miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma.Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4079-4086.
333 G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis.J Neurooncol. 2019 Sep;144(3):463-473. doi: 10.1007/s11060-019-03252-6. Epub 2019 Aug 7.
334 miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors.Int J Oncol. 2012 Jul;41(1):228-34. doi: 10.3892/ijo.2012.1420. Epub 2012 Mar 28.
335 Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells.Free Radic Biol Med. 1998 May;24(7-8):1256-68. doi: 10.1016/s0891-5849(97)00443-7.
336 Correction: Opposing Effects of PI3K/Akt and Smad-Dependent Signaling Pathways in NAG-1-Induced Glioblastoma Cell Apoptosis.PLoS One. 2018 Oct 3;13(10):e0205391. doi: 10.1371/journal.pone.0205391. eCollection 2018.
337 Glial Cell Line-Derived Neurotrophic Factor (GDNF) Promotes Angiogenesis through the Demethylation of the Fibromodulin (FMOD) Promoter in Glioblastoma.Med Sci Monit. 2018 Sep 3;24:6137-6143. doi: 10.12659/MSM.911669.
338 Development of a Cx46 Targeting Strategy for Cancer Stem Cells.Cell Rep. 2019 Apr 23;27(4):1062-1072.e5. doi: 10.1016/j.celrep.2019.03.079.
339 Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy.Neuro Oncol. 2015 Mar;17(3):392-406. doi: 10.1093/neuonc/nou215. Epub 2014 Aug 25.
340 Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.PLoS One. 2019 Mar 6;14(3):e0212455. doi: 10.1371/journal.pone.0212455. eCollection 2019.
341 Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):38-47. doi: 10.1016/j.hbpd.2018.08.008. Epub 2018 Aug 29.
342 AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro.PLoS One. 2019 Feb 4;14(2):e0211644. doi: 10.1371/journal.pone.0211644. eCollection 2019.
343 Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.Oncotarget. 2013 Mar;4(3):422-32. doi: 10.18632/oncotarget.917.
344 The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis.Front Endocrinol (Lausanne). 2017 Aug 4;8:187. doi: 10.3389/fendo.2017.00187. eCollection 2017.
345 GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile.Cell Stem Cell. 2019 Aug 1;25(2):241-257.e8. doi: 10.1016/j.stem.2019.06.004. Epub 2019 Jul 11.
346 The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.Neuro Oncol. 2018 Nov 12;20(12):1594-1605. doi: 10.1093/neuonc/noy117.
347 Transcriptional modulation of calcium-permeable AMPA receptor subunits in glioblastoma by MEK-ERK1/2 inhibitors and their role in invasion.Cell Biol Int. 2020 Mar;44(3):830-837. doi: 10.1002/cbin.11279. Epub 2019 Dec 19.
348 Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.Nat Med. 2002 Sep;8(9):971-8. doi: 10.1038/nm746. Epub 2002 Aug 12.
349 G-protein-coupled receptor kinase-5 promotes glioblastoma progression by targeting the nuclear factor kappa B pathway.Am J Transl Res. 2018 Nov 15;10(11):3370-3384. eCollection 2018.
350 Matched-pair, (86)Y/(90)Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.Nucl Med Biol. 2018 Jul-Aug;62-63:71-77. doi: 10.1016/j.nucmedbio.2018.06.001. Epub 2018 Jun 8.
351 Survival of glioblastoma cells in response to endogenous and exogenous oxidative challenges: possible implication of NMDA receptor-mediated regulation of redox homeostasis.Cell Biol Int. 2019 Dec;43(12):1443-1452. doi: 10.1002/cbin.11193. Epub 2019 Jun 24.
352 Corrigendum: HAX-1 Protects Glioblastoma Cells From Apoptosis Through the Akt1 Pathway.Front Cell Neurosci. 2019 Jan 31;13:13. doi: 10.3389/fncel.2019.00013. eCollection 2019.
353 Aberrant Transcriptional Regulation of Super-enhancers by RET Finger Protein-histone Deacetylase 1 Complex in Glioblastoma: Chemoresistance to Temozolomide.Neurol Med Chir (Tokyo). 2019 Aug 15;59(8):293-298. doi: 10.2176/nmc.ra.2019-0049. Epub 2019 Jun 7.
354 HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.Cancer Lett. 2017 Jul 1;397:1-11. doi: 10.1016/j.canlet.2017.03.028. Epub 2017 Mar 23.
355 Abnormal methylation of histone deacetylase genes: implications on etiology and epigenetic therapy of astrocytomas.Anticancer Res. 2011 Apr;31(4):1337-43.
356 Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.Cancer Chemother Pharmacol. 2018 Dec;82(6):945-952. doi: 10.1007/s00280-018-3684-7. Epub 2018 Sep 12.
357 Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.Int J Cancer. 2006 Feb 1;118(3):583-92. doi: 10.1002/ijc.21362.
358 Measles virus-specific dsRNAs are targets for unwinding/modifying activity in neural cells in vitro.J Neurovirol. 1995 Mar;1(1):92-100. doi: 10.3109/13550289509111013.
359 The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.Mol Cancer Res. 2019 May;17(5):1129-1141. doi: 10.1158/1541-7786.MCR-18-1306. Epub 2019 Feb 22.
360 Dissociation of mitochondrial HK-II elicits mitophagy and confers cardioprotection against ischemia.Cell Death Dis. 2019 Sep 30;10(10):730. doi: 10.1038/s41419-019-1965-7.
361 Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially.PLoS One. 2017 Jan 3;12(1):e0169032. doi: 10.1371/journal.pone.0169032. eCollection 2017.
362 Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.Int J Cancer. 2018 Apr 15;142(8):1627-1639. doi: 10.1002/ijc.31179. Epub 2017 Dec 11.
363 High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.Mol Ther. 2009 Jun;17(6):1003-11. doi: 10.1038/mt.2009.22. Epub 2009 Feb 24.
364 Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors.J Neurochem. 1996 Aug;67(2):482-9. doi: 10.1046/j.1471-4159.1996.67020482.x.
365 HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF- pathways.Oncotarget. 2015 Sep 29;6(29):27778-93. doi: 10.18632/oncotarget.4813.
366 Discovery of Small-Molecule Inhibitors of the HSP90-Calcineurin-NFAT Pathway against Glioblastoma.Cell Chem Biol. 2019 Mar 21;26(3):352-365.e7. doi: 10.1016/j.chembiol.2018.11.009. Epub 2019 Jan 10.
367 GRP78-targeted in-silico virtual screening of novel anticancer agents.Chem Biol Drug Des. 2018 Aug;92(2):1555-1566. doi: 10.1111/cbdd.13322. Epub 2018 May 31.
368 Hsp22 (HspB8/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells.J Cell Physiol. 2011 Nov;226(11):2747-51. doi: 10.1002/jcp.22868.
369 Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.Crit Rev Oncol Hematol. 2018 Aug;128:96-109. doi: 10.1016/j.critrevonc.2018.06.004. Epub 2018 Jun 11.
370 ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.Cancer Res. 2019 Aug 15;79(16):4057-4071. doi: 10.1158/0008-5472.CAN-18-1357. Epub 2019 Jul 10.
371 Downregulation of Id2 increases chemosensitivity of glioma.Tumour Biol. 2015 Jun;36(6):4189-96. doi: 10.1007/s13277-015-3055-5. Epub 2015 Mar 14.
372 Toxoplasma Effector GRA15-Dependent Suppression of IFN--Induced Antiparasitic Response in Human Neurons.Front Cell Infect Microbiol. 2019 May 1;9:140. doi: 10.3389/fcimb.2019.00140. eCollection 2019.
373 JCOG0911 INTEGRA study: a randomized screening phase II trial of interferon plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20.
374 IGFBP2 promotes neural stem cell maintenance and proliferation differentially associated with glioblastoma subtypes.Brain Res. 2019 Feb 1;1704:174-186. doi: 10.1016/j.brainres.2018.10.018. Epub 2018 Oct 19.
375 IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.Cell Commun Signal. 2018 Sep 19;16(1):61. doi: 10.1186/s12964-018-0273-7.
376 Isoalantolactone inhibits IKK kinase activity to interrupt the NF-B/COX-2-mediated signaling cascade and induces apoptosis regulated by the mitochondrial translocation of cofilin in glioblastoma.Cancer Med. 2019 Apr;8(4):1655-1670. doi: 10.1002/cam4.2013. Epub 2019 Feb 10.
377 A novel interleukin-13 receptor alpha 2-targeted hybrid peptide for effective glioblastoma therapy.Chem Biol Drug Des. 2019 Jul;94(1):1402-1413. doi: 10.1111/cbdd.13517. Epub 2019 Apr 22.
378 Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors.Arch Immunol Ther Exp (Warsz). 2007 Jan-Feb;55(1):41-7. doi: 10.1007/s00005-007-0003-0.
379 IL-20 is regulated by hypoxia-inducible factor and up-regulated after experimental ischemic stroke.J Immunol. 2009 Apr 15;182(8):5003-12. doi: 10.4049/jimmunol.0803653.
380 Differential effects of ferritin, calcium, zinc, and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes.J Lab Clin Med. 1994 Apr;123(4):547-55.
381 Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.Clin Cancer Res. 2008 Oct 15;14(20):6640-6. doi: 10.1158/1078-0432.CCR-07-4681.
382 Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling. Sci Rep. 2017 Jun 19;7(1):3815.
383 IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma.Nat Cell Biol. 2019 Aug;21(8):1003-1014. doi: 10.1038/s41556-019-0363-9. Epub 2019 Aug 1.
384 Molecular and Structural Traits of Insulin Receptor Substrate 1/LC3 Nuclear Structures and Their Role in Autophagy Control and Tumor Cell Survival.Mol Cell Biol. 2018 Apr 30;38(10):e00608-17. doi: 10.1128/MCB.00608-17. Print 2018 May 15.
385 Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines.Int J Cancer. 2011 Nov 15;129(10):2527-31. doi: 10.1002/ijc.25917. Epub 2011 Apr 1.
386 ITGA2 as a potential nanotherapeutic target for glioblastoma.Sci Rep. 2019 Apr 17;9(1):6195. doi: 10.1038/s41598-019-42643-7.
387 Loss of CHSY1, a secreted FRINGE enzyme, causes syndromic brachydactyly in humans via increased NOTCH signaling. Am J Hum Genet. 2010 Dec 10;87(6):768-78. doi: 10.1016/j.ajhg.2010.11.005.
388 Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.Tumour Biol. 2015 Aug;36(8):5873-9. doi: 10.1007/s13277-015-3259-8. Epub 2015 Feb 25.
389 MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether--go-go (EAG1). Eur J Cancer. 2013 Feb;49(3):710-24.
390 Administration of Non-Torsadogenic human Ether--go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients.Clin Cancer Res. 2017 Jan 1;23(1):73-80. doi: 10.1158/1078-0432.CCR-15-3169. Epub 2016 Sep 15.
391 Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.Tumour Biol. 2014 Mar;35(3):1855-62. doi: 10.1007/s13277-013-1247-4. Epub 2013 Oct 6.
392 Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.Biol Pharm Bull. 2019;42(3):481-488. doi: 10.1248/bpb.b18-00892.
393 Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.Oncotarget. 2017 May 23;8(21):34896-34910. doi: 10.18632/oncotarget.16820.
394 Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells.Cancers (Basel). 2019 Jun 24;11(6):878. doi: 10.3390/cancers11060878.
395 HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3.Theranostics. 2019 Mar 16;9(7):1909-1922. doi: 10.7150/thno.30578. eCollection 2019.
396 KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?.BMC Cancer. 2009 Jun 22;9:196. doi: 10.1186/1471-2407-9-196.
397 NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.J Immunol. 2014 Dec 15;193(12):6192-206. doi: 10.4049/jimmunol.1400859. Epub 2014 Nov 7.
398 Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma.Int J Cancer. 2018 Dec 15;143(12):3201-3208. doi: 10.1002/ijc.31661. Epub 2018 Sep 24.
399 LAPTM4B-35 is a novel prognostic factor for glioblastoma.J Neurooncol. 2017 Apr;132(2):295-303. doi: 10.1007/s11060-017-2369-0. Epub 2017 Jan 18.
400 Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles.Int J Nanomedicine. 2017 Nov 27;12:8495-8510. doi: 10.2147/IJN.S145326. eCollection 2017.
401 Upregulation of LGMNP1 confers radiotherapy resistance in glioblastoma.Oncol Rep. 2019 Jun;41(6):3435-3443. doi: 10.3892/or.2019.7128. Epub 2019 Apr 18.
402 Bidirectional Regulation between NDRG1 and GSK3 Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.Cancer Res. 2020 Jan 15;80(2):234-248. doi: 10.1158/0008-5472.CAN-19-0438. Epub 2019 Nov 13.
403 Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.Oncotarget. 2014 Aug 30;5(16):6687-700. doi: 10.18632/oncotarget.2235.
404 Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.Cancer Res. 2020 Jan 1;80(1):69-78. doi: 10.1158/0008-5472.CAN-19-1237. Epub 2019 Oct 22.
405 HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.Cancer Res. 2004 Jul 15;64(14):4980-6. doi: 10.1158/0008-5472.CAN-03-3504.
406 Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.EMBO J. 2020 Jan 2;39(1):e102030. doi: 10.15252/embj.2019102030. Epub 2019 Nov 27.
407 Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma.CNS Neurosci Ther. 2020 Mar;26(3):297-308. doi: 10.1111/cns.13197. Epub 2019 Jul 18.
408 Inhibition of SAPK2/p38 enhances sensitivity to mTORC1 inhibition by blocking IRES-mediated translation initiation in glioblastoma.Mol Cancer Ther. 2011 Dec;10(12):2244-56. doi: 10.1158/1535-7163.MCT-11-0478. Epub 2011 Sep 12.
409 TNF inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNF signaling.Cancer Biol Med. 2019 Aug;16(3):606-617. doi: 10.20892/j.issn.2095-3941.2019.0011.
410 Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation.Biochem J. 2005 Oct 15;391(Pt 2):191-202. doi: 10.1042/BJ20050272.
411 Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol. 2019 Jun;54(6):2039-2053. doi: 10.3892/ijo.2019.4766. Epub 2019 Mar 29.
412 Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.FASEB J. 2012 Jun;26(6):2639-47. doi: 10.1096/fj.11-202820. Epub 2012 Mar 13.
413 Evidence for a mechanism of demyelination by human JC virus: negative transcriptional regulation of RNA and protein levels from myelin basic protein gene by large tumor antigen in human glioblastoma cells.J Med Virol. 1996 Jul;49(3):205-11. doi: 10.1002/(SICI)1096-9071(199607)49:3<205::AID-JMV8>3.0.CO;2-8.
414 Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.Mol Neurobiol. 2018 Feb;55(2):1396-1404. doi: 10.1007/s12035-017-0414-9. Epub 2017 Feb 1.
415 Transient Receptor Potential Mucolipin-1 Channels in Glioblastoma: Role in Patient's Survival.Cancers (Basel). 2019 Apr 12;11(4):525. doi: 10.3390/cancers11040525.
416 Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR.Brain Tumor Pathol. 2011 Oct;28(4):291-6. doi: 10.1007/s10014-011-0046-0. Epub 2011 Jun 21.
417 Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2.J Neurooncol. 2018 Jan;136(2):243-254. doi: 10.1007/s11060-017-2663-x. Epub 2017 Nov 8.
418 N-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1.FEBS Lett. 2020 Jan;594(2):358-366. doi: 10.1002/1873-3468.13596. Epub 2019 Sep 17.
419 Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.ChemMedChem. 2019 Jun 18;14(12):1152-1161. doi: 10.1002/cmdc.201900180. Epub 2019 May 14.
420 Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric Glioma.Pathobiology. 2017;84(2):99-107. doi: 10.1159/000447951. Epub 2016 Aug 24.
421 Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.Neurol Res. 2015 Feb;37(2):95-105. doi: 10.1179/1743132814Y.0000000409. Epub 2014 Jul 4.
422 Dual functions of ARP101 in targeting membrane type-1 matrix metalloproteinase: Impact on U87 glioblastoma cell invasion and autophagy signaling.Chem Biol Drug Des. 2019 Mar;93(3):272-282. doi: 10.1111/cbdd.13410. Epub 2018 Oct 30.
423 Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.Am J Pathol. 1999 Feb;154(2):417-28. doi: 10.1016/S0002-9440(10)65288-1.
424 miR-146b-5p inhibits glioma migration and invasion by targeting MMP16.Cancer Lett. 2013 Oct 10;339(2):260-9. doi: 10.1016/j.canlet.2013.06.018. Epub 2013 Jun 22.
425 Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma: The PLATUM trial.Neurology. 2019 Nov 5;93(19):e1799-e1806. doi: 10.1212/WNL.0000000000008440. Epub 2019 Oct 4.
426 Musashi1 enhances chemotherapy resistance of pediatric glioblastoma cells in vitro.Pediatr Res. 2020 Mar;87(4):669-676. doi: 10.1038/s41390-019-0628-9. Epub 2019 Nov 22.
427 Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.Oncotarget. 2017 Aug 16;8(46):80208-80222. doi: 10.18632/oncotarget.20303. eCollection 2017 Oct 6.
428 BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells.Cell Death Dis. 2019 Nov 21;10(12):881. doi: 10.1038/s41419-019-2120-1.
429 NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis.Oncotarget. 2017 Aug 28;8(59):99514-99530. doi: 10.18632/oncotarget.20577. eCollection 2017 Nov 21.
430 NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.Nat Med. 2012 Dec;18(12):1827-34. doi: 10.1038/nm.3013. Epub 2012 Nov 25.
431 GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1 destabilization.Carcinogenesis. 2013 Aug;34(8):1728-36. doi: 10.1093/carcin/bgt125. Epub 2013 Apr 11.
432 The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.Cancers (Basel). 2019 Nov 22;11(12):1849. doi: 10.3390/cancers11121849.
433 NFKB1: a suppressor of inflammation, ageing and cancer.FEBS J. 2016 May;283(10):1812-22. doi: 10.1111/febs.13627. Epub 2016 Jan 13.
434 A mechanism of c-raf-1 activation: fusion of the lipocortin II amino-terminal sequence with the c-raf-1 kinase domain.Oncogene. 1989 Apr;4(4):437-42.
435 NEK9 depletion induces catastrophic mitosis by impairment of mitotic checkpoint control and spindle dynamics.Biochem Biophys Res Commun. 2013 Dec 13;442(3-4):139-46. doi: 10.1016/j.bbrc.2013.04.105. Epub 2013 May 9.
436 miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.Int J Cancer. 2018 Aug 1;143(3):635-644. doi: 10.1002/ijc.31329. Epub 2018 Mar 2.
437 Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.Int J Mol Med. 2014 Nov;34(5):1233-40. doi: 10.3892/ijmm.2014.1932. Epub 2014 Sep 12.
438 Cancer stem cell markers in glioblastoma - an update.Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3207-3211.
439 A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.Front Neurol. 2018 Dec 17;9:1087. doi: 10.3389/fneur.2018.01087. eCollection 2018.
440 miR-331-3p regulates expression of neuropilin-2 in glioblastoma.J Neurooncol. 2014 Jan;116(1):67-75. doi: 10.1007/s11060-013-1271-7. Epub 2013 Oct 19.
441 Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.Cell Physiol Biochem. 2018;49(6):2382-2395. doi: 10.1159/000493838. Epub 2018 Sep 27.
442 miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.Int J Mol Med. 2016 Jun;37(6):1627-35. doi: 10.3892/ijmm.2016.2562. Epub 2016 Apr 13.
443 Modeled microgravity suppressed invasion and migration of human glioblastoma U87 cells through downregulating store-operated calcium entry.Biochem Biophys Res Commun. 2015 Feb 13;457(3):378-84. doi: 10.1016/j.bbrc.2014.12.120. Epub 2015 Jan 9.
444 Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.J Cell Physiol. 2019 Sep;234(9):15496-15509. doi: 10.1002/jcp.28197. Epub 2019 Jan 28.
445 Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells.PLoS One. 2014 Jan 22;9(1):e85591. doi: 10.1371/journal.pone.0085591. eCollection 2014.
446 Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.Oncogene. 2019 May;38(21):4154-4168. doi: 10.1038/s41388-019-0714-9. Epub 2019 Jan 31.
447 Glioblastomas require integrin v3/PAK4 signaling to escape senescence.Cancer Res. 2015 Nov 1;75(21):4466-73. doi: 10.1158/0008-5472.CAN-15-0988. Epub 2015 Aug 21.
448 Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.Nat Commun. 2019 Dec 11;10(1):5654. doi: 10.1038/s41467-019-13508-4.
449 PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.J Mol Neurosci. 2020 Jan;70(1):56-64. doi: 10.1007/s12031-019-01400-1. Epub 2019 Oct 15.
450 Identification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genes.Neuropathol Appl Neurobiol. 2012 Apr;38(2):201-12. doi: 10.1111/j.1365-2990.2011.01207.x.
451 PD-L1/PD-1 Axis in Glioblastoma Multiforme.Int J Mol Sci. 2019 Oct 28;20(21):5347. doi: 10.3390/ijms20215347.
452 Characterization of inhibitors of phosphodiesterase 1C on a human cellular system.FEBS J. 2007 Sep;274(18):4812-24. doi: 10.1111/j.1742-4658.2007.06001.x. Epub 2007 Aug 14.
453 Identification of novel genetic alterations in samples of malignant glioma patients.PLoS One. 2013 Dec 16;8(12):e82108. doi: 10.1371/journal.pone.0082108. eCollection 2013.
454 PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines.Cells. 2018 Sep 6;7(9):131. doi: 10.3390/cells7090131.
455 The PDK1/cJun pathway activated by TGF?induces EMT and promotes proliferation and invasion in human glioblastoma.Int J Oncol. 2018 Nov;53(5):2067-2080. doi: 10.3892/ijo.2018.4525. Epub 2018 Aug 14.
456 IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.Cancer Res. 2015 Aug 1;75(15):2999-3009. doi: 10.1158/0008-5472.CAN-15-0840. Epub 2015 Jun 4.
457 TGF- induces oncofetal fibronectin that, in turn, modulates TGF- superfamily signaling in endothelial cells.J Cell Sci. 2018 Jan 9;131(1):jcs209619. doi: 10.1242/jcs.209619.
458 Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells.Biochem Biophys Res Commun. 2018 Jun 7;500(3):569-576. doi: 10.1016/j.bbrc.2018.04.091. Epub 2018 Apr 25.
459 PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.Cell Death Dis. 2019 Jan 18;10(2):51. doi: 10.1038/s41419-018-1293-3.
460 The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.Biomolecules. 2018 Oct 11;8(4):112. doi: 10.3390/biom8040112.
461 Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis.Front Oncol. 2019 Oct 2;9:993. doi: 10.3389/fonc.2019.00993. eCollection 2019.
462 The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.Sci Rep. 2018 Feb 14;8(1):2982. doi: 10.1038/s41598-018-21358-1.
463 Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.Mol Neurobiol. 2016 Nov;53(9):6511-6525. doi: 10.1007/s12035-015-9518-2. Epub 2015 Nov 28.
464 Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells.J Biol Chem. 2014 Jan 10;289(2):600-16. doi: 10.1074/jbc.M113.532978. Epub 2013 Nov 20.
465 The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle.Nanomedicine. 2018 Apr;14(3):991-1003. doi: 10.1016/j.nano.2018.01.004. Epub 2018 Jan 12.
466 PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.Cancer Lett. 2019 Feb 28;443:91-107. doi: 10.1016/j.canlet.2018.11.034. Epub 2018 Dec 4.
467 Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma.J Cell Mol Med. 2020 Mar;24(5):2847-2856. doi: 10.1111/jcmm.14840. Epub 2019 Nov 28.
468 The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.Oncotarget. 2015 Sep 8;6(26):22653-65. doi: 10.18632/oncotarget.4248.
469 Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow.Methods. 2017 Feb 1;114:60-73. doi: 10.1016/j.ymeth.2016.09.014. Epub 2016 Oct 7.
470 Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.Cancer Gene Ther. 2005 Dec;12(12):947-53. doi: 10.1038/sj.cgt.7700855.
471 shRNA-mediated PPAR knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth.J Pathol. 2019 Apr;247(4):422-434. doi: 10.1002/path.5201. Epub 2018 Dec 27.
472 Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes.Cancer Res. 2010 Aug 15;70(16):6437-47. doi: 10.1158/0008-5472.CAN-10-0819. Epub 2010 Jul 27.
473 Cooperative Blockade of PKC and JAK2 Drives Apoptosis in Glioblastoma.Cancer Res. 2020 Feb 15;80(4):709-718. doi: 10.1158/0008-5472.CAN-18-2808. Epub 2019 Dec 5.
474 Enhancement of DNA double-strand break induction and cell killing by K-shell absorption of phosphorus in human cell lines.Int J Radiat Biol. 2016 Nov;92(11):724-732. doi: 10.1080/09553002.2016.1179811. Epub 2016 May 17.
475 The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells.Sci Rep. 2019 Nov 4;9(1):15925. doi: 10.1038/s41598-019-52291-6.
476 Prion Protein in Glioblastoma Multiforme.Int J Mol Sci. 2019 Oct 15;20(20):5107. doi: 10.3390/ijms20205107.
477 Discovery of physiological and cancer-related regulators of 3' UTR processing with KAPAC.Genome Biol. 2018 Mar 28;19(1):44. doi: 10.1186/s13059-018-1415-3.
478 Methylation of hypoxia-inducible factor (HIF)-1 by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration.Nucleic Acids Res. 2018 Jul 27;46(13):6576-6591. doi: 10.1093/nar/gky449.
479 Interplay of VEGFa and MMP2 regulates invasion of glioblastoma.Tumour Biol. 2014 Dec;35(12):11879-85. doi: 10.1007/s13277-014-2438-3. Epub 2014 Sep 12.
480 Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth.Nat Commun. 2017 Jun 1;8:15080. doi: 10.1038/ncomms15080.
481 PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.Theranostics. 2018 Feb 7;8(6):1527-1539. doi: 10.7150/thno.22699. eCollection 2018.
482 miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma. Oncogene. 2019 Apr;38(16):2923-2936.
483 Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.Cell Oncol (Dordr). 2019 Jun;42(3):287-301. doi: 10.1007/s13402-019-00425-3. Epub 2019 Mar 11.
484 CREB regulates AChE-R-induced proliferation of human glioblastoma cells.Neoplasia. 2004 May-Jun;6(3):279-86. doi: 10.1593/neo.3424.
485 CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.Sci Rep. 2019 Mar 14;9(1):4444. doi: 10.1038/s41598-019-40327-w.
486 CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.Br J Cancer. 2017 Jun 27;117(1):102-112. doi: 10.1038/bjc.2017.157. Epub 2017 Jun 1.
487 The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.Int J Biochem Cell Biol. 2014 Apr;49:8-16. doi: 10.1016/j.biocel.2014.01.007. Epub 2014 Jan 13.
488 RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NFB and p38 signaling pathways.Oncol Rep. 2018 Jun;39(6):2915-2923. doi: 10.3892/or.2018.6397. Epub 2018 Apr 23.
489 RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.Genome Res. 2014 Nov;24(11):1765-73. doi: 10.1101/gr.165126.113. Epub 2014 Aug 18.
490 GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1089-1099. doi: 10.1093/jnen/nlz093.
491 RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics.Oncotarget. 2016 Nov 29;7(48):79869-79884. doi: 10.18632/oncotarget.13084.
492 With GBM, T Cells May Be Stuck in Bone Marrow.Cancer Discov. 2018 Oct;8(10):1203-1204. doi: 10.1158/2159-8290.CD-NB2018-117. Epub 2018 Sep 5.
493 miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1.Oncol Lett. 2019 Feb;17(2):1819-1825. doi: 10.3892/ol.2018.9777. Epub 2018 Nov 28.
494 Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.Cancer Cell. 2015 Nov 9;28(5):569-581. doi: 10.1016/j.ccell.2015.09.021.
495 Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.Elife. 2017 Oct 4;6:e25281. doi: 10.7554/eLife.25281.
496 Upregulation of C1-inhibitor in pancreatic cancer.Oncotarget. 2019 Oct 1;10(55):5703-5712. doi: 10.18632/oncotarget.27191. eCollection 2019 Oct 1.
497 Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma.Cancers (Basel). 2018 Dec 27;11(1):25. doi: 10.3390/cancers11010025.
498 Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.Cancer Res. 2019 Apr 1;79(7):1369-1382. doi: 10.1158/0008-5472.CAN-18-2558. Epub 2019 Jan 25.
499 SIRT5 downregulation is associated with poor prognosis in glioblastoma.Cancer Biomark. 2019;24(4):449-459. doi: 10.3233/CBM-182197.
500 A Derivate of Benzimidazole-Isoquinolinone Induces SKP2 Transcriptional Inhibition to Exert Anti-Tumor Activity in Glioblastoma Cells.Molecules. 2019 Jul 26;24(15):2722. doi: 10.3390/molecules24152722.
501 NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.J Cell Physiol. 2019 Feb;234(2):1630-1642. doi: 10.1002/jcp.27033. Epub 2018 Aug 29.
502 Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins.Eur J Neurosci. 2003 May;17(10):2106-18. doi: 10.1046/j.1460-9568.2003.02657.x.
503 Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma.Int J Cancer. 2019 May 15;144(10):2539-2554. doi: 10.1002/ijc.31985. Epub 2019 Jan 5.
504 Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.J Neurooncol. 2018 Jul;138(3):557-569. doi: 10.1007/s11060-018-2823-7. Epub 2018 Mar 10.
505 Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.Anticancer Drugs. 2020 Jan;31(1):27-34. doi: 10.1097/CAD.0000000000000825.
506 Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H?extrusion, cell migration and survival.Carcinogenesis. 2014 Sep;35(9):2014-24. doi: 10.1093/carcin/bgu089. Epub 2014 Apr 9.
507 Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.J Exp Clin Cancer Res. 2012 May 31;31(1):52. doi: 10.1186/1756-9966-31-52.
508 Phytochemical, antioxidant, anti-proliferative and antimicrobial properties of Catharanthus roseus root extract, saponin-enriched and aqueous fractions.Mol Biol Rep. 2019 Jun;46(3):3265-3273. doi: 10.1007/s11033-019-04786-8. Epub 2019 Apr 3.
509 Sortilin promotes glioblastoma invasion and mesenchymal transition through GSK-3/-catenin/twist pathway.Cell Death Dis. 2019 Feb 27;10(3):208. doi: 10.1038/s41419-019-1449-9.
510 Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.Oncotarget. 2017 Apr 11;8(15):24815-24827. doi: 10.18632/oncotarget.15820.
511 Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.FASEB J. 2019 May;33(5):5864-5875. doi: 10.1096/fj.201801450RRR. Epub 2019 Feb 28.
512 MicroRNA regulating stanniocalcin-1 is a metastasis and dissemination promoting factor in glioblastoma.J Neurooncol. 2019 Apr;142(2):241-251. doi: 10.1007/s11060-019-03113-2. Epub 2019 Jan 30.
513 Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma.PLoS One. 2013 Nov 28;8(11):e81803. doi: 10.1371/journal.pone.0081803. eCollection 2013.
514 Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.PLoS Genet. 2015 Jan 28;11(1):e1004976. doi: 10.1371/journal.pgen.1004976. eCollection 2015 Jan.
515 Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma Cells. Chem Res Toxicol. 2016 Jan 19;29(1):101-8. doi: 10.1021/acs.chemrestox.5b00452. Epub 2015 Dec 30.
516 Inhibition of Human DNA Polymerases Eta and Kappa by Indole-Derived Molecules Occurs through Distinct Mechanisms.ACS Chem Biol. 2019 Jun 21;14(6):1337-1351. doi: 10.1021/acschembio.9b00304. Epub 2019 May 22.
517 Multiple cancer pathways regulate telomereprotection.EMBO Mol Med. 2019 Jul;11(7):e10292. doi: 10.15252/emmm.201910292. Epub 2019 Jun 13.
518 Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells.Glia. 2014 Oct;62(10):1687-98. doi: 10.1002/glia.22708. Epub 2014 Jun 7.
519 Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines.J Cell Physiol. 2012 Mar;227(3):939-51. doi: 10.1002/jcp.22805.
520 TGF-2 Induces Gli1 in a Smad3-Dependent Manner Against Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.Front Neurosci. 2019 Jun 26;13:636. doi: 10.3389/fnins.2019.00636. eCollection 2019.
521 The complex role of transglutaminase 2 in glioblastoma proliferation.Neuro Oncol. 2017 Feb 1;19(2):208-218. doi: 10.1093/neuonc/now157.
522 Deciphering the complex role of thrombospondin-1 in glioblastoma development.Nat Commun. 2019 Mar 8;10(1):1146. doi: 10.1038/s41467-019-08480-y.
523 Thymosin 4 gene silencing decreases stemness and invasiveness in glioblastoma.Brain. 2014 Feb;137(Pt 2):433-48. doi: 10.1093/brain/awt333. Epub 2013 Dec 18.
524 Epigenetic reactivation of RANK in glioblastoma cells by curcumin: involvement of STAT3 inhibition.DNA Cell Biol. 2013 Jun;32(6):292-7. doi: 10.1089/dna.2013.2042. Epub 2013 Apr 27.
525 The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.Oncogene. 2016 Apr 28;35(17):2145-55. doi: 10.1038/onc.2015.310. Epub 2015 Aug 24.
526 CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers.Ann Clin Transl Neurol. 2018 Oct 19;5(12):1611-1616. doi: 10.1002/acn3.668. eCollection 2018 Dec.
527 DR4-Ser424 O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death.Cancer Res. 2019 Jun 1;79(11):2839-2852. doi: 10.1158/0008-5472.CAN-18-1991. Epub 2019 Apr 15.
528 The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors.Am J Pathol. 2003 Apr;162(4):1313-21. doi: 10.1016/S0002-9440(10)63927-2.
529 Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.Oncogene. 2004 Apr 15;23(17):3005-12. doi: 10.1038/sj.onc.1207350.
530 TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.Neuroreport. 2019 Jan 16;30(2):127-133. doi: 10.1097/WNR.0000000000001171.
531 Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.Eur J Neurosci. 2004 Nov;20(10):2617-28. doi: 10.1111/j.1460-9568.2004.03729.x.
532 Expression of TRH and TRH-like peptides in a human glioblastoma-astrocytoma cell line (U-373-MG).J Endocrinol. 2000 Sep;166(3):697-703. doi: 10.1677/joe.0.1660697.
533 TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.Nat Commun. 2017 Nov 13;8(1):1454. doi: 10.1038/s41467-017-01731-w.
534 Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.Cell Rep. 2019 Feb 26;26(9):2274-2281.e5. doi: 10.1016/j.celrep.2019.01.109.
535 TRIM28 activates autophagy and promotes cell proliferation in glioblastoma.Onco Targets Ther. 2019 Jan 3;12:397-404. doi: 10.2147/OTT.S188101. eCollection 2019.
536 Selenium Enhances the Apoptotic Efficacy of Docetaxel Through Activation of TRPM2 Channel in DBTRG Glioblastoma Cells.Neurotox Res. 2019 May;35(4):797-808. doi: 10.1007/s12640-019-0009-5. Epub 2019 Feb 22.
537 The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7.Oncotarget. 2018 Sep 7;9(70):33302-33311. doi: 10.18632/oncotarget.26048. eCollection 2018 Sep 7.
538 TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.Neuro Oncol. 2020 Feb 20;22(2):240-252. doi: 10.1093/neuonc/noz183.
539 FUS1 acts as a tumor-suppressor gene by upregulating miR-197 in human glioblastoma.Oncol Rep. 2015 Aug;34(2):868-76. doi: 10.3892/or.2015.4069. Epub 2015 Jun 16.
540 SK channel activation potentiates auranofin-induced cell death in glio- and neuroblastoma cells.Biochem Pharmacol. 2020 Jan;171:113714. doi: 10.1016/j.bcp.2019.113714. Epub 2019 Nov 15.
541 Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma.Hum Mol Genet. 2019 Nov 1;28(21):3664-3679. doi: 10.1093/hmg/ddz152.
542 NCoR controls glioblastoma tumor cell characteristics.Neuro Oncol. 2014 Jan;16(2):241-9. doi: 10.1093/neuonc/not214. Epub 2013 Dec 12.
543 Aberrant Activation of -Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.Cancer Res. 2019 Jan 1;79(1):72-85. doi: 10.1158/0008-5472.CAN-18-1304. Epub 2018 Nov 13.
544 Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway.Oncol Rep. 2016 Nov;36(5):2935-2945. doi: 10.3892/or.2016.5099. Epub 2016 Sep 16.
545 Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept.Cells. 2019 Oct 28;8(11):1330. doi: 10.3390/cells8111330.
546 VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.Neuro Oncol. 2018 Oct 9;20(11):1462-1474. doi: 10.1093/neuonc/noy103.
547 Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells.Brain Tumor Pathol. 2002;19(2):77-81. doi: 10.1007/BF02478931.
548 Targeting VPAC1 Receptors for Imaging Glioblastoma.Mol Imaging Biol. 2020 Apr;22(2):293-302. doi: 10.1007/s11307-019-01388-5.
549 Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.Neuro Oncol. 2018 Jan 10;20(1):78-91. doi: 10.1093/neuonc/nox128.
550 Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.Cancer Manag Res. 2019 Apr 10;11:2803-2815. doi: 10.2147/CMAR.S190999. eCollection 2019.
551 Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.Lab Invest. 2011 Jul;91(7):1068-78. doi: 10.1038/labinvest.2011.56. Epub 2011 Apr 11.
552 Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.
553 The involvement of anterior gradient 2 in the stromal cell-derived factor 1-induced epithelial-mesenchymal transition of glioblastoma.Tumour Biol. 2016 May;37(5):6091-7. doi: 10.1007/s13277-015-4481-0. Epub 2015 Nov 25.
554 Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.Stem Cells. 2014 May;32(5):1110-23. doi: 10.1002/stem.1614.
555 Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.J Neurooncol. 2013 Jul;113(3):441-9. doi: 10.1007/s11060-013-1133-3. Epub 2013 Apr 28.
556 ATP7B expression in human glioblastoma is related to temozolomide resistance.Oncol Lett. 2017 Dec;14(6):7777-7782. doi: 10.3892/ol.2017.7249. Epub 2017 Oct 23.
557 MicroRNA-339-5p down-regulates protein expression of -site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.J Biol Chem. 2014 Feb 21;289(8):5184-98. doi: 10.1074/jbc.M113.518241. Epub 2013 Dec 18.
558 Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.Neuropharmacology. 2019 Jan;144:143-154. doi: 10.1016/j.neuropharm.2018.10.033. Epub 2018 Oct 23.
559 Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment.J Neurosci Res. 2012 Apr;90(4):769-81. doi: 10.1002/jnr.22794. Epub 2011 Dec 20.
560 Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.Nature. 2015 Mar 19;519(7543):366-9. doi: 10.1038/nature14320. Epub 2015 Mar 11.
561 Expression and prognostic significance of CCL11/CCR3 in glioblastoma.Oncotarget. 2016 May 31;7(22):32617-27. doi: 10.18632/oncotarget.8958.
562 Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis.Nat Commun. 2016 Feb 3;7:10637. doi: 10.1038/ncomms10637.
563 EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.Int J Oncol. 2015 Aug;47(2):481-9. doi: 10.3892/ijo.2015.3051. Epub 2015 Jun 16.
564 Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.Cell Signal. 2014 Dec;26(12):2896-902. doi: 10.1016/j.cellsig.2014.08.027. Epub 2014 Sep 6.
565 DGK Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma.Int J Biol Sci. 2019 Jul 20;15(9):1872-1881. doi: 10.7150/ijbs.35193. eCollection 2019.
566 Common genetic variations of deiodinase genes and prognosis of brain tumor patients.Endocrine. 2019 Dec;66(3):563-572. doi: 10.1007/s12020-019-02016-6. Epub 2019 Aug 26.
567 ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.Cell Death Dis. 2019 Sep 18;10(10):690. doi: 10.1038/s41419-019-1934-1.
568 Molecular features of pleomorphic xanthoastrocytoma.Hum Pathol. 2019 Apr;86:38-48. doi: 10.1016/j.humpath.2018.08.038. Epub 2018 Nov 26.
569 Liposomal delivery of ferritin heavy chain 1 (FTH1) siRNA in patient xenograft derived glioblastoma initiating cells suggests different sensitivities to radiation and distinct survival mechanisms.PLoS One. 2019 Sep 6;14(9):e0221952. doi: 10.1371/journal.pone.0221952. eCollection 2019.
570 GLI2 promotes cell proliferation and migration through transcriptional activation of ARHGEF16 in human glioma cells.J Exp Clin Cancer Res. 2018 Oct 11;37(1):247. doi: 10.1186/s13046-018-0917-x.
571 The Role of Integrin 6 (CD49f) in Stem Cells: More than a Conserved Biomarker.Stem Cells Dev. 2017 Aug 1;26(15):1090-1099. doi: 10.1089/scd.2016.0319. Epub 2017 Jun 12.
572 Inhibiting Integrin 8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.
573 Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.Neuro Oncol. 2013 Mar;15(3):305-18. doi: 10.1093/neuonc/nos313. Epub 2013 Jan 10.
574 Common variation in genes related to innate immunity and risk of adult glioma.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1651-8. doi: 10.1158/1055-9965.EPI-08-1041.
575 Circular RNA circ-PITX1 promotes the progression of glioblastoma by acting as a competing endogenous RNA to regulate miR-379-5p/MAP3K2 axis.Eur J Pharmacol. 2019 Nov 15;863:172643. doi: 10.1016/j.ejphar.2019.172643. Epub 2019 Sep 4.
576 Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.Sci Rep. 2019 Sep 30;9(1):14020. doi: 10.1038/s41598-019-50160-w.
577 Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells.Oncol Rep. 2015 Jan;33(1):413-8. doi: 10.3892/or.2014.3570. Epub 2014 Oct 24.
578 The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth.J Biol Chem. 2014 Jun 20;289(25):17689-98. doi: 10.1074/jbc.M113.536227. Epub 2014 May 1.
579 Site-1 protease, a novel metabolic target for glioblastoma.Biochem Biophys Res Commun. 2017 Aug 26;490(3):760-766. doi: 10.1016/j.bbrc.2017.06.114. Epub 2017 Jun 20.
580 Expression and clinicopathological significance of Nck1 in human astrocytoma progression.Int J Neurosci. 2019 Feb;129(2):171-178. doi: 10.1080/00207454.2018.1516655. Epub 2018 Nov 22.
581 Interleukin-8 Secreted by Glioblastoma Cells Induces Microvascular Hyperpermeability Through NO Signaling Involving S-Nitrosylation of VE-Cadherin and p120 in Endothelial Cells.Front Physiol. 2019 Aug 8;10:988. doi: 10.3389/fphys.2019.00988. eCollection 2019.
582 Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach.Mol Neurobiol. 2020 Feb;57(2):635-649. doi: 10.1007/s12035-019-01730-6. Epub 2019 Aug 12.
583 Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.J Exp Clin Cancer Res. 2017 Jan 9;36(1):9. doi: 10.1186/s13046-016-0482-0.
584 Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.Cell Mol Biol (Noisy-le-grand). 2015 Mar 9;61(1):42-50.
585 PKC- promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.Biochim Biophys Acta. 2011 Jun;1813(6):1190-7. doi: 10.1016/j.bbamcr.2011.03.007. Epub 2011 Mar 17.
586 Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro.Exp Cell Res. 2013 Aug 1;319(13):2037-2048. doi: 10.1016/j.yexcr.2013.03.029. Epub 2013 Apr 4.
587 KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway.Oncogene. 2015 Mar 12;34(11):1432-41. doi: 10.1038/onc.2014.49. Epub 2014 Apr 7.
588 System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).Amino Acids. 2015 Feb;47(2):335-44. doi: 10.1007/s00726-014-1863-3. Epub 2014 Nov 11.
589 TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.Oncol Rep. 2019 Feb;41(2):753-764. doi: 10.3892/or.2018.6859. Epub 2018 Nov 9.
590 Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents.Cancers (Basel). 2019 Sep 23;11(10):1416. doi: 10.3390/cancers11101416.
591 Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.Brain Res. 2007 Feb 23;1134(1):45-52. doi: 10.1016/j.brainres.2006.11.093. Epub 2007 Jan 2.
592 The Prognostic Landscape of Tumor-Infiltrating Immune Cells and Immune Checkpoints in Glioblastoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819869949. doi: 10.1177/1533033819869949.
593 Alpha lipoic acid attenuates hypoxia-induced apoptosis, inflammation and mitochondrial oxidative stress via inhibition of TRPA1 channel in human glioblastoma cell line.Biomed Pharmacother. 2019 Mar;111:292-304. doi: 10.1016/j.biopha.2018.12.077. Epub 2018 Dec 24.
594 MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.Oncogene. 2017 Aug 31;36(35):5006-5022. doi: 10.1038/onc.2017.129. Epub 2017 May 1.
595 Large Amino Acid Transporter 1 Selective Liposomes of l-DOPA Functionalized Amphiphile for Combating Glioblastoma.Mol Pharm. 2017 Nov 6;14(11):3834-3847. doi: 10.1021/acs.molpharmaceut.7b00569. Epub 2017 Oct 10.
596 Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.Oncotarget. 2015 Mar 10;6(7):5369-81. doi: 10.18632/oncotarget.3030.
597 Gefitinib inhibits sodium phosphate co-transporter III isoform 1 in a model of human malignant glioma.Anticancer Res. 2014 Nov;34(11):6527-35.
598 Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3 and causes increased cell migration.Biometals. 2016 Dec;29(6):995-1004. doi: 10.1007/s10534-016-9971-z. Epub 2016 Sep 21.
599 Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.Int J Cancer. 2002 Mar 10;98(2):173-80. doi: 10.1002/ijc.10135.
600 MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.Mol Cancer Res. 2016 Oct;14(10):984-993. doi: 10.1158/1541-7786.MCR-16-0172. Epub 2016 Jun 30.
601 HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.Cancer Lett. 2010 Apr 1;290(1):58-67. doi: 10.1016/j.canlet.2009.08.028. Epub 2009 Sep 17.
602 In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7601-5. doi: 10.1073/pnas.89.16.7601.
603 Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.BMC Cancer. 2014 Jun 4;14:401. doi: 10.1186/1471-2407-14-401.
604 Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.Neuro Oncol. 2013 Feb;15(2):172-88. doi: 10.1093/neuonc/nos298. Epub 2012 Dec 20.
605 Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.Med Oncol. 2013 Mar;30(1):384. doi: 10.1007/s12032-012-0384-8. Epub 2013 Feb 14.
606 The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.Mol Cells. 2017 Oct;40(10):761-772. doi: 10.14348/molcells.2017.0104. Epub 2017 Oct 17.
607 A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression.J Cell Mol Med. 2019 Nov;23(11):7859-7872. doi: 10.1111/jcmm.14665. Epub 2019 Sep 18.
608 Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.Neuropathol Appl Neurobiol. 2009 Aug;35(4):342-52. doi: 10.1111/j.1365-2990.2009.00993.x.
609 Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.Cancer Cell. 2017 Dec 11;32(6):856-868.e5. doi: 10.1016/j.ccell.2017.10.016. Epub 2017 Nov 30.
610 Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy.Autophagy. 2017 Oct 3;13(10):1790-1791. doi: 10.1080/15548627.2017.1349581. Epub 2017 Aug 18.
611 miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.Oncol Lett. 2018 Aug;16(2):1439-1448. doi: 10.3892/ol.2018.8846. Epub 2018 May 30.
612 Expression analysis of CYP27B1 in tumor biopsies and cell cultures.Anticancer Res. 2006 Jul-Aug;26(4A):2683-6.
613 Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.Biochem Biophys Res Commun. 2019 Sep 17;517(2):238-243. doi: 10.1016/j.bbrc.2019.07.049. Epub 2019 Jul 22.
614 Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma.Oncotarget. 2019 Oct 22;10(58):6049-6061. doi: 10.18632/oncotarget.27071. eCollection 2019 Oct 22.
615 Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.PLoS One. 2018 Apr 25;13(4):e0196283. doi: 10.1371/journal.pone.0196283. eCollection 2018.
616 Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway.Cancers (Basel). 2019 Jan 19;11(1):115. doi: 10.3390/cancers11010115.
617 Author Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.Nat Cell Biol. 2018 Nov;20(11):1328. doi: 10.1038/s41556-018-0203-3.
618 Nicotinamide metabolism regulates glioblastoma stem cell maintenance.JCI Insight. 2017 May 18;2(10):e90019. doi: 10.1172/jci.insight.90019. eCollection 2017 May 18.
619 Cytotoxicity against tumor cell lines and anti-inflammatory properties of chitinases from Calotropis procera latex.Naunyn Schmiedebergs Arch Pharmacol. 2017 Oct;390(10):1005-1013. doi: 10.1007/s00210-017-1397-9. Epub 2017 Jul 11.
620 TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells.Oncol Rep. 2017 Nov;38(5):2836-2842. doi: 10.3892/or.2017.5991. Epub 2017 Sep 22.
621 HARP111-136 enhances radiation-induced apoptosis of U87MG glioblastoma by induction of the proapoptotic protein CHOP.Int J Oncol. 2011 Jan;38(1):179-88.
622 Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma.Cancer Gene Ther. 2000 Jul;7(7):1008-14. doi: 10.1038/sj.cgt.7700190.
623 Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1channel in an in vitro seizure model.Mol Cell Biochem. 2019 Mar;453(1-2):143-155. doi: 10.1007/s11010-018-3439-0. Epub 2018 Aug 29.
624 The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.PLoS One. 2014 Jan 23;9(1):e86102. doi: 10.1371/journal.pone.0086102. eCollection 2014.
625 Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):37-40. doi: 10.1016/j.prostaglandins.2011.06.005. Epub 2011 Jul 6.
626 Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma.Autophagy. 2020 Jan;16(1):106-122. doi: 10.1080/15548627.2019.1598752. Epub 2019 Apr 9.
627 Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma.Mol Cancer Ther. 2008 Oct;7(10):3420-8. doi: 10.1158/1535-7163.MCT-08-0629.
628 Overexpression of SSAT by DENSPM treatment induces cell detachment and apoptosis in glioblastoma.Oncol Rep. 2012 Apr;27(4):1227-32. doi: 10.3892/or.2011.1592. Epub 2011 Dec 14.
629 Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status.J Gene Med. 2004 Dec;6(12):1320-32. doi: 10.1002/jgm.611.
630 Actin, alpha, cardiac muscle 1 (ACTC1) knockdown inhibits the migration of glioblastoma cells in vitro.J Neurol Sci. 2018 Sep 15;392:117-121. doi: 10.1016/j.jns.2018.07.013. Epub 2018 Jul 17.
631 ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.Nucleic Acids Res. 2018 Feb 28;46(4):2045-2059. doi: 10.1093/nar/gkx1257.
632 MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.Oncotarget. 2017 Sep 30;8(54):92545-92554. doi: 10.18632/oncotarget.21442. eCollection 2017 Nov 3.
633 ADARs and editing: The role of A-to-I RNA modification in cancer progression.Semin Cell Dev Biol. 2018 Jul;79:123-130. doi: 10.1016/j.semcdb.2017.11.018. Epub 2017 Nov 16.
634 PI3K/AKT/Afadin signaling pathway contributes to pathological vascularization in glioblastomas.Oncol Lett. 2018 Feb;15(2):1893-1899. doi: 10.3892/ol.2017.7461. Epub 2017 Nov 21.
635 Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme.Oncotarget. 2019 Jul 9;10(43):4449-4465. doi: 10.18632/oncotarget.27056. eCollection 2019 Jul 9.
636 Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma.Mol Cancer Res. 2012 Feb;10(2):208-17. doi: 10.1158/1541-7786.MCR-10-0109. Epub 2012 Jan 12.
637 Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma.Acta Neuropathol Commun. 2018 Aug 21;6(1):81. doi: 10.1186/s40478-018-0583-4.
638 Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.J Clin Invest. 2019 Apr 8;129(5):1833-1835. doi: 10.1172/JCI128742. eCollection 2019 Apr 8.
639 Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.PLoS One. 2017 Aug 2;12(8):e0180541. doi: 10.1371/journal.pone.0180541. eCollection 2017.
640 ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity.Biochem Biophys Res Commun. 2017 Apr 29;486(2):300-306. doi: 10.1016/j.bbrc.2017.03.032. Epub 2017 Mar 12.
641 N(6)-methyladenine DNA Modification in Glioblastoma.Cell. 2018 Nov 15;175(5):1228-1243.e20. doi: 10.1016/j.cell.2018.10.006. Epub 2018 Nov 1.
642 Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.Acta Neuropathol. 2018 Feb;135(2):267-283. doi: 10.1007/s00401-017-1783-x. Epub 2017 Nov 17.
643 Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur.J Med Chem. 2019 Jan 24;62(2):987-992. doi: 10.1021/acs.jmedchem.8b01723. Epub 2018 Dec 19.
644 The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.Cell Death Differ. 2019 Sep;26(9):1813-1831. doi: 10.1038/s41418-018-0248-7. Epub 2018 Dec 11.
645 The HIF?/miR?24?p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxiainduced protective autophagy in glioblastoma and astrocytoma.Oncol Rep. 2019 Mar;41(3):1759-1768. doi: 10.3892/or.2018.6929. Epub 2018 Dec 13.
646 Targeting 2 subunit of Na(+)/K(+)-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca(2).Am J Cancer Res. 2019 Jun 1;9(6):1293-1308. eCollection 2019.
647 ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.J Neurooncol. 2016 Feb;126(3):405-13. doi: 10.1007/s11060-015-1984-x. Epub 2015 Nov 2.
648 Human glioblastomas overexpress ADAMTS-5 that degrades brevican.Acta Neuropathol. 2005 Sep;110(3):239-46. doi: 10.1007/s00401-005-1032-6. Epub 2005 Aug 30.
649 Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.Oncol Rep. 2015 Aug;34(2):961-71. doi: 10.3892/or.2015.4071. Epub 2015 Jun 16.
650 Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo.Adv Mater. 2018 Jul;30(30):e1800316. doi: 10.1002/adma.201800316. Epub 2018 Jun 11.
651 C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.Mol Oncol. 2018 Sep;12(9):1464-1479. doi: 10.1002/1878-0261.12349. Epub 2018 Aug 2.
652 Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.Mol Cancer Ther. 2017 Jan;16(1):217-227. doi: 10.1158/1535-7163.MCT-16-0169-T. Epub 2016 Nov 9.
653 Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.Cell Cycle. 2018;17(10):1199-1211. doi: 10.1080/15384101.2018.1469872. Epub 2018 Jul 23.
654 Identification of WISP1 as a novel oncogene in glioblastoma.Int J Oncol. 2017 Oct;51(4):1261-1270. doi: 10.3892/ijo.2017.4119. Epub 2017 Sep 5.
655 Cord blood natural killer cells expressing a dominant negative TGF- receptor: Implications for adoptive immunotherapy for glioblastoma.Cytotherapy. 2017 Mar;19(3):408-418. doi: 10.1016/j.jcyt.2016.12.005. Epub 2017 Jan 19.
656 Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.BMC Cancer. 2018 Mar 9;18(1):270. doi: 10.1186/s12885-018-4179-y.
657 Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma.Oncogene. 2014 Mar 20;33(12):1558-69. doi: 10.1038/onc.2013.97. Epub 2013 Apr 8.
658 MiR?00a?p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5.Mol Med Rep. 2018 Sep;18(3):2689-2696. doi: 10.3892/mmr.2018.9259. Epub 2018 Jul 9.
659 TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas.Oncotarget. 2018 Dec 25;9(101):37564-37580. doi: 10.18632/oncotarget.26500. eCollection 2018 Dec 25.
660 CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.Oncogene. 2017 Feb 23;36(8):1134-1144. doi: 10.1038/onc.2016.280. Epub 2016 Aug 22.
661 Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.FASEB J. 2018 Jun 1:fj201701568R. doi: 10.1096/fj.201701568R. Online ahead of print.
662 A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity.Neurogenetics. 2019 Aug;20(3):129-143. doi: 10.1007/s10048-019-00578-1. Epub 2019 Apr 30.
663 Knockdown of Collagen Triple Helix Repeat Containing 1 (CTHRC1) Inhibits Epithelial-Mesenchymal Transition and Cellular Migration in Glioblastoma Cells.Oncol Res. 2017 Jan 26;25(2):225-232. doi: 10.3727/096504016X14732772150587.
664 The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.Int J Mol Sci. 2017 Jul 8;18(7):1468. doi: 10.3390/ijms18071468.
665 Daam1 activates RhoA to regulate Wnt5ainduced glioblastoma cell invasion.Oncol Rep. 2018 Feb;39(2):465-472. doi: 10.3892/or.2017.6124. Epub 2017 Dec 1.
666 Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro.Clin Cancer Res. 2001 Aug;7(8):2480-9.
667 Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells.Cancer Res. 2006 Dec 15;66(24):11726-35. doi: 10.1158/0008-5472.CAN-06-1978.
668 Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms.Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):264-275. doi: 10.1016/j.bbagen.2016.11.033. Epub 2016 Nov 25.
669 Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing Zebrafish.Front Pharmacol. 2018 Apr 10;9:340. doi: 10.3389/fphar.2018.00340. eCollection 2018.
670 Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma.Oncogene. 1997 Mar 6;14(9):1075-81. doi: 10.1038/sj.onc.1200925.
671 DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.Oncogene. 2018 Jan 11;37(2):241-254. doi: 10.1038/onc.2017.323. Epub 2017 Sep 18.
672 Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.J Radiat Res. 2018 Mar 1;59(2):122-128. doi: 10.1093/jrr/rrx080.
673 NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy.Anticancer Agents Med Chem. 2013 Mar;13(3):502-14.
674 Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma.Clin Cancer Res. 2001 Apr;7(4):868-75.
675 Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma.Dis Markers. 2017;2017:9253495. doi: 10.1155/2017/9253495. Epub 2017 Oct 19.
676 Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.Brain. 2019 Aug 1;142(8):2352-2366. doi: 10.1093/brain/awz202.
677 15-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.Mol Cancer Ther. 2017 Apr;16(4):601-613. doi: 10.1158/1535-7163.MCT-16-0291. Epub 2017 Jan 9.
678 HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.J Biol Chem. 2018 Oct 5;293(40):15397-15418. doi: 10.1074/jbc.RA118.003063. Epub 2018 Aug 14.
679 Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cells.Oncotarget. 2017 Oct 7;8(56):95945-95964. doi: 10.18632/oncotarget.21606. eCollection 2017 Nov 10.
680 Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.Tumour Biol. 2017 Apr;39(4):1010428317694552. doi: 10.1177/1010428317694552.
681 Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells.Oncol Rep. 2017 Feb;37(2):1196-1202. doi: 10.3892/or.2017.5344. Epub 2017 Jan 2.
682 Assessment of ApoC1, LuzP6, C12orf75 and OCC-1 in cystic glioblastoma using MALDI-TOF mass spectrometry, immunohistochemistry and qRT-PCR.Med Mol Morphol. 2019 Dec;52(4):217-225. doi: 10.1007/s00795-019-00223-8. Epub 2019 Apr 20.
683 Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression.EBioMedicine. 2018 Nov;37:56-67. doi: 10.1016/j.ebiom.2018.10.008. Epub 2018 Oct 9.
684 Golgi Phosphoprotein 3 Promotes Wls Recycling and Wnt Secretion in Glioma Progression.Cell Physiol Biochem. 2018;47(6):2445-2457. doi: 10.1159/000491618. Epub 2018 Jul 10.
685 Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-B and FGF2.Mol Biosyst. 2017 Jun 27;13(7):1345-1354. doi: 10.1039/c7mb00139h.
686 Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.Br J Cancer. 2002 Apr 22;86(8):1322-7. doi: 10.1038/sj.bjc.6600235.
687 HBP1 phosphorylation by AKT regulates its transcriptional activity and glioblastoma cell proliferation.Cell Signal. 2018 Apr;44:158-170. doi: 10.1016/j.cellsig.2018.01.014. Epub 2018 Feb 16.
688 Signal Peptide Peptidase, Encoded by HM13, Contributes to Tumor Progression by Affecting EGFRvIII Secretion Profiles in Glioblastoma.CNS Neurosci Ther. 2017 Mar;23(3):257-265. doi: 10.1111/cns.12672.
689 HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p.Cell Biochem Funct. 2018 Oct;36(7):357-365. doi: 10.1002/cbf.3355. Epub 2018 Sep 19.
690 Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.Neuro Oncol. 2016 Jun;18(6):819-29. doi: 10.1093/neuonc/nov281. Epub 2015 Nov 17.
691 miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition.Signal Transduct Target Ther. 2018 Dec 28;3:33. doi: 10.1038/s41392-018-0033-6. eCollection 2018.
692 ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.Oncogene. 2018 Jan 18;37(3):286-301. doi: 10.1038/onc.2017.324. Epub 2017 Sep 18.
693 Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B.Mol Oncol. 2018 Mar;12(3):406-420. doi: 10.1002/1878-0261.12174. Epub 2018 Feb 12.
694 KLF6 depletion promotes NF-B signaling in glioblastoma.Oncogene. 2017 Jun 22;36(25):3562-3575. doi: 10.1038/onc.2016.507. Epub 2017 Feb 6.
695 KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.J Cell Mol Med. 2017 Feb;21(2):244-253. doi: 10.1111/jcmm.12960. Epub 2016 Sep 19.
696 Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion.Biochem Biophys Res Commun. 2018 Dec 2;506(4):833-839. doi: 10.1016/j.bbrc.2018.10.076. Epub 2018 Oct 30.
697 Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells.J Cell Physiol. 2006 Jun;207(3):711-21. doi: 10.1002/jcp.20627.
698 A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma.Neuro Oncol. 2018 May 18;20(6):764-775. doi: 10.1093/neuonc/nox215.
699 Sinomenine Hydrochloride Inhibits the Metastasis of Human Glioblastoma Cells by Suppressing the Expression of Matrix Metalloproteinase-2/-9 and Reversing the Endogenous and Exogenous Epithelial-Mesenchymal Transition.Int J Mol Sci. 2018 Mar 14;19(3):844. doi: 10.3390/ijms19030844.
700 Hydrogen sulfide generation from l-cysteine in the human glioblastoma-astrocytoma U-87 MG and neuroblastoma SHSY5Y cell lines.Acta Biochim Pol. 2017;64(1):171-176. doi: 10.18388/abp.2016_1394. Epub 2017 Mar 14.
701 Suppression of p53-inducible gene 3 is significant for glioblastoma progression and predicts poor patient prognosis.Tumour Biol. 2017 Mar;39(3):1010428317694572. doi: 10.1177/1010428317694572.
702 MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility.Transl Oncol. 2017 Feb;10(1):70-79. doi: 10.1016/j.tranon.2016.11.006. Epub 2016 Dec 15.
703 Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.J Clin Pathol. 2019 Oct;72(10):677-681. doi: 10.1136/jclinpath-2019-205834. Epub 2019 Jul 3.
704 Analysis of transcriptional activity by the Myt1 and Myt1l transcription factors.J Cell Biochem. 2018 Jun;119(6):4644-4655. doi: 10.1002/jcb.26636. Epub 2018 Mar 9.
705 Genetic alterations of the NRP/B gene are associated with human brain tumors.Oncogene. 2004 Aug 5;23(35):5890-900. doi: 10.1038/sj.onc.1207776.
706 Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.
707 MiRNA-191 functions as an oncogene in primary glioblastoma by directly targeting NDST1.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6242-6249. doi: 10.26355/eurrev_201907_18443.
708 NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.Neuro Oncol. 2020 Jan 11;22(1):46-57. doi: 10.1093/neuonc/noz136.
709 The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter.Oncotarget. 2018 Feb 14;9(21):15512-15525. doi: 10.18632/oncotarget.24496. eCollection 2018 Mar 20.
710 Glioblastoma recurrence correlates with NLGN3 levels.Cancer Med. 2018 Jul;7(7):2848-2859. doi: 10.1002/cam4.1538. Epub 2018 May 18.
711 In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.Oncotarget. 2015 Aug 21;6(24):20145-59. doi: 10.18632/oncotarget.3980.
712 Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.FEBS J. 2018 Oct;285(20):3769-3785. doi: 10.1111/febs.14628. Epub 2018 Sep 24.
713 Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.Oncogene. 2018 Aug;37(35):4838-4853. doi: 10.1038/s41388-018-0319-8. Epub 2018 May 18.
714 A Novel Positive Feedback Loop Between NTSR1 and Wnt/-Catenin Contributes to Tumor Growth of Glioblastoma.Cell Physiol Biochem. 2017;43(5):2133-2142. doi: 10.1159/000484232. Epub 2017 Oct 24.
715 Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.J Neurooncol. 2017 Mar;132(1):15-26. doi: 10.1007/s11060-016-2337-0. Epub 2016 Dec 20.
716 Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug.World Neurosurg. 2018 Jan;109:e329-e342. doi: 10.1016/j.wneu.2017.09.176. Epub 2017 Oct 6.
717 PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.J Neurosurg. 2017 Jun;126(6):1829-1838. doi: 10.3171/2016.5.JNS152831. Epub 2016 Aug 19.
718 PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/-catenin axis.Cell Death Dis. 2018 Oct 15;9(11):1049. doi: 10.1038/s41419-018-1082-z.
719 TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.Mol Oncol. 2017 Mar;11(3):280-294. doi: 10.1002/1878-0261.12034. Epub 2017 Feb 15.
720 A Feedforward Mechanism Mediated by Mechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes Glioma Aggression.Neuron. 2018 Nov 21;100(4):799-815.e7. doi: 10.1016/j.neuron.2018.09.046. Epub 2018 Oct 18.
721 MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.Brain Res. 2017 Dec 1;1676:69-76. doi: 10.1016/j.brainres.2017.08.014. Epub 2017 Aug 24.
722 Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma.Oncotarget. 2013 Dec;4(12):2261-70. doi: 10.18632/oncotarget.1302.
723 Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia.Mol Cell Biochem. 2017 Jun;430(1-2):179-190. doi: 10.1007/s11010-017-2965-5. Epub 2017 Feb 15.
724 Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression.Am J Pathol. 2003 Jan;162(1):19-27. doi: 10.1016/S0002-9440(10)63794-7.
725 DNA-PKcs is activated under nutrient starvation and activates Akt, MST1, FoxO3a, and NDR1.Biochem Biophys Res Commun. 2020 Jan 15;521(3):668-673. doi: 10.1016/j.bbrc.2019.10.133. Epub 2019 Nov 1.
726 Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2.Oncol Res. 2018 Mar 5;26(2):219-230. doi: 10.3727/096504017X14944585873659. Epub 2017 May 17.
727 Oncogenic miR?32 sustains proliferation and selfrenewal potential by inhibition of polypyrimidine tractbinding protein 2 in glioblastoma cells.Mol Med Rep. 2017 Nov;16(5):7221-7228. doi: 10.3892/mmr.2017.7572. Epub 2017 Sep 21.
728 The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.Cancer Lett. 2019 Oct 10;462:33-42. doi: 10.1016/j.canlet.2019.07.018. Epub 2019 Aug 1.
729 High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma.Med Sci Monit. 2018 Oct 23;24:7556-7562. doi: 10.12659/MSM.911531.
730 Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.Oncotarget. 2017 Apr 11;8(15):24949-24963. doi: 10.18632/oncotarget.15327.
731 Functional Blockade of Small GTPase RAN Inhibits Glioblastoma Cell Viability.Front Oncol. 2019 Jan 8;8:662. doi: 10.3389/fonc.2018.00662. eCollection 2018.
732 RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.Biochem Biophys Res Commun. 2019 Aug 27;516(3):999-1006. doi: 10.1016/j.bbrc.2019.06.097. Epub 2019 Jul 2.
733 Similarity in targets with REST points to neural and glioblastoma related miRNAs.Nucleic Acids Res. 2014 May;42(9):5436-46. doi: 10.1093/nar/gku231. Epub 2014 Apr 11.
734 RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082. eCollection 2018 Sep 18.
735 The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.Oncotarget. 2017 Feb 28;8(9):14462-14478. doi: 10.18632/oncotarget.14895.
736 Identification of an alternatively spliced RNA for the Ras suppressor RSU-1 in human gliomas.J Neurooncol. 2002 Dec;60(3):201-11. doi: 10.1023/a:1021130620178.
737 Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.Am J Epidemiol. 2011 Apr 15;173(8):915-22. doi: 10.1093/aje/kwq457. Epub 2011 Feb 24.
738 Knockdown of RWD domain containing 3 inhibits the malignant phenotypes of glioblastoma cells via inhibition of phosphoinositide 3-kinase/protein kinase B signaling.Exp Ther Med. 2018 Jul;16(1):384-393. doi: 10.3892/etm.2018.6135. Epub 2018 May 7.
739 Knockdown of SALL4 expression using RNA interference induces cell cycle arrest, enhances early apoptosis, inhibits invasion and increases chemosensitivity to temozolomide in U251 glioma cells.Oncol Lett. 2017 Oct;14(4):4263-4269. doi: 10.3892/ol.2017.6722. Epub 2017 Aug 4.
740 Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells.Bioorg Med Chem Lett. 2017 Apr 1;27(7):1561-1565. doi: 10.1016/j.bmcl.2017.02.033. Epub 2017 Feb 17.
741 miR-135a-5p and miR-124-3p Inhibit Malignancy of Glioblastoma by Downregulation of Syndecan Binding Protein.J Biomed Nanotechnol. 2018 Jul 1;14(7):1317-1329. doi: 10.1166/jbn.2018.2579.
742 SETMAR isoforms in glioblastoma: A matter of protein stability.Oncotarget. 2017 Feb 7;8(6):9835-9848. doi: 10.18632/oncotarget.14218.
743 A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.Int J Cancer. 2019 Nov 1;145(9):2535-2546. doi: 10.1002/ijc.32531. Epub 2019 Jul 8.
744 Schlafen 11 Restricts Flavivirus Replication.J Virol. 2019 Jul 17;93(15):e00104-19. doi: 10.1128/JVI.00104-19. Print 2019 Aug 1.
745 Identification of novel LncRNA targeting Smad2/PKC signal pathway to negatively regulate malignant progression of glioblastoma.J Cell Physiol. 2020 Apr;235(4):3835-3848. doi: 10.1002/jcp.29278. Epub 2019 Oct 11.
746 Roles of zinc-fingers and homeoboxes 1 during the proliferation, migration, and invasion of glioblastoma cells.Tumour Biol. 2017 Mar;39(3):1010428317694575. doi: 10.1177/1010428317694575.
747 Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report.Cell Oncol (Dordr). 2018 Apr;41(2):213-221. doi: 10.1007/s13402-017-0362-4. Epub 2017 Dec 7.
748 Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.Hum Cell. 2007 Nov;20(4):100-6. doi: 10.1111/j.1749-0774.2007.00035.x.
749 MicroRNA-145 Promotes the Phenotype of Human Glioblastoma Cells Selected for Invasion.Anticancer Res. 2015 Jun;35(6):3209-15.
750 Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics.Onco Targets Ther. 2017 Feb 20;10:1059-1069. doi: 10.2147/OTT.S124012. eCollection 2017.
751 TET1 regulates DNA repair in human glial cells.Toxicol Appl Pharmacol. 2019 Oct 1;380:114646. doi: 10.1016/j.taap.2019.114646. Epub 2019 Jul 3.
752 Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.J Natl Cancer Inst. 2004 Mar 17;96(6):483-6. doi: 10.1093/jnci/djh064.
753 PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.Int J Cancer. 2016 Jul 1;139(1):99-111. doi: 10.1002/ijc.30041. Epub 2016 Mar 2.
754 Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.Neurosci Lett. 2017 Apr 3;645:106-112. doi: 10.1016/j.neulet.2017.02.076. Epub 2017 Mar 2.
755 Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma-initiating cells.Mol Oncol. 2018 Jun;12(6):775-787. doi: 10.1002/1878-0261.12168. Epub 2018 Apr 27.
756 Potential targets of TMEM176A in the growth of glioblastoma cells.Onco Targets Ther. 2018 Nov 2;11:7763-7775. doi: 10.2147/OTT.S179725. eCollection 2018.
757 The antitumor effect of TAT-DCF1 peptide in glioma cells.Neuropeptides. 2018 Oct;71:21-31. doi: 10.1016/j.npep.2018.06.004. Epub 2018 Jun 25.
758 A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.Mol Cancer Res. 2018 Feb;16(2):322-332. doi: 10.1158/1541-7786.MCR-17-0454. Epub 2017 Nov 8.
759 Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.Acta Neuropathol. 2005 Mar;109(3):294-8. doi: 10.1007/s00401-004-0956-6. Epub 2004 Dec 31.
760 Prognostic Significance of TNFR-Associated Factor 1 and 2 (TRAF1 and TRAF2) in Glioblastoma.Med Sci Monit. 2017 Sep 19;23:4506-4512. doi: 10.12659/msm.903397.
761 Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells.Mol Cancer Res. 2015 Sep;13(9):1283-95. doi: 10.1158/1541-7786.MCR-15-0075. Epub 2015 Jun 3.
762 Mutual Stabilization between TRIM9 Short Isoform and MKK6 Potentiates p38 Signaling to Synergistically Suppress Glioblastoma Progression.Cell Rep. 2018 Apr 17;23(3):838-851. doi: 10.1016/j.celrep.2018.03.096.
763 GPR124 regulates microtubule assembly, mitotic progression, and glioblastoma cell proliferation.Glia. 2019 Aug;67(8):1558-1570. doi: 10.1002/glia.23628. Epub 2019 May 6.
764 Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis.FASEB J. 2019 Sep;33(9):9959-9973. doi: 10.1096/fj.201900342RR. Epub 2019 Jun 14.
765 ASPM gene expression in medulloblastoma.Childs Nerv Syst. 2011 Jan;27(1):71-4. doi: 10.1007/s00381-010-1252-5. Epub 2010 Aug 6.
766 MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.Cancer Cell. 2017 Dec 11;32(6):840-855.e8. doi: 10.1016/j.ccell.2017.11.005.
767 Significance of H3K27M mutation with specific histomorphological features and associated molecular alterations in pediatric high-grade glial tumors.Childs Nerv Syst. 2018 Jan;34(1):107-116. doi: 10.1007/s00381-017-3633-5. Epub 2017 Oct 24.
768 Betacellulin drives therapy resistance in glioblastoma.Neuro Oncol. 2020 Apr 15;22(4):457-469. doi: 10.1093/neuonc/noz206.
769 Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.Biomed Res Int. 2019 Apr 30;2019:2582416. doi: 10.1155/2019/2582416. eCollection 2019.
770 Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.J Transl Med. 2019 May 28;17(1):179. doi: 10.1186/s12967-019-1930-3.
771 Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition - implications for the next generation of DC vaccines.Oncoimmunology. 2019 Apr 13;8(7):1593803. doi: 10.1080/2162402X.2019.1593803. eCollection 2019.
772 Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.J Neurooncol. 2007 Jan;81(2):139-48. doi: 10.1007/s11060-006-9220-3. Epub 2006 Sep 27.
773 Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.Mol Cancer Res. 2012 Jul;10(7):958-68. doi: 10.1158/1541-7786.MCR-11-0616. Epub 2012 May 9.
774 LINC01579 promotes cell proliferation by acting as a ceRNA of miR-139-5p to upregulate EIF4G2 expression in glioblastoma.J Cell Physiol. 2019 Dec;234(12):23658-23666. doi: 10.1002/jcp.28933. Epub 2019 Jun 11.
775 Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis.PeerJ. 2019 Mar 7;7:e6560. doi: 10.7717/peerj.6560. eCollection 2019.
776 HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells.Cancer Gene Ther. 2020 May;27(5):319-329. doi: 10.1038/s41417-019-0103-0. Epub 2019 May 29.
777 Inhibition of 13-cis retinoic acid-induced gene expression of homeobox B7 by thalidomide.Int J Cancer. 2007 Sep 15;121(6):1205-11. doi: 10.1002/ijc.22815.
778 Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.Neuro Oncol. 2010 Nov;12(11):1088-101. doi: 10.1093/neuonc/noq079. Epub 2010 Aug 2.
779 Cancer genetic markers according to radiotherapeutic response in patients with primary glioblastoma - Radiogenomic approach for precision medicine.Radiother Oncol. 2019 Feb;131:66-74. doi: 10.1016/j.radonc.2018.11.025. Epub 2018 Dec 31.
780 Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.Cancer Res. 2007 Mar 15;67(6):2552-8. doi: 10.1158/0008-5472.CAN-06-3870.
781 [Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFR signaling.Int J Oncol. 2019 Jun;54(6):2257. doi: 10.3892/ijo.2019.4769. Epub 2019 Apr 2.
782 Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.Sci Rep. 2019 Mar 7;9(1):3891. doi: 10.1038/s41598-019-39473-y.
783 L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.EMBO J. 2011 Mar 2;30(5):800-13. doi: 10.1038/emboj.2011.10. Epub 2011 Feb 4.
784 MicroRNA-139-3p suppresses growth and metastasis of glioblastoma via inhibition of NIN1/RPNI2 binding protein 1 homolog.Eur Rev Med Pharmacol Sci. 2019 May;23(10):4264-4274. doi: 10.26355/eurrev_201905_17931.
785 Nucleobindin-2 Promotes the Growth and Invasion of Glioblastoma.Cancer Biother Radiopharm. 2019 Nov;34(9):581-588. doi: 10.1089/cbr.2019.2829.
786 Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.Neuropathol Appl Neurobiol. 2007 Feb;33(1):77-85. doi: 10.1111/j.1365-2990.2006.00786.x.
787 Squalene-PEG: Pyropheophorbide-a nanoconstructs for tumor theranostics.Nanomedicine. 2019 Jan;15(1):243-251. doi: 10.1016/j.nano.2018.09.013. Epub 2018 Oct 7.
788 lncRNAs combine and crosstalk with NSPc1 in ATRA-induced differentiation of U87 glioma cells.Oncol Lett. 2019 Jun;17(6):5821-5829. doi: 10.3892/ol.2019.10254. Epub 2019 Apr 15.
789 Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.J Neurooncol. 2010 Dec;100(3):449-57. doi: 10.1007/s11060-010-0201-1. Epub 2010 May 9.
790 Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library.BMC Med Genomics. 2012 Aug 9;5:34. doi: 10.1186/1755-8794-5-34.
791 Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4.
792 TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways.Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):491-501. doi: 10.1016/j.bbagen.2018.12.001. Epub 2018 Dec 5.
793 EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.Cancer Res. 2006 Feb 1;66(3):1583-90. doi: 10.1158/0008-5472.CAN-05-2424.
794 Knockdown of RAD18 inhibits glioblastoma development.J Cell Physiol. 2019 Nov;234(11):21100-21112. doi: 10.1002/jcp.28713. Epub 2019 May 12.
795 Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma.Med Sci Monit. 2019 May 16;25:3624-3635. doi: 10.12659/MSM.916648.
796 Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells.Oncol Lett. 2017 May;13(5):3882-3888. doi: 10.3892/ol.2017.5875. Epub 2017 Mar 17.
797 LncRNA TRG-AS1 promotes glioblastoma cell proliferation by competitively binding with miR-877-5p to regulate SUZ12 expression.Pathol Res Pract. 2019 Aug;215(8):152476. doi: 10.1016/j.prp.2019.152476. Epub 2019 May 28.
798 In vitro evaluation of (225) Ac-DOTA-substance P for targeted alpha therapy of glioblastoma multiforme.Chem Biol Drug Des. 2018 Jul;92(1):1344-1356. doi: 10.1111/cbdd.13199. Epub 2018 Apr 23.
799 High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.Mol Med Rep. 2019 Feb;19(2):877-884. doi: 10.3892/mmr.2018.9716. Epub 2018 Dec 3.
800 Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.Cancer Gene Ther. 2006 Apr;13(4):385-92. doi: 10.1038/sj.cgt.7700898.
801 GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.Cell Rep. 2017 Nov 21;21(8):2183-2197. doi: 10.1016/j.celrep.2017.10.083.
802 Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma.Mol Carcinog. 2016 Feb;55(2):148-60. doi: 10.1002/mc.22264. Epub 2015 Jan 15.
803 Mitochondrial AKAP1 supports mTOR pathway and tumor growth.Cell Death Dis. 2017 Jun 1;8(6):e2842. doi: 10.1038/cddis.2017.241.
804 Potential role of annexin A7 in cancers.Clin Chim Acta. 2013 Aug 23;423:83-9. doi: 10.1016/j.cca.2013.04.018. Epub 2013 Apr 29.
805 CD151-31 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.Oncotarget. 2015 Oct 6;6(30):29675-93. doi: 10.18632/oncotarget.4896.
806 Absence of host NF-B p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.Cancer Immunol Immunother. 2018 Oct;67(10):1491-1503. doi: 10.1007/s00262-018-2184-2. Epub 2018 Jul 21.
807 Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo.Oncotarget. 2017 Jul 20;8(53):91052-91066. doi: 10.18632/oncotarget.19409. eCollection 2017 Oct 31.
808 Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patients.Onco Targets Ther. 2018 Dec 4;11:8673-8684. doi: 10.2147/OTT.S176549. eCollection 2018.
809 The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma.Oncotarget. 2016 Jan 12;7(2):2080-92. doi: 10.18632/oncotarget.6712.
810 Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.Br J Cancer. 2017 Sep 5;117(6):813-825. doi: 10.1038/bjc.2017.263. Epub 2017 Aug 10.
811 Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation.Elife. 2016 Mar 17;5:e08711. doi: 10.7554/eLife.08711.
812 miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells.PLoS One. 2016 Jul 7;11(7):e0158537. doi: 10.1371/journal.pone.0158537. eCollection 2016.
813 Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.Mol Cancer Ther. 2017 Jan;16(1):156-168. doi: 10.1158/1535-7163.MCT-16-0262. Epub 2016 Oct 24.
814 Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/-Catenin Signaling in Glioblastoma Cells.Anticancer Res. 2017 Aug;37(8):4285-4294. doi: 10.21873/anticanres.11821.
815 miR?7a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2.Int J Oncol. 2015 Apr;46(4):1601-8. doi: 10.3892/ijo.2015.2843. Epub 2015 Jan 22.
816 Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.Neoplasia. 2016 Mar;18(3):185-98. doi: 10.1016/j.neo.2016.02.003.
817 Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.Oncotarget. 2017 Sep 5;8(60):101244-101254. doi: 10.18632/oncotarget.20643. eCollection 2017 Nov 24.
818 Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.J Neurosurg. 2015 Jan;122(1):69-77. doi: 10.3171/2014.9.JNS132373.
819 Intersectin1-S, a multidomain adapter protein, is essential for malignant glioma proliferation.Glia. 2015 Sep;63(9):1595-605. doi: 10.1002/glia.22830. Epub 2015 Apr 2.
820 The C/EBP protein is stabilized by estrogen receptor activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.Oncogene. 2016 Dec 1;35(48):6166-6176. doi: 10.1038/onc.2016.156. Epub 2016 May 16.
821 Promotion of Cancer Cell Proliferation by Cleaved and Secreted Luminal Domains of ER Stress Transducer BBF2H7.PLoS One. 2015 May 8;10(5):e0125982. doi: 10.1371/journal.pone.0125982. eCollection 2015.
822 CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway.Int J Oncol. 2016 Aug;49(2):519-28. doi: 10.3892/ijo.2016.3576. Epub 2016 Jun 9.
823 Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.BMC Cancer. 2016 Mar 16;16:226. doi: 10.1186/s12885-016-2273-6.
824 Involvement of DDX6 gene in radio- and chemoresistance in glioblastoma.Int J Oncol. 2016 Mar;48(3):1053-62. doi: 10.3892/ijo.2016.3328. Epub 2016 Jan 11.
825 Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.Adv Clin Exp Med. 2019 Dec;28(12):1639-1645. doi: 10.17219/acem/110323.
826 Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.Int J Biochem Cell Biol. 2012 Feb;44(2):302-10. doi: 10.1016/j.biocel.2011.10.025. Epub 2011 Nov 7.
827 EMC6/TMEM93 suppresses glioblastoma proliferation by modulating autophagy.Cell Death Dis. 2016 Jan 14;7(1):e2043. doi: 10.1038/cddis.2015.408.
828 Analysis of DNA repair gene polymorphisms in glioblastoma.Gene. 2014 Feb 15;536(1):79-83. doi: 10.1016/j.gene.2013.11.077. Epub 2013 Dec 8.
829 Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.Neurosurgery. 2016 Sep;79(3):481-91. doi: 10.1227/NEU.0000000000001174.
830 The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.Cell Oncol (Dordr). 2019 Aug;42(4):521-536. doi: 10.1007/s13402-019-00443-1. Epub 2019 Apr 13.
831 Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway.PLoS One. 2016 Feb 12;11(2):e0149361. doi: 10.1371/journal.pone.0149361. eCollection 2016.
832 MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma.Mol Med Rep. 2016 May;13(5):4279-88. doi: 10.3892/mmr.2016.5076. Epub 2016 Mar 31.
833 GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.Cell Death Differ. 2020 Jun;27(6):1862-1877. doi: 10.1038/s41418-019-0466-7. Epub 2019 Dec 4.
834 Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.Sci Rep. 2015 Nov 13;5:15494. doi: 10.1038/srep15494.
835 ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.Oncotarget. 2017 Jul 25;8(30):48545-48562. doi: 10.18632/oncotarget.18153.
836 Ubiquitin Specific Peptidase 15 (USP15) suppresses glioblastoma cell growth via stabilization of HECTD1 E3 ligase attenuating WNT pathway activity.Oncotarget. 2017 Nov 30;8(66):110490-110502. doi: 10.18632/oncotarget.22798. eCollection 2017 Dec 15.
837 Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas.Tumour Biol. 2016 Nov;37(11):15065-15077. doi: 10.1007/s13277-016-5402-6. Epub 2016 Sep 22.
838 High-mobility group AT-hook protein 2 expression and its prognostic significance in MGMT methylated and unmethylated glioblastoma.Int J Oncol. 2016 Apr;48(4):1485-92. doi: 10.3892/ijo.2016.3397. Epub 2016 Feb 17.
839 INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.Hum Gene Ther. 2009 Nov;20(11):1308-18. doi: 10.1089/hum.2008.168.
840 Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-B(p65) Signaling.Cell Physiol Biochem. 2018;51(6):2925-2937. doi: 10.1159/000496044. Epub 2018 Oct 11.
841 Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.Nature. 2017 Jul 20;547(7663):355-359. doi: 10.1038/nature23000. Epub 2017 Jul 5.
842 Tip60 regulates MT1-MMP transcription and invasion of glioblastoma cells through NF-B pathway.Clin Exp Metastasis. 2016 Jan;33(1):45-52. doi: 10.1007/s10585-015-9756-8.
843 Inhibition of KIF14 Suppresses Tumor Cell Growth and Promotes Apoptosis in Human Glioblastoma.Cell Physiol Biochem. 2015;37(5):1659-70. doi: 10.1159/000438532. Epub 2015 Nov 5.
844 Disruption of KIF3A in patient-derived glioblastoma cells: effects on ciliogenesis, hedgehog sensitivity, and tumorigenesis.Oncotarget. 2016 Feb 9;7(6):7029-43. doi: 10.18632/oncotarget.6854.
845 Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.Biol Res. 2016 Jul 27;49(1):33. doi: 10.1186/s40659-016-0091-6.
846 LRP1B deletion is associated with poor outcome for glioblastoma patients.J Neurol Sci. 2015 Nov 15;358(1-2):440-3. doi: 10.1016/j.jns.2015.09.345. Epub 2015 Sep 11.
847 Phostine PST3.1a Targets MGAT5 and Inhibits Glioblastoma-Initiating Cell Invasiveness and Proliferation.Mol Cancer Res. 2017 Oct;15(10):1376-1387. doi: 10.1158/1541-7786.MCR-17-0120. Epub 2017 Jun 20.
848 Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-B Signaling Pathway.Cancer Res. 2016 Jan 1;76(1):171-81. doi: 10.1158/0008-5472.CAN-15-0884. Epub 2015 Dec 17.
849 MSX1 inhibits cell migration and invasion through regulating the Wnt/-catenin pathway in glioblastoma.Tumour Biol. 2016 Jan;37(1):1097-104. doi: 10.1007/s13277-015-3892-2. Epub 2015 Aug 15.
850 Upstream stimulating factor1 (USF1) enhances the proliferation of glioblastoma stem cells mainly by activating the transcription of mucin13 (MUC13).Pharmazie. 2017 Feb 1;72(2):98-102. doi: 10.1691/ph.2017.6788.
851 Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus.Mol Ther Oncolytics. 2017 Sep 29;7:57-66. doi: 10.1016/j.omto.2017.09.005. eCollection 2017 Dec 15.
852 The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells.Biochem Biophys Res Commun. 2016 Aug 5;476(4):508-514. doi: 10.1016/j.bbrc.2016.05.154. Epub 2016 May 28.
853 Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.Mol Cancer. 2015 Aug 21;14:160. doi: 10.1186/s12943-015-0432-z.
854 Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.Diagn Pathol. 2016 Jan 27;11:13. doi: 10.1186/s13000-016-0455-9.
855 NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.Anticancer Res. 2016 Mar;36(3):887-97.
856 Silencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-B Pathway.Front Mol Neurosci. 2017 Dec 19;10:420. doi: 10.3389/fnmol.2017.00420. eCollection 2017.
857 Preferential Association of Lissencephaly-1 Gene Expression with CD133+ Glioblastoma Cells.J Cancer. 2017 May 11;8(7):1284-1291. doi: 10.7150/jca.17635. eCollection 2017.
858 High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma.Biomed Pharmacother. 2017 Oct;94:659-665. doi: 10.1016/j.biopha.2017.07.103. Epub 2017 Aug 5.
859 miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.Cancer Res. 2016 Jul 15;76(14):4293-304. doi: 10.1158/0008-5472.CAN-15-3073. Epub 2016 May 31.
860 Author Correction: TGF-1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.Sci Rep. 2019 Apr 17;9(1):6400. doi: 10.1038/s41598-019-42588-x.
861 Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.Nat Commun. 2017 Oct 16;8(1):949. doi: 10.1038/s41467-017-00906-9.
862 MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma.Oncotarget. 2017 Sep 27;8(70):114677-114684. doi: 10.18632/oncotarget.21309. eCollection 2017 Dec 29.
863 Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status.Oncotarget. 2016 Sep 13;7(37):60245-60269. doi: 10.18632/oncotarget.11197.
864 PRMT1 and PRMT8 regulate retinoic acid-dependent neuronal differentiation with implications to neuropathology.Stem Cells. 2015 Mar;33(3):726-41. doi: 10.1002/stem.1894.
865 MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.Folia Neuropathol. 2015;53(3):236-44. doi: 10.5114/fn.2015.54424.
866 Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.Cell Rep. 2016 Mar 22;14(11):2587-98. doi: 10.1016/j.celrep.2016.02.045. Epub 2016 Mar 10.
867 c-Myc-miR-29c-REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma.Brain. 2015 Dec;138(Pt 12):3654-72. doi: 10.1093/brain/awv287. Epub 2015 Oct 8.
868 The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.Cell Physiol Biochem. 2016;38(1):94-109. doi: 10.1159/000438612. Epub 2016 Jan 8.
869 Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.Biochem Biophys Res Commun. 2015 Sep 18;465(2):194-9. doi: 10.1016/j.bbrc.2015.07.149. Epub 2015 Aug 1.
870 MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma.Oncogene. 2015 Apr 23;34(17):2204-14. doi: 10.1038/onc.2014.168. Epub 2014 Jun 23.
871 Lentivirus-mediated silencing of spindle and kinetochore-associated protein 1 inhibits the proliferation and invasion of neuronal glioblastoma cells.Mol Med Rep. 2015 May;11(5):3533-8. doi: 10.3892/mmr.2015.3175. Epub 2015 Jan 9.
872 P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.Cancer Lett. 2016 Oct 10;381(1):67-75. doi: 10.1016/j.canlet.2016.07.029. Epub 2016 Jul 26.
873 Genome-wide methylation profiling reveals new biomarkers for prognosis prediction of glioblastoma.J Cancer Res Ther. 2015 Oct;11 Suppl 2:C212-5. doi: 10.4103/0973-1482.168188.
874 Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.Genome Biol. 2016 Jun 10;17(1):125. doi: 10.1186/s13059-016-0990-4.
875 MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.Biomed Pharmacother. 2016 May;80:121-126. doi: 10.1016/j.biopha.2016.03.008. Epub 2016 Mar 19.
876 Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.Mol Cancer Ther. 2014 Mar;13(3):724-32. doi: 10.1158/1535-7163.MCT-13-0749. Epub 2013 Dec 19.
877 Correction to: Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.Cell Death Differ. 2019 Jan;26(1):197. doi: 10.1038/s41418-018-0145-0.
878 A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK.Stem Cell Reports. 2017 Aug 8;9(2):451-463. doi: 10.1016/j.stemcr.2017.06.007. Epub 2017 Jul 14.
879 Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest/apoptosis in glioblastoma cells.World J Surg Oncol. 2016 Oct 19;14(1):267. doi: 10.1186/s12957-016-1018-y.
880 Histochemical analysis of testis specific gene 13 in human normal and malignant tissues.Cell Tissue Res. 2015 Dec;362(3):653-63. doi: 10.1007/s00441-015-2227-3. Epub 2015 Jun 27.
881 Polysaccharide sulphated derivative from Aconitumcoreanum induces cell apoptosis in the human brain glioblastoma U87MG cell line via the NF-B/Bcl-2 cell apoptotic signaling pathway.Oncol Rep. 2018 Mar;39(3):1469-1474. doi: 10.3892/or.2017.6165. Epub 2017 Dec 19.
882 On the influence of cannabinoids on cell morphology and motility of glioblastoma cells.PLoS One. 2019 Feb 12;14(2):e0212037. doi: 10.1371/journal.pone.0212037. eCollection 2019.
883 Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-B Signaling.Clin Cancer Res. 2019 Nov 15;25(22):6868-6881. doi: 10.1158/1078-0432.CCR-19-0747. Epub 2019 Sep 6.
884 ADAM23 methylation and expression analysis in brain tumors.Neurosci Lett. 2005 Jun 3;380(3):260-4. doi: 10.1016/j.neulet.2005.01.050. Epub 2005 Feb 8.
885 RNA binding candidates for human ADAR3 from substrates of a gain of function mutant expressed in neuronal cells.Nucleic Acids Res. 2019 Nov 18;47(20):10801-10814. doi: 10.1093/nar/gkz815.
886 MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.Neuro Oncol. 2013 Oct;15(10):1302-16. doi: 10.1093/neuonc/not090. Epub 2013 Jun 28.
887 Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1).Cytogenet Cell Genet. 1997;79(1-2):103-8. doi: 10.1159/000134693.
888 Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.PLoS One. 2015 Feb 25;10(2):e0111532. doi: 10.1371/journal.pone.0111532. eCollection 2015.
889 Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.Acta Neuropathol Commun. 2018 Jun 11;6(1):49. doi: 10.1186/s40478-018-0544-y.
890 AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells.Sci Rep. 2019 Oct 10;9(1):14577. doi: 10.1038/s41598-019-51068-1.
891 Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.Oncogene. 2017 Aug 10;36(32):4562-4572. doi: 10.1038/onc.2017.67. Epub 2017 Apr 3.
892 Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas.Acta Neuropathol. 2000 Dec;100(6):673-80. doi: 10.1007/s004010000233.
893 Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma.Sci Rep. 2019 Jun 11;9(1):8480. doi: 10.1038/s41598-019-44854-4.
894 Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.Front Mol Neurosci. 2017 Mar 13;10:68. doi: 10.3389/fnmol.2017.00068. eCollection 2017.
895 siRNA-mediated knockdown of JUB expression suppresses the proliferation of glioblastoma cells.Cancer Biomark. 2015;15(4):477-84. doi: 10.3233/CBM-150491.
896 Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro.Oncotarget. 2018 Apr 27;9(32):22703-22716. doi: 10.18632/oncotarget.25210. eCollection 2018 Apr 27.
897 The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.Neuro Oncol. 2013 Mar;15(3):269-78. doi: 10.1093/neuonc/nos301. Epub 2012 Dec 20.
898 Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population.J Res Med Sci. 2018 Nov 28;23:96. doi: 10.4103/jrms.JRMS_305_18. eCollection 2018.
899 Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines.Mol Cancer Ther. 2008 Jun;7(6):1461-71. doi: 10.1158/1535-7163.MCT-07-2010.
900 Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.Cancer Res. 2010 Sep 15;70(18):7283-93. doi: 10.1158/0008-5472.CAN-09-4125. Epub 2010 Sep 7.
901 A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma.Cancer Gene Ther. 2003 Sep;10(9):678-88. doi: 10.1038/sj.cgt.7700620.
902 ANO6 promotes cell proliferation and invasion in glioma through regulating the ERK signaling pathway.Onco Targets Ther. 2019 Aug 20;12:6721-6731. doi: 10.2147/OTT.S211725. eCollection 2019.
903 Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways.Endocr Relat Cancer. 2013 Dec 20;21(1):85-99. doi: 10.1530/ERC-13-0181. Print 2014 Feb.
904 MiR-224 expression increases radiation sensitivity of glioblastoma cells.Biochem Biophys Res Commun. 2014 May 30;448(2):225-30. doi: 10.1016/j.bbrc.2014.04.095. Epub 2014 Apr 29.
905 Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.Folia Neuropathol. 2018;56(1):30-38. doi: 10.5114/fn.2018.74657.
906 Multifunctional protein APPL2 contributes to survival of human glioma cells.Mol Oncol. 2013 Feb;7(1):67-84. doi: 10.1016/j.molonc.2012.08.003. Epub 2012 Sep 5.
907 Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794.Cell Prolif. 2020 Jan;53(1):e12732. doi: 10.1111/cpr.12732. Epub 2019 Nov 20.
908 Expression of aquaporin8 in human astrocytomas: correlation with pathologic grade.Biochem Biophys Res Commun. 2013 Oct 11;440(1):168-72. doi: 10.1016/j.bbrc.2013.09.057. Epub 2013 Sep 18.
909 Identification of ADP-ribosylation factor 4 as a suppressor of N-(4-hydroxyphenyl)retinamide-induced cell death.Cancer Lett. 2009 Apr 8;276(1):53-60. doi: 10.1016/j.canlet.2008.10.031. Epub 2008 Nov 28.
910 ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells.Biochim Biophys Acta. 2013 Feb;1832(2):365-74. doi: 10.1016/j.bbadis.2012.11.010. Epub 2012 Nov 28.
911 PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.Neoplasia. 2018 Oct;20(10):1045-1058. doi: 10.1016/j.neo.2018.08.008. Epub 2018 Sep 13.
912 SGEF Is Regulated via TWEAK/Fn14/NF-B Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.Mol Cancer Res. 2016 Mar;14(3):302-12. doi: 10.1158/1541-7786.MCR-15-0183. Epub 2016 Jan 13.
913 Expression of ADP-ribosyltransferase 1 Is Associated with Poor Prognosis of Glioma Patients.Tohoku J Exp Med. 2016 Aug;239(4):269-78. doi: 10.1620/tjem.239.269.
914 Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.Cell Death Dis. 2013 Jan 17;4(1):e458. doi: 10.1038/cddis.2012.197.
915 ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.Dev Growth Differ. 2010 Dec;52(9):747-55. doi: 10.1111/j.1440-169X.2010.01211.x.
916 (Pro)renin receptor is crucial for glioma development via the Wnt/-catenin signaling pathway.J Neurosurg. 2017 Oct;127(4):819-828. doi: 10.3171/2016.9.JNS16431. Epub 2017 Jan 6.
917 Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.Cancer Res. 2006 Apr 1;66(7):3852-8. doi: 10.1158/0008-5472.CAN-05-3062.
918 Microtubule actin cross-linking factor 1, a novel target in glioblastoma.Int J Oncol. 2017 Jan;50(1):310-316. doi: 10.3892/ijo.2016.3798. Epub 2016 Dec 9.
919 Comparison between MRI-derived ADC maps and (18)FLT-PET in pre-operative glioblastoma.J Neuroradiol. 2019 Nov;46(6):359-366. doi: 10.1016/j.neurad.2019.05.011. Epub 2019 Jun 20.
920 Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6668-73. doi: 10.1073/pnas.1203756109. Epub 2012 Apr 9.
921 Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway.EMBO Rep. 2008 Oct;9(10):983-9. doi: 10.1038/embor.2008.151. Epub 2008 Aug 15.
922 Flavopiridol's antiproliferative effects in glioblastoma multiforme.J Cancer Res Ther. 2016 Apr-Jun;12(2):811-7. doi: 10.4103/0973-1482.172132.
923 Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5682-7. doi: 10.1073/pnas.1316700111. Epub 2014 Mar 31.
924 Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.Exp Cell Res. 2019 Mar 15;376(2):221-226. doi: 10.1016/j.yexcr.2019.02.014. Epub 2019 Feb 16.
925 Emerging microtubule targets in glioma therapy.Semin Pediatr Neurol. 2015 Mar;22(1):49-72. doi: 10.1016/j.spen.2015.03.009. Epub 2015 Apr 4.
926 Induction of basic helix-loop-helix protein DEC1 (BHLHB2)/Stra13/Sharp2 in response to the cyclic adenosine monophosphate pathway.Eur J Cell Biol. 2001 May;80(5):329-34. doi: 10.1078/0171-9335-00167.
927 BHLHE41 promotes U87 and U251 cell proliferation via ERK/cyclinD1 signaling pathway.Cancer Manag Res. 2019 Aug 14;11:7657-7672. doi: 10.2147/CMAR.S214697. eCollection 2019.
928 Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.Oncotarget. 2014 Nov 15;5(21):10901-15. doi: 10.18632/oncotarget.2543.
929 Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.Cancer Biomark. 2018;22(2):311-316. doi: 10.3233/CBM-171019.
930 Mislocalization of the E3 ligase, -transducin repeat-containing protein 1 (-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.J Biol Chem. 2011 Jun 3;286(22):19777-88. doi: 10.1074/jbc.M111.237081. Epub 2011 Mar 28.
931 Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.Cancer Discov. 2013 Feb;3(2):198-211. doi: 10.1158/2159-8290.CD-12-0353. Epub 2012 Nov 15.
932 PKM2 regulates chromosome segregation and mitosis progression of tumor cells.Mol Cell. 2014 Jan 9;53(1):75-87. doi: 10.1016/j.molcel.2013.11.001. Epub 2013 Dec 5.
933 Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.Int J Oncol. 2015 Aug;47(2):465-72. doi: 10.3892/ijo.2015.3054. Epub 2015 Jun 18.
934 Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.Clin Cancer Res. 2018 Jun 1;24(11):2574-2584. doi: 10.1158/1078-0432.CCR-17-2954. Epub 2018 Mar 6.
935 CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells.EMBO J. 2011 Aug 19;30(20):4309-22. doi: 10.1038/emboj.2011.301.
936 Calpastatin phosphorylation regulates radiation-induced calpain activity in glioblastoma.Oncotarget. 2018 Feb 19;9(18):14597-14607. doi: 10.18632/oncotarget.24523. eCollection 2018 Mar 6.
937 Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae.Oncogene. 2004 Sep 9;23(41):6967-79. doi: 10.1038/sj.onc.1207911.
938 Yes and PI3K bind CD95 to signal invasion of glioblastoma.Cancer Cell. 2008 Mar;13(3):235-48. doi: 10.1016/j.ccr.2008.02.003.
939 CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling.Lab Invest. 2020 Apr;100(4):619-629. doi: 10.1038/s41374-019-0345-3. Epub 2019 Nov 20.
940 NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism.FASEB J. 2003 Oct;17(13):1919-21. doi: 10.1096/fj.02-1023fje. Epub 2003 Aug 15.
941 Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.Neoplasia. 2013 Nov;15(11):1272-81. doi: 10.1593/neo.131440.
942 Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.J Neurooncol. 2018 May;138(1):141-145. doi: 10.1007/s11060-018-2780-1. Epub 2018 Jan 31.
943 Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival.Oncotarget. 2014 Aug 30;5(16):6576-83. doi: 10.18632/oncotarget.2134.
944 CD109 attenuates TGF-1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.Biochem Biophys Res Commun. 2015 Apr 3;459(2):252-258. doi: 10.1016/j.bbrc.2015.02.093. Epub 2015 Feb 25.
945 CD164 regulates proliferation, progression, and invasion of human glioblastoma cells.Oncotarget. 2019 Mar 12;10(21):2041-2054. doi: 10.18632/oncotarget.26724. eCollection 2019 Mar 12.
946 Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.Cancer Res. 2015 Nov 1;75(21):4504-16. doi: 10.1158/0008-5472.CAN-14-3636. Epub 2015 Sep 11.
947 CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion.Int J Mol Sci. 2019 Mar 6;20(5):1137. doi: 10.3390/ijms20051137.
948 ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis.Oncogene. 2013 Feb 21;32(8):998-1009. doi: 10.1038/onc.2012.125. Epub 2012 Apr 23.
949 Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth.Cancer Res. 2014 Feb 1;74(3):787-96. doi: 10.1158/0008-5472.CAN-13-1423. Epub 2013 Dec 18.
950 RNASEQR--a streamlined and accurate RNA-seq sequence analysis program.Nucleic Acids Res. 2012 Mar;40(6):e42. doi: 10.1093/nar/gkr1248. Epub 2011 Dec 22.
951 Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.AJNR Am J Neuroradiol. 2018 Aug;39(8):1415-1422. doi: 10.3174/ajnr.A5732. Epub 2018 Jul 19.
952 CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.Carcinogenesis. 2020 May 14;41(3):377-389. doi: 10.1093/carcin/bgz113.
953 On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.Exp Cell Res. 2013 Jul 15;319(12):1828-1838. doi: 10.1016/j.yexcr.2013.03.025. Epub 2013 Mar 26.
954 Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.Clin Cancer Res. 2018 Dec 15;24(24):6471-6482. doi: 10.1158/1078-0432.CCR-18-1052. Epub 2018 Aug 31.
955 CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature.Sci Rep. 2019 Mar 8;9(1):3952. doi: 10.1038/s41598-019-39564-w.
956 CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.Front Mol Neurosci. 2017 Oct 17;10:324. doi: 10.3389/fnmol.2017.00324. eCollection 2017.
957 CIC protein instability contributes to tumorigenesis in glioblastoma.Nat Commun. 2019 Feb 8;10(1):661. doi: 10.1038/s41467-018-08087-9.
958 Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma.ASN Neuro. 2018 Jan-Dec;10:1759091418781949. doi: 10.1177/1759091418781949.
959 C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.Cell Prolif. 2019 May;52(3):e12584. doi: 10.1111/cpr.12584. Epub 2019 Mar 4.
960 Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.Genes Chromosomes Cancer. 2015 Jul;54(7):433-43. doi: 10.1002/gcc.22255. Epub 2015 Apr 30.
961 Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.Cancer Res. 2005 Jul 1;65(13):5523-34. doi: 10.1158/0008-5472.CAN-04-2582.
962 Knockdown of collagen -1(III) inhibits glioma cell proliferation and migration and is regulated by miR128-3p.Oncol Lett. 2018 Aug;16(2):1917-1923. doi: 10.3892/ol.2018.8830. Epub 2018 May 30.
963 The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis.Diagn Pathol. 2019 Nov 5;14(1):124. doi: 10.1186/s13000-019-0903-4.
964 Identification of COX5B as a novel biomarker in high-grade glioma patients.Onco Targets Ther. 2017 Nov 15;10:5463-5470. doi: 10.2147/OTT.S139243. eCollection 2017.
965 Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.J Neurooncol. 2018 Jan;136(1):41-50. doi: 10.1007/s11060-017-2637-z. Epub 2017 Oct 27.
966 Primary Glioblastoma of Cerebellopontine Angle in Adult Mimicking Acoustic Neuroma.World Neurosurg. 2019 Feb;122:48-52. doi: 10.1016/j.wneu.2018.10.073. Epub 2018 Oct 19.
967 miR?54?p suppresses cell migration and invasion by targeting CPEB1 in human glioblastoma.Mol Med Rep. 2018 Oct;18(4):3965-3972. doi: 10.3892/mmr.2018.9386. Epub 2018 Aug 14.
968 CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.Clin Neurol Neurosurg. 2018 Jun;169:92-97. doi: 10.1016/j.clineuro.2018.04.008. Epub 2018 Apr 3.
969 High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism.Cancer Biol Ther. 2014 Jun 1;15(6):735-41. doi: 10.4161/cbt.28408. Epub 2014 Mar 11.
970 cDNA cloning of a novel trypsin inhibitor with similarity to pathogenesis-related proteins, and its frequent expression in human brain cancer cells.Biochim Biophys Acta. 1998 Jan 21;1395(2):202-8. doi: 10.1016/s0167-4781(97)00149-8.
971 Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas.Br J Cancer. 1995 Sep;72(3):627-33. doi: 10.1038/bjc.1995.384.
972 Cullin1 regulates proliferation, migration and invasion of glioma cells.Med Oncol. 2014 Oct;31(10):227. doi: 10.1007/s12032-014-0227-x. Epub 2014 Sep 9.
973 The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.Int J Mol Sci. 2019 May 21;20(10):2496. doi: 10.3390/ijms20102496.
974 Overexpression and Nucleolar Localization of -Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma.J Neuropathol Exp Neurol. 2015 Jul;74(7):723-42. doi: 10.1097/NEN.0000000000000212.
975 Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR.J Neurooncol. 2015 May;123(1):35-42. doi: 10.1007/s11060-015-1772-7. Epub 2015 Apr 11.
976 Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells.Acta Physiol (Oxf). 2011 Jul;202(3):563-81. doi: 10.1111/j.1748-1716.2010.02205.x. Epub 2010 Nov 12.
977 RELN signaling modulates glioblastoma growth and substrate-dependent migration.Brain Pathol. 2018 Sep;28(5):695-709. doi: 10.1111/bpa.12584. Epub 2018 Jan 10.
978 Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells.Oncol Rep. 2014 Aug;32(2):619-26. doi: 10.3892/or.2014.3235. Epub 2014 Jun 5.
979 Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3.Nat Commun. 2018 May 25;9:16217. doi: 10.1038/ncomms16217.
980 Acyl-CoA-Binding Protein Fuels Gliomagenesis.Cell Metab. 2019 Aug 6;30(2):229-230. doi: 10.1016/j.cmet.2019.07.007.
981 Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.Int J Cancer. 2010 Jun 1;126(11):2622-34. doi: 10.1002/ijc.24957.
982 Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.Eur J Med Chem. 2018 May 10;151:186-198. doi: 10.1016/j.ejmech.2018.03.055. Epub 2018 Mar 23.
983 Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).Genes Chromosomes Cancer. 2003 May;37(1):58-71. doi: 10.1002/gcc.10207.
984 DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.
985 Mammalian diaphanous-related formin 1 is required for motility and invadopodia formation in human U87 glioblastoma cells.Int J Mol Med. 2014 Feb;33(2):383-91. doi: 10.3892/ijmm.2013.1577. Epub 2013 Dec 5.
986 Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma.BMC Cancer. 2019 May 14;19(1):441. doi: 10.1186/s12885-019-5643-z.
987 Haptoglobin gene expression in human glioblastoma cell lines.Neurosci Lett. 2001 May 11;303(3):181-4. doi: 10.1016/s0304-3940(01)01748-7.
988 Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype.Curr Mol Med. 2013 Mar;13(3):438-45.
989 Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.Cancer Genet Cytogenet. 2006 Mar;165(2):121-34. doi: 10.1016/j.cancergencyto.2005.08.009.
990 Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.Br J Cancer. 2014 Mar 4;110(5):1307-15. doi: 10.1038/bjc.2014.39. Epub 2014 Feb 11.
991 In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion.J Cell Sci. 2012 Feb 15;125(Pt 4):858-68. doi: 10.1242/jcs.089995. Epub 2012 Mar 7.
992 The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells.Sci Rep. 2017 Apr 18;7(1):889. doi: 10.1038/s41598-017-00982-3.
993 The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma.Neuro Oncol. 2018 Jun 18;20(7):930-941. doi: 10.1093/neuonc/noy007.
994 CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.Cancer Res. 2015 Sep 1;75(17):3519-28. doi: 10.1158/0008-5472.CAN-14-0631. Epub 2015 Jun 29.
995 DRAM1 regulates the migration and invasion of hepatoblastoma cells via autophagy-EMT pathway.Oncol Lett. 2018 Aug;16(2):2427-2433. doi: 10.3892/ol.2018.8937. Epub 2018 Jun 8.
996 Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.Eur Radiol. 2019 Oct;29(10):5539-5548. doi: 10.1007/s00330-019-06097-9. Epub 2019 Mar 15.
997 Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas.Oncogene. 2011 Sep 1;30(35):3813-20. doi: 10.1038/onc.2011.99. Epub 2011 Apr 18.
998 MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):1044-1050. doi: 10.26355/eurrev_201802_14387.
999 Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.J Exp Clin Cancer Res. 2015 Jan 22;34(1):4. doi: 10.1186/s13046-014-0118-1.
1000 Suppression of virus replication via down-modulation of mitochondrial short chain enoyl-CoA hydratase in human glioblastoma cells.Antiviral Res. 2007 Aug;75(2):152-8. doi: 10.1016/j.antiviral.2007.02.002. Epub 2007 Mar 16.
1001 Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells.Mol Cancer Res. 2011 Dec;9(12):1668-85. doi: 10.1158/1541-7786.MCR-10-0563. Epub 2011 Oct 19.
1002 Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma.Clin Cancer Res. 2018 Feb 15;24(4):821-833. doi: 10.1158/1078-0432.CCR-17-1628. Epub 2017 Nov 16.
1003 EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma.Cancer Biomark. 2019;24(3):343-350. doi: 10.3233/CBM-181740.
1004 c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.Br J Cancer. 1996 Mar;73(5):620-3. doi: 10.1038/bjc.1996.107.
1005 Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells.Int J Mol Sci. 2014 Jan 29;15(2):2172-90. doi: 10.3390/ijms15022172.
1006 Analysis of the close relationship between human astrocytoma-specific antigens detected by murine monoclonal antibodies and c-kit proto-oncogene product.Biochem Biophys Res Commun. 1992 Jan 31;182(2):474-80. doi: 10.1016/0006-291x(92)91756-g.
1007 Epigenetic Control of Fatty-Acid Metabolism Sustains Glioma Stem Cells.Cancer Discov. 2019 Sep;9(9):1161-1163. doi: 10.1158/2159-8290.CD-19-0733.
1008 Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.Oncol Rep. 2019 Aug;42(2):605-614. doi: 10.3892/or.2019.7204. Epub 2019 Jun 19.
1009 Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):245-254. doi: 10.1167/iovs.18-24345.
1010 High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.Medicine (Baltimore). 2018 Jan;97(1):e9538. doi: 10.1097/MD.0000000000009538.
1011 The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line.BMC Cancer. 2018 Dec 4;18(1):1213. doi: 10.1186/s12885-018-5094-y.
1012 The effect of GHRH antagonists on human glioblastomas and their mechanism of action.Int J Cancer. 2010 Nov 15;127(10):2313-22. doi: 10.1002/ijc.25259.
1013 Overexpression of Epsin3 enhances migration and invasion of glioma cells by inducing epithelialmesenchymal transition.Oncol Rep. 2018 Nov;40(5):3049-3059. doi: 10.3892/or.2018.6691. Epub 2018 Sep 10.
1014 Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines.Exp Cell Res. 2012 Sep 10;318(15):1901-12. doi: 10.1016/j.yexcr.2012.05.010. Epub 2012 Jun 8.
1015 microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.Cancer Res. 2014 Mar 1;74(5):1541-53. doi: 10.1158/0008-5472.CAN-13-1449. Epub 2014 Jan 14.
1016 A human glioblastoma line with karyotypic nullisomy 13 containing several chromosome 13-specific sequences.Cancer Genet Cytogenet. 1988 Jul 1;33(1):127-32. doi: 10.1016/0165-4608(88)90058-1.
1017 Cohesin gene mutations in tumorigenesis: from discovery to clinical significance.BMB Rep. 2014 Jun;47(6):299-310. doi: 10.5483/bmbrep.2014.47.6.092.
1018 ETV2 mediates endothelial transdifferentiation of glioblastoma.Signal Transduct Target Ther. 2018 Feb 9;3:4. doi: 10.1038/s41392-018-0007-8. eCollection 2018.
1019 Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.Clin Cancer Res. 2001 Feb;7(2):267-76.
1020 In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion.J Biomol Struct Dyn. 2017 Oct;35(13):2815-2829. doi: 10.1080/07391102.2016.1231633. Epub 2016 Sep 28.
1021 Fatty acid binding protein 7 as a marker of glioma stem cells.Pathol Int. 2013 Nov;63(11):546-53. doi: 10.1111/pin.12109.
1022 DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation.Cancer Lett. 2018 Jun 1;423:86-94. doi: 10.1016/j.canlet.2018.03.015. Epub 2018 Mar 13.
1023 Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma.Oncogene. 2020 Jan;39(1):36-49. doi: 10.1038/s41388-019-0974-4. Epub 2019 Aug 23.
1024 Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.PLoS One. 2018 Jul 5;13(7):e0199414. doi: 10.1371/journal.pone.0199414. eCollection 2018.
1025 FEN1 is overexpressed in testis, lung and brain tumors.Anticancer Res. 2009 Jul;29(7):2453-9.
1026 FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.Neurosci Lett. 2017 Sep 14;657:77-83. doi: 10.1016/j.neulet.2017.07.057. Epub 2017 Aug 1.
1027 Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.Oncogene. 2018 Feb 8;37(6):777-786. doi: 10.1038/onc.2017.373. Epub 2017 Oct 23.
1028 Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors.Neurosurgery. 1998 Aug;43(2):337-46. doi: 10.1097/00006123-199808000-00098.
1029 FHL2 interacts with EGFR to promote glioblastoma growth.Oncogene. 2018 Mar;37(10):1386-1398. doi: 10.1038/s41388-017-0068-0. Epub 2018 Jan 11.
1030 KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.Brain. 2012 Apr;135(Pt 4):1027-41. doi: 10.1093/brain/aws045. Epub 2012 Mar 16.
1031 Combinatorial Synthesis of New Pyrimidine- and Purine--d-Ribonucleoside Nucleolipids: Their Distribution Between Aqueous and Organic Phases and Their In Vitro Activity Against Human- and Rat Glioblastoma Cells In Vitro.Chem Biodivers. 2018 Sep;15(9):e1800173. doi: 10.1002/cbdv.201800173. Epub 2018 Aug 20.
1032 FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma.Biochem Biophys Res Commun. 2018 Sep 26;504(1):46-53. doi: 10.1016/j.bbrc.2018.08.118. Epub 2018 Aug 29.
1033 FOXK1 promotes glioblastoma proliferation and metastasis through activation of Snail transcription.Exp Ther Med. 2018 Mar;15(3):3108-3116. doi: 10.3892/etm.2018.5732. Epub 2018 Jan 10.
1034 Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.PLoS One. 2013 Apr 17;8(4):e61206. doi: 10.1371/journal.pone.0061206. Print 2013.
1035 Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining.Brain Tumor Pathol. 2014 Apr;31(2):85-93. doi: 10.1007/s10014-013-0153-1. Epub 2013 Jun 9.
1036 The Mammalian Hairless Protein as a DNA Binding Phosphoprotein.J Cell Biochem. 2017 Feb;118(2):341-350. doi: 10.1002/jcb.25641. Epub 2016 Sep 21.
1037 Effects of IGFBP-3 and GalNAc-T14 on proliferation and cell cycle of glioblastoma cells and its mechanism.J Pharm Pharmacol. 2020 Feb;72(2):218-226. doi: 10.1111/jphp.13187. Epub 2019 Nov 12.
1038 Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.Sci Rep. 2018 Oct 16;8(1):15286. doi: 10.1038/s41598-018-33306-0.
1039 Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.J Cancer Res Clin Oncol. 2014 Oct;140(10):1641-9. doi: 10.1007/s00432-014-1716-1. Epub 2014 Jun 1.
1040 MicroRNA-135b exerts oncogenic activity in glioblastoma via the inhibition of glycerol kinase 5 expression.Mol Med Rep. 2015 Aug;12(2):2721-6. doi: 10.3892/mmr.2015.3708. Epub 2015 Apr 30.
1041 CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.Sci Rep. 2015 Jul 9;5:11483. doi: 10.1038/srep11483.
1042 Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.Neuro Oncol. 2019 Feb 19;21(3):337-347. doi: 10.1093/neuonc/noy185.
1043 -Ketoglutarate-Activated NF-B Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.Mol Cell. 2019 Oct 3;76(1):148-162.e7. doi: 10.1016/j.molcel.2019.07.007. Epub 2019 Aug 22.
1044 GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/-catenin signaling pathway.Brain Res. 2019 Aug 15;1717:117-126. doi: 10.1016/j.brainres.2019.03.035. Epub 2019 Mar 29.
1045 Development of a predictor for human brain tumors based on gene expression values obtained from two types of microarray technologies.OMICS. 2010 Apr;14(2):157-64. doi: 10.1089/omi.2009.0093.
1046 Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.Oncogene. 2018 Aug;37(31):4313-4333. doi: 10.1038/s41388-018-0277-1. Epub 2018 May 3.
1047 Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1(+/-) mouse models of medulloblastoma.Exp Neurol. 2019 Feb;312:33-42. doi: 10.1016/j.expneurol.2018.11.004. Epub 2018 Nov 16.
1048 Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.Clin Neurol Neurosurg. 2018 Jan;164:132-137. doi: 10.1016/j.clineuro.2017.11.017. Epub 2017 Nov 29.
1049 Coronarin D Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Glioblastoma Cell Line.Molecules. 2019 Dec 9;24(24):4498. doi: 10.3390/molecules24244498.
1050 Detecting the H3F3A mutant allele found in high-grade pediatric glioma by real-time PCR.J Neurooncol. 2016 Jan;126(1):27-36. doi: 10.1007/s11060-015-1936-5. Epub 2015 Sep 16.
1051 The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells.J Cell Biochem. 2009 Aug 15;107(6):1129-38. doi: 10.1002/jcb.22215.
1052 Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.Neoplasia. 2018 Oct;20(10):1023-1037. doi: 10.1016/j.neo.2018.08.007. Epub 2018 Sep 6.
1053 Tetramethylpyrazine attenuates sinusoidal angiogenesis via inhibition of hedgehog signaling in liver fibrosis.IUBMB Life. 2017 Feb;69(2):115-127. doi: 10.1002/iub.1598. Epub 2017 Jan 23.
1054 Detailed delineation of an interferon-gamma-responsive element important in human HLA-DRA gene expression in a glioblastoma multiform line.Proc Natl Acad Sci U S A. 1988 Nov;85(22):8618-22. doi: 10.1073/pnas.85.22.8618.
1055 HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.J Neuropathol Exp Neurol. 2005 Jun;64(6):523-8. doi: 10.1093/jnen/64.6.523.
1056 COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor.Oncotarget. 2017 Sep 15;8(50):87353-87363. doi: 10.18632/oncotarget.20928. eCollection 2017 Oct 20.
1057 Regulation of survival in adult hippocampal and glioblastoma stem cell lineages by the homeodomain-only protein HOP.Neural Dev. 2008 May 28;3:13. doi: 10.1186/1749-8104-3-13.
1058 A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.Oncotarget. 2015 Apr 10;6(10):7657-74. doi: 10.18632/oncotarget.3150.
1059 Modulation of HOX2 gene expression following differentiation of neuronal cell lines.Differentiation. 1992 Sep;51(1):39-47. doi: 10.1111/j.1432-0436.1992.tb00678.x.
1060 Long non-coding RNA HOXB-AS1 promotes proliferation, migration and invasion of glioblastoma cells via HOXB-AS1/miR-885-3p/HOXB2 axis.Neoplasma. 2019 May 23;66(3):386-396. doi: 10.4149/neo_2018_180606N377.
1061 Homeobox B8 Targets Sterile Alpha Motif Domain-Containing Protein 9 and Drives Glioma Progression.Neurosci Bull. 2020 Apr;36(4):359-371. doi: 10.1007/s12264-019-00436-y. Epub 2019 Oct 23.
1062 Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.Cancer Manag Res. 2019 Sep 3;11:8167-8179. doi: 10.2147/CMAR.S209904. eCollection 2019.
1063 HPCAL1 promotes glioblastoma proliferation via activation of Wnt/-catenin signalling pathway.J Cell Mol Med. 2019 May;23(5):3108-3117. doi: 10.1111/jcmm.14083. Epub 2019 Mar 6.
1064 Histidine-rich glycoprotein can prevent development of mouse experimental glioblastoma.PLoS One. 2009 Dec 31;4(12):e8536. doi: 10.1371/journal.pone.0008536.
1065 Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells.Mol Cancer. 2005 Mar 11;4(1):12. doi: 10.1186/1476-4598-4-12.
1066 Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer.Front Immunol. 2019 Mar 22;10:454. doi: 10.3389/fimmu.2019.00454. eCollection 2019.
1067 Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone.Cancer Res. 2001 May 15;61(10):4206-13.
1068 Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.PLoS One. 2013 Apr 16;8(4):e61605. doi: 10.1371/journal.pone.0061605. Print 2013.
1069 Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.Oncogene. 2017 Oct 26;36(43):6006-6019. doi: 10.1038/onc.2017.205. Epub 2017 Jul 3.
1070 Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.Glia. 2006 Jun;53(8):845-57. doi: 10.1002/glia.20345.
1071 Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.Neoplasia. 2009 Jan;11(1):77-86, 4p following 86. doi: 10.1593/neo.81180.
1072 IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.Oncol Rep. 2019 Apr;41(4):2148-2158. doi: 10.3892/or.2019.7007. Epub 2019 Feb 11.
1073 Receptor-type protein-tyrosine phosphatase is a functional receptor for interleukin-34.J Biol Chem. 2013 Jul 26;288(30):21972-86. doi: 10.1074/jbc.M112.442731. Epub 2013 Jun 6.
1074 alpha-Internexin expression identifies 1p19q codeleted gliomas.Neurology. 2009 Jan 13;72(2):156-61. doi: 10.1212/01.wnl.0000339055.64476.cb.
1075 Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma.Cell Death Dis. 2018 Oct 9;9(10):1032. doi: 10.1038/s41419-018-1058-z.
1076 Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma.FEBS J. 2019 Mar;286(6):1120-1135. doi: 10.1111/febs.14769. Epub 2019 Feb 16.
1077 Integrin 10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival.Cancers (Basel). 2019 Apr 25;11(4):587. doi: 10.3390/cancers11040587.
1078 Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.Int J Cancer. 2014 Mar 15;134(6):1300-10. doi: 10.1002/ijc.28465. Epub 2013 Sep 30.
1079 A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations.Sci Rep. 2019 Jan 29;9(1):842. doi: 10.1038/s41598-018-37462-1.
1080 Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.Front Oncol. 2019 Sep 20;9:904. doi: 10.3389/fonc.2019.00904. eCollection 2019.
1081 Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells.Curr HIV Res. 2005 Jul;3(3):277-88. doi: 10.2174/1570162054368048.
1082 Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.Cancer Res. 2009 Mar 15;69(6):2540-9. doi: 10.1158/0008-5472.CAN-08-1547. Epub 2009 Mar 10.
1083 MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.Cancer Med. 2019 Dec;8(18):7793-7808. doi: 10.1002/cam4.2639. Epub 2019 Nov 5.
1084 Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.Sci Rep. 2019 Mar 14;9(1):4599. doi: 10.1038/s41598-018-37622-3.
1085 Differential display of messenger ribonucleic acid: a useful technique for analyzing differential gene expression in human brain tumors.Neurosurgery. 1995 Sep;37(3):464-9; discussion 469-70. doi: 10.1227/00006123-199509000-00014.
1086 Small interfering RNA targeting Krppel-like factor 8 inhibits U251 glioblastoma cell growth by inducing apoptosis.Mol Med Rep. 2012 Feb;5(2):347-50. doi: 10.3892/mmr.2011.669. Epub 2011 Nov 8.
1087 Krppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.BMC Cancer. 2018 Oct 22;18(1):1025. doi: 10.1186/s12885-018-4874-8.
1088 Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.J Neurosurg. 2017 May;126(5):1461-1471. doi: 10.3171/2016.4.JNS1652. Epub 2016 Jul 1.
1089 Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.PLoS One. 2011;6(5):e19868. doi: 10.1371/journal.pone.0019868. Epub 2011 May 23.
1090 Laminin alpha 2 enables glioblastoma stem cell growth.Ann Neurol. 2012 Nov;72(5):766-78. doi: 10.1002/ana.23674.
1091 NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability.Clin Cancer Res. 2017 May 1;23(9):2325-2334. doi: 10.1158/1078-0432.CCR-16-1323. Epub 2016 Nov 3.
1092 Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.EMBO J. 2018 Aug 1;37(15):e97115. doi: 10.15252/embj.201797115. Epub 2018 Jun 14.
1093 Outlining involvement of stem cell program in regulation of O6-methylguanine DNA methyltransferase and development of temozolomide resistance in glioblastoma: An Editorial Highlight for 'Transcriptional control of O(6) -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma' on page 780.J Neurochem. 2018 Mar;144(6):688-690. doi: 10.1111/jnc.14280.
1094 Stable knockdown of LRG1 by RNA interference inhibits growth and promotes apoptosis of glioblastoma cells in vitro and in vivo.Tumour Biol. 2015 Jun;36(6):4271-8. doi: 10.1007/s13277-015-3065-3. Epub 2015 Jan 15.
1095 Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.Oncogenesis. 2018 Feb 2;7(2):13. doi: 10.1038/s41389-017-0012-8.
1096 The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.Front Oncol. 2019 Jun 6;9:447. doi: 10.3389/fonc.2019.00447. eCollection 2019.
1097 LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.J Cell Biochem. 2008 Jan 1;103(1):245-55. doi: 10.1002/jcb.21400.
1098 Oligo-astrocytoma in LZTR1-related Noonan syndrome.Eur J Med Genet. 2020 Jan;63(1):103617. doi: 10.1016/j.ejmg.2019.01.007. Epub 2019 Jan 19.
1099 Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response.Cancers (Basel). 2019 Jun 13;11(6):825. doi: 10.3390/cancers11060825.
1100 Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases.Mol Cell. 2007 May 11;26(3):367-79. doi: 10.1016/j.molcel.2007.03.021.
1101 RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma.Mol Cell Biol. 2015 Sep 1;35(17):2965-78. doi: 10.1128/MCB.00410-15. Epub 2015 Jun 22.
1102 Prolactin increases expression of cytoskeletal proteins in SK-N-SH cells.Folia Biol (Praha). 2014;60(6):281-5.
1103 -Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.Int J Oncol. 2011 Feb;38(2):419-26. doi: 10.3892/ijo.2010.855. Epub 2010 Dec 3.
1104 A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.J Neurooncol. 2020 Jan;146(1):79-89. doi: 10.1007/s11060-019-03337-2. Epub 2019 Nov 27.
1105 Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma.Cancer Res. 2018 Oct 1;78(19):5574-5585. doi: 10.1158/0008-5472.CAN-17-3714. Epub 2018 Jun 19.
1106 The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines.Oncogene. 2003 May 1;22(17):2581-91. doi: 10.1038/sj.onc.1206336.
1107 A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes.PLoS One. 2013 May 22;8(5):e64873. doi: 10.1371/journal.pone.0064873. Print 2013.
1108 Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.Cancer. 2004 Sep 1;101(5):1018-27. doi: 10.1002/cncr.20442.
1109 Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation.Int J Cancer. 2020 Mar 1;146(5):1281-1292. doi: 10.1002/ijc.32649. Epub 2019 Oct 11.
1110 Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression.Oncotarget. 2016 Jul 12;7(28):43654-43668. doi: 10.18632/oncotarget.9661.
1111 RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.J Cell Mol Med. 2009 Nov-Dec;13(11-12):4608-22. doi: 10.1111/j.1582-4934.2008.00499.x.
1112 Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:32-38. doi: 10.1016/j.msec.2017.03.292. Epub 2017 Apr 6.
1113 N(6)-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma.Cancer Res. 2019 Nov 15;79(22):5785-5798. doi: 10.1158/0008-5472.CAN-18-2868. Epub 2019 Sep 17.
1114 Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.BMC Cancer. 2009 Aug 27;9:302. doi: 10.1186/1471-2407-9-302.
1115 Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP.Oncogene. 2010 Jun 17;29(24):3501-8. doi: 10.1038/onc.2010.114. Epub 2010 Apr 26.
1116 Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.J Neuropathol Exp Neurol. 2010 Mar;69(3):215-23. doi: 10.1097/NEN.0b013e3181ce9f67.
1117 Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.Bosn J Basic Med Sci. 2019 May 20;19(2):164-171. doi: 10.17305/bjbms.2019.3713.
1118 MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma.J Neurooncol. 2019 Sep;144(2):293-301. doi: 10.1007/s11060-019-03226-8. Epub 2019 Jun 24.
1119 Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.J Neurosurg. 2018 Mar 16;130(1):56-66. doi: 10.3171/2017.9.JNS172036.
1120 p55 and p75 tumor necrosis factor receptor expression on human glioblastoma cells.Neurol Med Chir (Tokyo). 1995 Aug;35(8):567-74. doi: 10.2176/nmc.35.567.
1121 RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death.Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):113-124. doi: 10.1016/j.bbamcr.2016.10.014. Epub 2016 Oct 27.
1122 Up-regulation of MSH6 is associated with temozolomide resistance in human glioblastoma.Biochem Biophys Res Commun. 2018 Feb 19;496(4):1040-1046. doi: 10.1016/j.bbrc.2018.01.093. Epub 2018 Jan 31.
1123 Moesin Up-regulation Is Associated with Enhanced Tumor Progression Imaged Non-invasively in an Orthotopic Mouse Model of Human Glioblastoma.Anticancer Res. 2018 Jun;38(6):3267-3272. doi: 10.21873/anticanres.12591.
1124 MAX and MYC: a heritable breakup.Cancer Res. 2012 Jul 1;72(13):3119-24. doi: 10.1158/0008-5472.CAN-11-3891. Epub 2012 Jun 15.
1125 Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma.Front Mol Biosci. 2019 Feb 19;6:5. doi: 10.3389/fmolb.2019.00005. eCollection 2019.
1126 Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.J Exp Clin Cancer Res. 2017 Aug 7;36(1):105. doi: 10.1186/s13046-017-0573-6.
1127 Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.Cancer Res. 1994 Aug 15;54(16):4299-303.
1128 microRNA-100 targets SMRT/NCOR2, reduces proliferation, and improves survival in glioblastoma animal models.PLoS One. 2013 Nov 14;8(11):e80865. doi: 10.1371/journal.pone.0080865. eCollection 2013.
1129 Network modeling of the transcriptional effects of copy number aberrations in glioblastoma.Mol Syst Biol. 2011 Apr 26;7:486. doi: 10.1038/msb.2011.17.
1130 Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.Sci Rep. 2018 Sep 17;8(1):13930. doi: 10.1038/s41598-018-32353-x.
1131 The NFL-TBS.40-63 peptide targets and kills glioblastoma stem cells derived from human patients and also targets nanocapsules into these cells.Int J Pharm. 2019 Jul 20;566:218-228. doi: 10.1016/j.ijpharm.2019.05.060. Epub 2019 May 24.
1132 Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors.Neurol Med Chir (Tokyo). 2001 Dec;41(12):582-8; discussion 589. doi: 10.2176/nmc.41.582.
1133 Direct sequencing analysis of transmembrane region of human Neu gene by polymerase chain reaction.Mol Carcinog. 1990;3(4):198-201. doi: 10.1002/mc.2940030406.
1134 Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells.Biochem Biophys Res Commun. 2019 Jan 1;508(1):31-36. doi: 10.1016/j.bbrc.2018.11.086. Epub 2018 Nov 20.
1135 Sialidase NEU4 is involved in glioblastoma stem cell survival.Cell Death Dis. 2014 Aug 21;5(8):e1381. doi: 10.1038/cddis.2014.349.
1136 miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.Gene. 2019 Aug 20;710:233-239. doi: 10.1016/j.gene.2019.06.008. Epub 2019 Jun 7.
1137 Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.J Neurooncol. 2020 Jan;146(1):41-53. doi: 10.1007/s11060-019-03352-3. Epub 2019 Nov 23.
1138 Neuroglobin functions as a prognostic marker and promotes the tumor growth of glioma via suppressing apoptosis.Biomed Pharmacother. 2017 Apr;88:173-180. doi: 10.1016/j.biopha.2017.01.029. Epub 2017 Jan 17.
1139 Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.Cancer Res. 1997 Mar 15;57(6):1180-7.
1140 High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.Oncotarget. 2015 Mar 10;6(7):4901-19. doi: 10.18632/oncotarget.3208.
1141 GLTSCR2 contributes to the death resistance and invasiveness of hypoxia-selected cancer cells.FEBS Lett. 2012 Sep 21;586(19):3435-40. doi: 10.1016/j.febslet.2012.07.064. Epub 2012 Jul 28.
1142 MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.J Cell Biochem. 2019 Apr;120(4):6188-6197. doi: 10.1002/jcb.27906. Epub 2018 Oct 10.
1143 Downregulation of COUP-TFII inhibits glioblastoma growth via targeting MPC1.Oncol Lett. 2018 Jun;15(6):9697-9702. doi: 10.3892/ol.2018.8601. Epub 2018 Apr 27.
1144 Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection.Cancer Res. 2001 May 15;61(10):4190-6.
1145 EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.BMC Cancer. 2018 Dec 4;18(1):1215. doi: 10.1186/s12885-018-5056-4.
1146 MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells.Oncotarget. 2018 Jun 8;9(44):27547-27563. doi: 10.18632/oncotarget.25547. eCollection 2018 Jun 8.
1147 The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway.Oncogene. 2008 Feb 14;27(8):1155-66. doi: 10.1038/sj.onc.1210732. Epub 2007 Aug 13.
1148 Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.Cancer Med. 2020 Feb;9(3):1069-1078. doi: 10.1002/cam4.2592. Epub 2019 Sep 30.
1149 Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses.Dis Markers. 2019 Oct 20;2019:7049294. doi: 10.1155/2019/7049294. eCollection 2019.
1150 Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.J Med Chem. 2019 Apr 11;62(7):3447-3474. doi: 10.1021/acs.jmedchem.8b01951. Epub 2019 Apr 2.
1151 PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29.
1152 MicroRNA-365 suppressed cell proliferation and migration via targeting PAX6 in glioblastoma.Am J Transl Res. 2019 Jan 15;11(1):361-369. eCollection 2019.
1153 PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype.Nat Commun. 2015 Dec 3;6:10068. doi: 10.1038/ncomms10068.
1154 PCDH10 is required for the tumorigenicity of glioblastoma cells.Biochem Biophys Res Commun. 2014 Jan 31;444(1):13-8. doi: 10.1016/j.bbrc.2013.12.138. Epub 2014 Jan 6.
1155 PAF promotes stemness and radioresistance of glioma stem cells.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9086-E9095. doi: 10.1073/pnas.1708122114. Epub 2017 Oct 9.
1156 Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.J Neurooncol. 2019 Jan;141(1):31-41. doi: 10.1007/s11060-018-03017-7. Epub 2018 Nov 3.
1157 Inhibition of Casein Kinase II by CX-4945, But Not Yes-associated protein (YAP) by Verteporfin, Enhances the Antitumor Efficacy of Temozolomide in Glioblastoma.Transl Oncol. 2020 Jan;13(1):70-78. doi: 10.1016/j.tranon.2019.09.006. Epub 2019 Dec 3.
1158 Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1.Oncogene. 2016 Mar 17;35(11):1411-22. doi: 10.1038/onc.2015.199. Epub 2015 Jun 29.
1159 Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma.Neuro Oncol. 2019 Feb 19;21(3):326-336. doi: 10.1093/neuonc/noy184.
1160 Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression throughHIF-1 accumulation.Nat Cell Biol. 2014 May;16(5):445-56. doi: 10.1038/ncb2954. Epub 2014 Apr 20.
1161 Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway.Cancer Cell Int. 2019 Nov 27;19:314. doi: 10.1186/s12935-019-1040-6. eCollection 2019.
1162 Identification of genes and pathways potentially related to PHF20 by gene expression profile analysis of glioblastoma U87 cell line.Cancer Cell Int. 2017 Oct 4;17:87. doi: 10.1186/s12935-017-0459-x. eCollection 2017.
1163 Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.Sci Rep. 2014 Jun 11;4:5260. doi: 10.1038/srep05260.
1164 Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression.Int Immunopharmacol. 2016 May;34:229-234. doi: 10.1016/j.intimp.2016.02.034. Epub 2016 Mar 10.
1165 PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFB.Sci Rep. 2017 Apr 11;7(1):835. doi: 10.1038/s41598-017-00947-6.
1166 Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes.J Cell Sci. 2006 Apr 1;119(Pt 7):1219-32. doi: 10.1242/jcs.02833. Epub 2006 Mar 7.
1167 PIP4K2A as a negative regulator of PI3K in PTEN-deficient glioblastoma.J Exp Med. 2019 May 6;216(5):1120-1134. doi: 10.1084/jem.20172170. Epub 2019 Mar 21.
1168 Polycystin-1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines.J Cell Mol Med. 2019 Sep;23(9):6215-6227. doi: 10.1111/jcmm.14506. Epub 2019 Jun 28.
1169 Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.Neuro Oncol. 2011 Jul;13(7):710-24. doi: 10.1093/neuonc/nor084.
1170 High expression of TIG3 predicts poor survival in patients with primary glioblastoma.Tumour Biol. 2017 Jun;39(6):1010428317712135. doi: 10.1177/1010428317712135.
1171 The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: expression of a tumor-specific variant and association with microtubules.J Neurooncol. 2002 Aug;59(1):15-26. doi: 10.1023/a:1016373015569.
1172 Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression.Mol Cell Biol. 2011 Mar;31(6):1225-39. doi: 10.1128/MCB.00607-10. Epub 2011 Jan 18.
1173 Lipid phosphate phosphatase-3 regulates tumor growth via -catenin and CYCLIN-D1 signaling.Mol Cancer. 2011 May 11;10:51. doi: 10.1186/1476-4598-10-51.
1174 Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.Blood. 2011 Oct 13;118(15):4285-96. doi: 10.1182/blood-2011-03-341388. Epub 2011 Aug 10.
1175 PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.Oncogene. 2020 Jan;39(5):1125-1139. doi: 10.1038/s41388-019-1050-9. Epub 2019 Oct 11.
1176 Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.Fam Cancer. 2019 Apr;18(2):173-178. doi: 10.1007/s10689-018-0102-6.
1177 Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.BMC Cancer. 2019 Apr 3;19(1):300. doi: 10.1186/s12885-019-5476-9.
1178 GAPDH is not regulated in human glioblastoma under hypoxic conditions.BMC Mol Biol. 2007 Jun 27;8:55. doi: 10.1186/1471-2199-8-55.
1179 Conversion of glioma cells to glioma stem-like cells by angiocrine factors.Biochem Biophys Res Commun. 2018 Feb 19;496(4):1013-1018. doi: 10.1016/j.bbrc.2017.02.076. Epub 2017 Feb 17.
1180 DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.Pathol Oncol Res. 2013 Apr;19(2):329-43. doi: 10.1007/s12253-012-9588-7. Epub 2012 Dec 20.
1181 Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease.Mol Cell Neurosci. 2017 Sep;83:83-91. doi: 10.1016/j.mcn.2017.07.002. Epub 2017 Jul 15.
1182 Regulation of the uPA gene in various grades of human glioma cells.Int J Oncol. 2001 Jan;18(1):71-9.
1183 Identification of the Gene Expression Rules That Define the Subtypes in Glioma.J Clin Med. 2018 Oct 13;7(10):350. doi: 10.3390/jcm7100350.
1184 PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.Nat Commun. 2018 Oct 31;9(1):4552. doi: 10.1038/s41467-018-06968-7.
1185 Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data.Eur Cytokine Netw. 2012 Jun;23(2):45-55. doi: 10.1684/ecn.2012.0302.
1186 Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.Cell Physiol Biochem. 2018;45(2):819-831. doi: 10.1159/000487174. Epub 2018 Jan 31.
1187 PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.Cancer Res. 2018 Jul 15;78(14):3809-3822. doi: 10.1158/0008-5472.CAN-18-0085. Epub 2018 May 9.
1188 Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma.PLoS One. 2018 Oct 4;13(10):e0204865. doi: 10.1371/journal.pone.0204865. eCollection 2018.
1189 Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.Aging (Albany NY). 2019 Aug 4;11(15):5463-5482. doi: 10.18632/aging.102131. Epub 2019 Aug 4.
1190 Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.CNS Neurosci Ther. 2017 Jan;23(1):69-75. doi: 10.1111/cns.12606. Epub 2016 Sep 17.
1191 Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth.J Neurooncol. 2010 Oct;100(1):31-41. doi: 10.1007/s11060-010-0144-6. Epub 2010 Mar 5.
1192 DNA-repair gene variants are associated with glioblastoma survival.Acta Oncol. 2012 Mar;51(3):325-32. doi: 10.3109/0284186X.2011.616284. Epub 2011 Oct 21.
1193 DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.Brain Pathol. 2012 Jan;22(1):17-25. doi: 10.1111/j.1750-3639.2011.00507.x. Epub 2011 Aug 16.
1194 Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity.PLoS One. 2011;6(5):e19629. doi: 10.1371/journal.pone.0019629. Epub 2011 May 13.
1195 RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation.Oncotarget. 2014 May 15;5(9):2820-6. doi: 10.18632/oncotarget.1924.
1196 Down syndrome candidate region 1 increases the stability of the IkappaBalpha protein: implications for its anti-inflammatory effects.J Biol Chem. 2006 Dec 22;281(51):39051-61. doi: 10.1074/jbc.M604659200. Epub 2006 Oct 24.
1197 Radixin knockdown by RNA interference suppresses human glioblastoma cell growth in vitro and in vivo.Asian Pac J Cancer Prev. 2014;15(22):9805-12. doi: 10.7314/apjcp.2014.15.22.9805.
1198 Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells.Technol Cancer Res Treat. 2014 Feb;13(1):87-93. doi: 10.7785/tcrt.2012.500362. Epub 2013 Jul 23.
1199 The Histone Demethylase NO66 Induces Glioma Cell Proliferation.Anticancer Res. 2019 Nov;39(11):6007-6014. doi: 10.21873/anticanres.13806.
1200 MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.Cell Death Dis. 2018 Oct 17;9(11):1062. doi: 10.1038/s41419-018-1084-x.
1201 Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.Int J Cancer. 2009 Dec 1;125(11):2624-30. doi: 10.1002/ijc.24639.
1202 RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.Oncol Rep. 2016 Jul;36(1):173-80. doi: 10.3892/or.2016.4802. Epub 2016 May 10.
1203 RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.Oncotarget. 2016 Dec 13;7(50):82411-82423. doi: 10.18632/oncotarget.12396.
1204 RNF138-mediated ubiquitination of rpS3 is required for resistance of glioblastoma cells to radiation-induced apoptosis.Exp Mol Med. 2018 Jan 26;50(1):e434. doi: 10.1038/emm.2017.247.
1205 RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma.Mol Cancer Ther. 2014 Dec;13(12):3049-61. doi: 10.1158/1535-7163.MCT-14-0244. Epub 2014 Oct 13.
1206 Lovastatin-induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells.J Neurochem. 2004 Apr;89(1):168-78. doi: 10.1111/j.1471-4159.2004.02319.x.
1207 Human S100A11 exhibits differential steady-state RNA levels in various tissues and a distinct subcellular localization.Biochem Biophys Res Commun. 1999 Sep 16;263(1):135-8. doi: 10.1006/bbrc.1999.1319.
1208 S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-B positive feedback loop.J Cell Mol Med. 2019 Oct;23(10):6907-6918. doi: 10.1111/jcmm.14574. Epub 2019 Aug 20.
1209 Identification of novel SNPs in glioblastoma using targeted resequencing.PLoS One. 2011;6(6):e18158. doi: 10.1371/journal.pone.0018158. Epub 2011 Jun 10.
1210 Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas.Int J Cancer. 2012 Aug 1;131(3):612-22. doi: 10.1002/ijc.26416. Epub 2011 Oct 5.
1211 Interaction of ASIC1 and ENaC subunits in human glioma cells and rat astrocytes.Am J Physiol Cell Physiol. 2011 Jun;300(6):C1246-59. doi: 10.1152/ajpcell.00199.2010. Epub 2011 Feb 23.
1212 Demethyl fruticulin A (SCO-1) causes apoptosis by inducing reactive oxygen species in mitochondria.J Cell Biochem. 2010 Dec 1;111(5):1149-59. doi: 10.1002/jcb.22801.
1213 MiR-374b targets GATA3 to promote progression and development of glioblastoma via regulating SEMA3B.Neoplasma. 2019 Jul 23;66(4):543-554. doi: 10.4149/neo_2018_180830N659. Epub 2019 Mar 7.
1214 The Anti-Tumorigenic Activity of Sema3C in the Chick Embryo Chorioallantoic Membrane Model.Int J Mol Sci. 2019 Nov 12;20(22):5672. doi: 10.3390/ijms20225672.
1215 Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain.PLoS One. 2012;7(8):e42912. doi: 10.1371/journal.pone.0042912. Epub 2012 Aug 24.
1216 Traceable Nanoparticles with Dual Targeting and ROS Response for RNAi-Based Immunochemotherapy of Intracranial Glioblastoma Treatment.Adv Mater. 2018 May;30(18):e1705054. doi: 10.1002/adma.201705054. Epub 2018 Mar 25.
1217 Human semaphorin 6B [(HSA)SEMA6B], a novel human class 6 semaphorin gene: alternative splicing and all-trans-retinoic acid-dependent downregulation in glioblastoma cell lines.Genomics. 2001 May 1;73(3):343-8. doi: 10.1006/geno.2001.6525.
1218 The integrated landscape of driver genomic alterations in glioblastoma.Nat Genet. 2013 Oct;45(10):1141-9. doi: 10.1038/ng.2734. Epub 2013 Aug 5.
1219 MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7.PLoS One. 2013;8(1):e55008. doi: 10.1371/journal.pone.0055008. Epub 2013 Jan 28.
1220 Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells.Brain Res. 2015 Mar 10;1600:59-69. doi: 10.1016/j.brainres.2014.06.017. Epub 2014 Jun 23.
1221 Inhibitors of urokinase and thrombin in cultured neural cells.J Neurochem. 1991 Jan;56(1):234-42. doi: 10.1111/j.1471-4159.1991.tb02586.x.
1222 Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell Niche.Cancer Microenviron. 2017 Dec;10(1-3):57-68. doi: 10.1007/s12307-017-0197-6. Epub 2017 Aug 18.
1223 Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.
1224 Shc3 affects human high-grade astrocytomas survival.Oncogene. 2005 Aug 4;24(33):5198-206. doi: 10.1038/sj.onc.1208708.
1225 Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas.Oncogene. 2018 Jul;37(30):4055-4057. doi: 10.1038/s41388-018-0230-3. Epub 2018 Apr 30.
1226 Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members.J Neurooncol. 2017 Jul;133(3):509-518. doi: 10.1007/s11060-017-2476-y. Epub 2017 Jun 22.
1227 Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.PLoS One. 2015 Feb 24;10(2):e0118302. doi: 10.1371/journal.pone.0118302. eCollection 2015.
1228 Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.Cancer Gene Ther. 2018 Dec;25(11-12):309-316. doi: 10.1038/s41417-018-0040-3. Epub 2018 Aug 24.
1229 Whole exome-wide association study identifies a missense variant in SLC2A4RG associated with glioblastoma risk.Am J Cancer Res. 2017 Sep 1;7(9):1937-1947. eCollection 2017.
1230 Expression of Slc35f1 in the murine brain.Cell Tissue Res. 2019 Aug;377(2):167-176. doi: 10.1007/s00441-019-03008-8. Epub 2019 Mar 13.
1231 When the guardian sleeps: Reactivation of the p53 pathway in cancer.Mutat Res Rev Mutat Res. 2017 Jul;773:1-13. doi: 10.1016/j.mrrev.2017.02.003. Epub 2017 Feb 17.
1232 SWI/SNF gene variants and glioma risk and outcome.Cancer Epidemiol. 2013 Apr;37(2):162-5. doi: 10.1016/j.canep.2012.12.001. Epub 2012 Dec 29.
1233 The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.Nat Commun. 2018 May 25;9(1):2087. doi: 10.1038/s41467-018-04448-6.
1234 Intratumoral heterogeneity of genomic imbalance in a case of epithelioid glioblastoma with BRAF V600E mutation.Brain Pathol. 2014 Apr;24(3):239-46. doi: 10.1111/bpa.12114. Epub 2014 Jan 13.
1235 siRNA-mediated knockdown of SMC1A expression suppresses the proliferation of glioblastoma cells.Mol Cell Biochem. 2013 Sep;381(1-2):209-15. doi: 10.1007/s11010-013-1704-9. Epub 2013 Jun 11.
1236 Comparative genomics on SNAI1, SNAI2, and SNAI3 orthologs.Oncol Rep. 2005 Oct;14(4):1083-6.
1237 Comparison of somatostatin receptor expression in human gliomas and medulloblastomas.J Neuroendocrinol. 2002 Jun;14(6):458-71. doi: 10.1046/j.1365-2826.2002.00801.x.
1238 Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/-catenin signaling.Mol Carcinog. 2018 Apr;57(4):494-502. doi: 10.1002/mc.22774. Epub 2018 Jan 5.
1239 miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin Via Regulation Of SOS1.Onco Targets Ther. 2019 Nov 11;12:9513-9525. doi: 10.2147/OTT.S210732. eCollection 2019.
1240 Oncogenic activity of SOX1 in glioblastoma.Sci Rep. 2017 Apr 20;7:46575. doi: 10.1038/srep46575.
1241 Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.J Clin Invest. 2013 Jan;123(1):418-31. doi: 10.1172/JCI64547. Epub 2012 Dec 17.
1242 SOX3 can promote the malignant behavior of glioblastoma cells.Cell Oncol (Dordr). 2019 Feb;42(1):41-54. doi: 10.1007/s13402-018-0405-5. Epub 2018 Sep 12.
1243 SP100 reduces malignancy of human glioma cells.Int J Oncol. 2011 Apr;38(4):1023-30. doi: 10.3892/ijo.2011.927. Epub 2011 Jan 27.
1244 Human sperm-associated antigen 4 as a potential biomarker of glioblastoma progression and prognosis.Neuroreport. 2019 Apr 10;30(6):446-451. doi: 10.1097/WNR.0000000000001226.
1245 Spermassociated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin.Mol Med Rep. 2014 Jul;10(1):417-22. doi: 10.3892/mmr.2014.2168. Epub 2014 Apr 24.
1246 Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis.Neurobiol Dis. 2020 Feb;134:104705. doi: 10.1016/j.nbd.2019.104705. Epub 2019 Dec 10.
1247 Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.Cancer Sci. 2018 Sep;109(9):2970-2979. doi: 10.1111/cas.13732. Epub 2018 Aug 16.
1248 Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway.Oncol Rep. 2018 Dec;40(6):3313-3322. doi: 10.3892/or.2018.6777. Epub 2018 Oct 9.
1249 SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.Cancer Res. 2019 Oct 15;79(20):5288-5301. doi: 10.1158/0008-5472.CAN-19-1504. Epub 2019 Aug 28.
1250 Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma.BMC Cancer. 2018 Dec 12;18(1):1244. doi: 10.1186/s12885-018-5158-z.
1251 The role of DNA methylation in ST6Gal1 expression in gliomas.Glycobiology. 2016 Dec;26(12):1271-1283. doi: 10.1093/glycob/cww058. Epub 2016 Aug 10.
1252 Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase.Molecules. 2012 Aug 10;17(8):9559-72. doi: 10.3390/molecules17089559.
1253 AdipoR1-mediated miR-3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.Oncol Rep. 2017 Jun;37(6):3387-3396. doi: 10.3892/or.2017.5589. Epub 2017 Apr 20.
1254 EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.Mol Cancer Res. 2018 Jul;16(7):1185-1195. doi: 10.1158/1541-7786.MCR-18-0125. Epub 2018 May 3.
1255 Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.Neoplasia. 2018 Jun;20(6):543-554. doi: 10.1016/j.neo.2018.04.002. Epub 2018 May 3.
1256 Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.Cancer Genet. 2019 Sep;237:1-9. doi: 10.1016/j.cancergen.2019.05.006. Epub 2019 Jun 3.
1257 Overexpression of SCLIP promotes growth and motility in glioblastoma cells.Cancer Biol Ther. 2015;16(1):97-105. doi: 10.4161/15384047.2014.987037.
1258 The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.Mol Cancer Res. 2012 Jan;10(1):143-55. doi: 10.1158/1541-7786.MCR-11-0208.
1259 SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s.Cancer Cell Int. 2019 Nov 21;19:305. doi: 10.1186/s12935-019-1035-3. eCollection 2019.
1260 Synemin promotes AKT-dependent glioblastoma cell proliferation by antagonizing PP2A.Mol Biol Cell. 2012 Apr;23(7):1243-53. doi: 10.1091/mbc.E11-08-0685. Epub 2012 Feb 15.
1261 Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis.Mol Med Rep. 2017 Dec;16(6):9017-9022. doi: 10.3892/mmr.2017.7723. Epub 2017 Oct 4.
1262 Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells.Mol Ther. 2007 Jan;15(1):94-102. doi: 10.1038/sj.mt.6300003.
1263 Expression and prognostic significance of TCTN1 in human glioblastoma.J Transl Med. 2014 Oct 11;12:288. doi: 10.1186/s12967-014-0288-9.
1264 Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma.Nat Commun. 2018 Oct 1;9(1):4020. doi: 10.1038/s41467-018-06258-2.
1265 ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.Oncogene. 2017 Mar 23;36(12):1733-1744. doi: 10.1038/onc.2016.341. Epub 2016 Sep 19.
1266 Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.Int J Cancer. 2020 Jan 15;146(2):373-387. doi: 10.1002/ijc.32520. Epub 2019 Jul 1.
1267 Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line.Molecules. 2018 May 9;23(5):1129. doi: 10.3390/molecules23051129.
1268 Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells.J Pineal Res. 2019 Apr;66(3):e12556. doi: 10.1111/jpi.12556. Epub 2019 Feb 14.
1269 Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma.Cell Death Dis. 2018 Nov 15;9(12):1139. doi: 10.1038/s41419-018-1183-8.
1270 CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.Clin Cancer Res. 2017 Dec 1;23(23):7360-7374. doi: 10.1158/1078-0432.CCR-17-1549. Epub 2017 Sep 22.
1271 TIGAR promotes growth, survival and metastasis through oxidation resistance and AKT activation in glioblastoma.Oncol Lett. 2019 Sep;18(3):2509-2517. doi: 10.3892/ol.2019.10574. Epub 2019 Jul 5.
1272 Luteolin reduces migration of human glioblastoma cell lines via inhibition of the p-IGF-1R/PI3K/AKT/mTOR signaling pathway.Oncol Lett. 2017 Sep;14(3):3545-3551. doi: 10.3892/ol.2017.6643. Epub 2017 Jul 21.
1273 Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma.J Neurooncol. 2012 Feb;106(3):461-71. doi: 10.1007/s11060-011-0691-5. Epub 2011 Aug 21.
1274 Suppression of Angiotensin-(1-7) on the Disruption of Blood-Brain Barrier in Rat of Brain Glioma.Pathol Oncol Res. 2019 Jan;25(1):429-435. doi: 10.1007/s12253-018-0471-z. Epub 2018 Sep 18.
1275 Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma.CNS Neurosci Ther. 2019 Sep;25(9):965-975. doi: 10.1111/cns.13137. Epub 2019 Jun 10.
1276 Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.Int J Cancer. 2015 Oct 15;137(8):1842-54. doi: 10.1002/ijc.29565. Epub 2015 Apr 29.
1277 Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGF2 in vascular abnormalization.J Pathol. 2012 Nov;228(3):378-90. doi: 10.1002/path.4072. Epub 2012 Aug 31.
1278 EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy.Oncol Rep. 2014 Jan;31(1):480-7. doi: 10.3892/or.2013.2864. Epub 2013 Nov 20.
1279 Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells.Mol Cancer. 2012 Aug 22;11:59. doi: 10.1186/1476-4598-11-59.
1280 Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study.Med Sci Monit. 2015 Jul 9;21:1983-8. doi: 10.12659/MSM.893723.
1281 Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.J Exp Clin Cancer Res. 2019 Feb 6;38(1):57. doi: 10.1186/s13046-019-1070-x.
1282 TRIM45 functions as a tumor suppressor in the brain via its E3 ligase activity by stabilizing p53 through K63-linked ubiquitination.Cell Death Dis. 2017 May 25;8(5):e2831. doi: 10.1038/cddis.2017.149.
1283 The roles of TRIO and F-actin-binding protein in glioblastoma cells.Mol Med Rep. 2018 Mar;17(3):4540-4546. doi: 10.3892/mmr.2018.8458. Epub 2018 Jan 18.
1284 TRIP6 regulates p27 KIP1 to promote tumorigenesis.Mol Cell Biol. 2013 Apr;33(7):1394-409. doi: 10.1128/MCB.01149-12. Epub 2013 Jan 22.
1285 MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.Cell Mol Neurobiol. 2018 Apr;38(3):669-677. doi: 10.1007/s10571-017-0525-x. Epub 2017 Aug 5.
1286 Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.Biochem Biophys Res Commun. 2015 Mar 13;458(3):476-482. doi: 10.1016/j.bbrc.2015.01.128. Epub 2015 Feb 11.
1287 EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.
1288 ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.J Pathol. 2019 Feb;247(2):266-278. doi: 10.1002/path.5189. Epub 2018 Dec 24.
1289 Glioma-amplified sequence KUB3 influences double-strand break repair after ionizing radiation.Int J Oncol. 2013 Jul;43(1):50-6. doi: 10.3892/ijo.2013.1937. Epub 2013 May 13.
1290 miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.Mol Carcinog. 2016 May;55(5):575-85. doi: 10.1002/mc.22304. Epub 2015 Mar 12.
1291 Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.Cancer Res. 2019 Oct 15;79(20):5218-5232. doi: 10.1158/0008-5472.CAN-19-0198. Epub 2019 Sep 5.
1292 Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells.Oncotarget. 2017 May 20;8(57):96697-96709. doi: 10.18632/oncotarget.18043. eCollection 2017 Nov 14.
1293 Actin-capping protein CapG is associated with prognosis, proliferation and metastasis in human glioma.Oncol Rep. 2018 Mar;39(3):1011-1022. doi: 10.3892/or.2018.6225. Epub 2018 Jan 22.
1294 Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.Proteomics. 2019 Jan;19(1-2):e1800157. doi: 10.1002/pmic.201800157.
1295 5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.Cell Rep. 2014 Oct 9;9(1):48-60. doi: 10.1016/j.celrep.2014.08.071. Epub 2014 Oct 2.
1296 A schizophrenia associated CMYA5 allele displays differential binding with desmin.J Psychiatr Res. 2019 Apr;111:8-15. doi: 10.1016/j.jpsychires.2019.01.007. Epub 2019 Jan 10.
1297 Knockdown of CREB3 activates endoplasmic reticulum stress and induces apoptosis in glioblastoma.Aging (Albany NY). 2019 Oct 13;11(19):8156-8168. doi: 10.18632/aging.102310. Epub 2019 Oct 13.
1298 The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition.Cell Signal. 2019 Feb;54:170-178. doi: 10.1016/j.cellsig.2018.12.005. Epub 2018 Dec 12.
1299 Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.Oncogene. 2019 Apr;38(15):2706-2721. doi: 10.1038/s41388-018-0596-2. Epub 2018 Dec 12.
1300 The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.Oncogene. 2019 Nov;38(47):7234-7248. doi: 10.1038/s41388-019-0922-3. Epub 2019 Sep 2.
1301 Transcription factor C/EBP- mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells.FEBS J. 2014 Mar;281(6):1629-41. doi: 10.1111/febs.12728. Epub 2014 Feb 17.
1302 Aberrant expression of Notch1, HES1, and DTX1 genes in glioblastoma formalin-fixed paraffin-embedded tissues.Tumour Biol. 2016 May;37(5):6935-42. doi: 10.1007/s13277-015-4592-7. Epub 2015 Dec 11.
1303 Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.Oncogene. 2009 Feb 5;28(5):752-61. doi: 10.1038/onc.2008.431. Epub 2008 Dec 1.
1304 Genome-Wide CRISPR-Cas9 Screening Identifies NF-B/E2F6 Responsible for EGFRvIII-Associated Temozolomide Resistance in Glioblastoma.Adv Sci (Weinh). 2019 Jul 24;6(17):1900782. doi: 10.1002/advs.201900782. eCollection 2019 Sep 4.
1305 Eukaryotic initiation factor 5B (eIF5B) provides a critical cell survival switch to glioblastoma cells via regulation of apoptosis.Cell Death Dis. 2019 Jan 22;10(2):57. doi: 10.1038/s41419-018-1283-5.
1306 ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.Neuro Oncol. 2011 Nov;13(11):1202-12. doi: 10.1093/neuonc/nor119. Epub 2011 Aug 16.
1307 Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.Neoplasia. 2019 Jan;21(1):106-116. doi: 10.1016/j.neo.2018.11.005. Epub 2018 Dec 5.
1308 MiR-9-5p Inhibits Glioblastoma Cells Proliferation Through Directly Targeting FOXP2 (Forkhead Box P2).Front Oncol. 2019 Nov 19;9:1176. doi: 10.3389/fonc.2019.01176. eCollection 2019.
1309 A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.Nat Commun. 2016 Oct 4;7:12885. doi: 10.1038/ncomms12885.
1310 Induced expression of GINS complex is an essential step for reactivation of quiescent stem-like tumor cells within the peri-necrotic niche in human glioblastoma.J Cancer Res Clin Oncol. 2019 Feb;145(2):363-371. doi: 10.1007/s00432-018-2797-z. Epub 2018 Nov 21.
1311 -Elemene inhibits proliferation through crosstalk between glia maturation factor and extracellular signalregulated kinase1/2 and impairs drug resistance to temozolomide in glioblastoma cells.Mol Med Rep. 2014 Aug;10(2):1122-8. doi: 10.3892/mmr.2014.2273. Epub 2014 May 27.
1312 Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.Genome Biol. 2015 Jan 27;16(1):16. doi: 10.1186/s13059-015-0583-7.
1313 Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.J Drug Target. 2019 Jan;27(1):60-66. doi: 10.1080/1061186X.2018.1473408. Epub 2018 Aug 6.
1314 Overexpression of immediate early gene X-1 (IEX-1) enhances gamma-radiation-induced apoptosis of human glioma cell line, U87-MG.Neuropathology. 2009 Feb;29(1):20-4. doi: 10.1111/j.1440-1789.2008.00932.x. Epub 2008 Jun 17.
1315 The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing.Cell Rep. 2016 May 24;15(8):1634-47. doi: 10.1016/j.celrep.2016.04.086. Epub 2016 May 12.
1316 MiR-148a inhibits the proliferation and migration of glioblastoma by targeting ITGA9.Hum Cell. 2019 Oct;32(4):548-556. doi: 10.1007/s13577-019-00279-9. Epub 2019 Sep 5.
1317 NETRIN-4 protects glioblastoma cells FROM temozolomide induced senescence.PLoS One. 2013 Nov 12;8(11):e80363. doi: 10.1371/journal.pone.0080363. eCollection 2013.
1318 KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.J Exp Clin Cancer Res. 2018 Aug 16;37(1):194. doi: 10.1186/s13046-018-0861-9.
1319 Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status.Neuroscience. 2015 Jun 25;297:243-51. doi: 10.1016/j.neuroscience.2015.04.005. Epub 2015 Apr 11.
1320 Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells.Oncotarget. 2017 Dec 4;8(68):112942-112958. doi: 10.18632/oncotarget.22896. eCollection 2017 Dec 22.
1321 MiR-18a regulates the proliferation, migration and invasion of human glioblastoma cell by targeting neogenin.Exp Cell Res. 2014 May 15;324(1):54-64. doi: 10.1016/j.yexcr.2014.03.009. Epub 2014 Mar 21.
1322 CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.Neuro Oncol. 2019 Oct 9;21(10):1284-1296. doi: 10.1093/neuonc/noz128.
1323 Carnosine influences transcription via epigenetic regulation as demonstrated by enhanced histone acetylation of the pyruvate dehydrogenase kinase 4 promoter in glioblastoma cells.Amino Acids. 2019 Jan;51(1):61-71. doi: 10.1007/s00726-018-2619-2. Epub 2018 Jul 20.
1324 PTEN Suppresses Glycolysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1.Mol Cell. 2019 Nov 7;76(3):516-527.e7. doi: 10.1016/j.molcel.2019.08.006. Epub 2019 Sep 3.
1325 Reduced Expression of PROX1 Transitions Glioblastoma Cells into a Mesenchymal Gene Expression Subtype.Cancer Res. 2018 Oct 15;78(20):5901-5916. doi: 10.1158/0008-5472.CAN-18-0320. Epub 2018 Aug 22.
1326 Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.Acta Neuropathol Commun. 2016 Sep 1;4(1):96. doi: 10.1186/s40478-016-0372-x.
1327 Parallel comparison of pre-conditioning and post-conditioning effects in human cancers and keratinocytes upon acute gamma irradiation.Int J Radiat Biol. 2019 Feb;95(2):170-178. doi: 10.1080/09553002.2019.1547850. Epub 2019 Jan 4.
1328 Retinoic Acid-Induced Protein 14 (RAI14) Promotes mTOR-Mediated Inflammation Under Inflammatory Stress and Chemical Hypoxia in a U87 Glioblastoma Cell Line.Cell Mol Neurobiol. 2019 Mar;39(2):241-254. doi: 10.1007/s10571-018-0644-z. Epub 2018 Dec 15.
1329 miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.Oncol Rep. 2014 Sep;32(3):957-64. doi: 10.3892/or.2014.3318. Epub 2014 Jul 10.
1330 RECQ1 Helicase Silencing Decreases the Tumour Growth Rate of U87 Glioblastoma Cell Xenografts in Zebrafish Embryos.Genes (Basel). 2017 Sep 6;8(9):222. doi: 10.3390/genes8090222.
1331 Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.Clin Cancer Res. 2009 Mar 1;15(5):1527-33. doi: 10.1158/1078-0432.CCR-08-2459. Epub 2009 Feb 17.
1332 Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.Neuro Oncol. 2014 Aug;16(8):1078-85. doi: 10.1093/neuonc/nou010. Epub 2014 Feb 12.
1333 A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study).Jpn J Clin Oncol. 2019 Dec 27;49(12):1172-1175. doi: 10.1093/jjco/hyz169.
1334 Down-regulation of ribosomal protein S15A inhibits proliferation of human glioblastoma cells in vivo and in vitro via AKT pathway.Tumour Biol. 2016 Apr;37(4):4979-90. doi: 10.1007/s13277-015-4323-0. Epub 2015 Nov 4.
1335 Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology.Stem Cell Res. 2019 Dec;41:101638. doi: 10.1016/j.scr.2019.101638. Epub 2019 Oct 26.
1336 SERPINA3 induced by astroglia/microglia co-culture facilitates glioblastoma stem-like cell invasion.Oncol Lett. 2018 Jan;15(1):285-291. doi: 10.3892/ol.2017.7275. Epub 2017 Oct 26.
1337 Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.J Cell Mol Med. 2017 Nov;21(11):2685-2694. doi: 10.1111/jcmm.13184. Epub 2017 May 4.
1338 Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.J Neurooncol. 2014 Nov;120(2):245-56. doi: 10.1007/s11060-014-1551-x. Epub 2014 Jul 26.
1339 Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells.J Extracell Vesicles. 2019 Aug 9;8(1):1648995. doi: 10.1080/20013078.2019.1648995. eCollection 2019.
1340 Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells.Cell Biol Int. 2019 Jan;43(1):2-11. doi: 10.1002/cbin.11037.
1341 Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest.J Exp Clin Cancer Res. 2013 Apr 11;32(1):20. doi: 10.1186/1756-9966-32-20.
1342 SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.Nat Commun. 2014 Jun 23;5:4234. doi: 10.1038/ncomms5234.
1343 Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells.Cancer Res. 2008 Jun 15;68(12):4614-22. doi: 10.1158/0008-5472.CAN-07-5291.
1344 TIPE3 is a regulator of cell apoptosis in glioblastoma.Cancer Lett. 2019 Apr 1;446:1-14. doi: 10.1016/j.canlet.2018.12.019. Epub 2019 Jan 11.
1345 The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells.J Neurooncol. 2018 May;137(3):481-492. doi: 10.1007/s11060-018-2755-2. Epub 2018 Feb 2.
1346 Loss of tumor suppressive microRNA-31 enhances TRADD/NF-B signaling in glioblastoma.Oncotarget. 2015 Jul 10;6(19):17805-16. doi: 10.18632/oncotarget.4596.
1347 Overexpression of Tripartite Motif-Containing 48 (TRIM48) Inhibits Growth of Human Glioblastoma Cells by Suppressing Extracellular Signal Regulated Kinase 1/2 (ERK1/2) Pathway.Med Sci Monit. 2019 Nov 8;25:8422-8429. doi: 10.12659/MSM.916024.